Nothing Special   »   [go: up one dir, main page]

US20180039753A1 - Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures - Google Patents

Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures Download PDF

Info

Publication number
US20180039753A1
US20180039753A1 US15/786,001 US201715786001A US2018039753A1 US 20180039753 A1 US20180039753 A1 US 20180039753A1 US 201715786001 A US201715786001 A US 201715786001A US 2018039753 A1 US2018039753 A1 US 2018039753A1
Authority
US
United States
Prior art keywords
antennas
interrogation
therapeutic
signals
monitoring equipment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/786,001
Inventor
William A. Blair
Bruce E. Barnes
David A. Poirier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien LP
RF Surgical Systems LLC
Original Assignee
Covidien LP
RF Surgical Systems LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Covidien LP, RF Surgical Systems LLC filed Critical Covidien LP
Priority to US15/786,001 priority Critical patent/US20180039753A1/en
Assigned to RF SURGICAL SYSTEMS, INC. reassignment RF SURGICAL SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BARNES, BRUCE E., BLAIR, WILLIAM A., POIRIER, DAVID A.
Assigned to RF SURGICAL SYSTEMS LLC reassignment RF SURGICAL SYSTEMS LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RF Surgical Systems, Inc
Assigned to RF SURGICAL SYSTEMS LLC reassignment RF SURGICAL SYSTEMS LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: RF Surgical Systems, Inc
Publication of US20180039753A1 publication Critical patent/US20180039753A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • G06F19/3418
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0006ECG or EEG signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/03Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs
    • A61B5/031Intracranial pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/70Means for positioning the patient in relation to the detecting, measuring or recording means
    • A61B5/704Tables
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/90Identification means for patients or instruments, e.g. tags
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/90Identification means for patients or instruments, e.g. tags
    • A61B90/94Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/90Identification means for patients or instruments, e.g. tags
    • A61B90/94Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text
    • A61B90/96Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text using barcodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/90Identification means for patients or instruments, e.g. tags
    • A61B90/98Identification means for patients or instruments, e.g. tags using electromagnetic means, e.g. transponders
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00212Electrical control of surgical instruments using remote controls
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00221Electrical control of surgical instruments with wireless transmission of data, e.g. by infrared radiation or radiowaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0266Operational features for monitoring or limiting apparatus function
    • A61B2560/0271Operational features for monitoring or limiting apparatus function using a remote monitoring unit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0247Pressure sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0261Strain gauges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04Arrangements of multiple sensors of the same type
    • A61B2562/046Arrangements of multiple sensors of the same type in a matrix array
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/16Details of sensor housings or probes; Details of structural supports for sensors
    • A61B2562/17Comprising radiolucent components

Definitions

  • the present disclosure generally relates to a wireless medical procedure environment, and more particularly detection of transponder tagged objects and communications with various pieces of medical equipment in an environment in which medical procedures are performed.
  • objects associated with a medical procedure may take a variety of forms used in medical procedures.
  • the objects may take the form of instruments, for instance scalpels, scissors, forceps, hemostats, and/or clamps.
  • the objects may take the form of related accessories and/or disposable objects, for instance surgical sponges, gauzes, and/or absorbent pads.
  • Some hospitals have instituted procedures which include checklists or requiring multiple counts to be performed to track the use and return of objects during surgery. Such a manual approach is inefficient, requiring the time of highly trained personnel, and is prone to error.
  • Another approach employs transponders and a wireless interrogation and detection system.
  • the interrogation and detection system includes a transmitter that emits pulsed wideband wireless signals (e.g., radio or microwave frequency) and a detector for detecting wireless signals returned by the transponders in response to the emitted pulsed wideband signals.
  • pulsed wideband wireless signals e.g., radio or microwave frequency
  • detector for detecting wireless signals returned by the transponders in response to the emitted pulsed wideband signals e.g., radio or microwave frequency
  • Such an automated system may advantageously increase accuracy while reducing the amount of time required of highly trained and highly compensated personnel. Examples of such an approach are discussed in U.S. Pat. No. 6,026,818, issued Feb. 22, 2000, and U.S. Patent Publication No. US 2004/0250819, published Dec. 16, 2004.
  • a system for use in a medical facility may be summarized as including a number of antennas and a controller communicatively coupled to the antennas and configured to selectively cause at least one of the antennas to emit an interrogation signal and to detect a response signal, if any, from a number of transponders physically coupled to a number of objects used in medical procedures, wherein the controller is further configured to provide wireless communications of at least one of data or instructions with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to emit the interrogation signal or receive the response signal.
  • At least a plurality of the number of antennas may be carried by a patient support structure that carries a patient during a medical procedure. At least one of the number of antennas may be a handheld antenna that inductively cooperates with the plurality of antennas carried by the patient support structure. At least one of the number of antennas may be a handheld antenna, and one of the handheld antenna or the plurality of antennas carried by the patient support structure may transmit an interrogation signal and the other one of the handheld antenna or the plurality of antennas carried by the patient support surface may receive response signals, if any, to the interrogation signal.
  • the number of antennas may include at least three loop antennas spaced along a longitudinal axis of the patient support structure, and the patient support surface may be one of an operating table, a bed, a mattress, or a sheet. At least a plurality of the number of antennas may be carried by a drape that at least partially surrounds a patient support structure that carries a patient during a medical procedure. At least a plurality of the number of antennas may be carried by a shade that extends from a light fixture positioned relatively above a patient support structure that carries a patient during a medical procedure.
  • the controller may be configured to receive data signals from the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the data signals representing physiological characteristics of the patient measured by the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the controller may be configured to receive data signals from the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the data signals representing operational characteristics of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the controller may be configured to transmit control signals to the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the control signals representing operational instructions to control operation of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the controller may be communicatively coupled to a display and may be operable to display information related to at least one of the patient or the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the controller may be communicatively coupled to a user input device and may be operable to receive user input entered via the user input device and to transmit control signals based on the received user input to the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the control signals representing operational instructions to control operation of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the controller may be configured to receive data signals from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment and to transmit the data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may be a transducer coupled to the patient and a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may be a dedicated control system for the transducer.
  • the first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may be one of an electrocardiogram electrode, a pulse oximetry transducer and the second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may be a dedicated electrocardiogram processing system or a pulse oximetry processing system.
  • At least one of the antennas may be responsive to a force exerted thereon and the controller may be configured to receive a signal indicative of the force exerted on the antenna and to produce a notification if the force exceeds at least one of an amplitude threshold or a time duration.
  • a method of operating a system in a medical facility including a plurality of antennas and a controller communicatively coupled to the antennas may be summarized as including from time-to-time, transmitting a number of wideband interrogation signals from at least one of the antennas; determining whether a response to the interrogation signals was received via at least one of the antennas from a transponder that marks an object used in a medical procedure; from time-to-time, providing communications with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to emit the interrogation signal or receive the response signal.
  • Providing communications with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the antennas may include receiving data signals from the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the data signals representing physiological characteristics of the patient measured by the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • Providing communications with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the antennas may include receiving data signals from the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the data signals representing operational characteristics of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • Providing communications with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the antennas may include transmitting control signals to the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the control signals representing operational instructions to control operation of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the method may further include transmitting information by the controller to a display to display information related to at least one of the patient or the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the method may further include receiving by the controller user input entered by a user via a user input device; and transmitting control signals by the controller based on the received user input to the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the control signals representing operational instructions to control operation of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the method may further include receiving data signals by the controller via at least one of the antennas from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment; and transmitting the received data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • Receiving data signals by the controller via at least one of the antennas from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may include receiving data signals from a transducer coupled to the patient and transmitting the received data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may include transmitting the data signals to a dedicated control system for the transducer.
  • Receiving data signals by the controller via at least one of the antennas from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may include receiving data signals from one of an electrocardiogram electrode, a pulse oximetry transducer and transmitting the received data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may include transmitting the data signals to one of a dedicated electrocardiogram processing system or a pulse oximetry processing system.
  • At least one of the antennas may be responsive to a force exerted thereon and may further include receiving signals by the controller indicative of the force exerted on the antenna; and may produce a notification if the force exceeds at least one of an amplitude threshold or a time duration.
  • a physiological condition monitor may be summarized as including a transducer coupleable to a patient to sense a physiological condition of the patient; an antenna physically coupled to the transducer; and a transmitter communicatively coupled to the transducer and to the antenna and configured to transmit signals indicative of the sensed physiological condition of the patient via the antenna to a plurality of antennas remote from the device.
  • the antennas may be positioned proximate a patient support surface.
  • the physiological condition monitor may further include an energy storage device electrically coupled to provide power to the transmitter.
  • the physiological condition monitor may further include a circuit configured to transform electromagnetic energy into electrical power, and coupled to supply the electrical power to the transmitter.
  • the physiological condition monitor may further include a circuit that encodes an identifier that uniquely identifiers the physiological condition monitor from other physiological condition monitors.
  • the physiological condition monitor may have a portion that bears an optical marking. The optical marking may encode an identifier which may uniquely identify the physiological condition monitor.
  • a system for use in a medical facility may be summarized as including a number of antennas, at least some of the antennas responsive to a force asserted thereon; and a controller communicatively coupled to the antennas and configured to selectively cause at least one of the antennas to emit an interrogation signal and to detect a response signal, if any, from a number of transponders physically coupled to a number of objects used in medical procedures, wherein the controller is further configured to receive signals from at least some of the antennas indicative of the force asserted on the antenna.
  • the controller may be configured to produce a notification if the force exerted on at least one of the antennas exceeds at least one of an amplitude threshold or a time duration threshold.
  • the controller may be configured to produce a notification if the force exerted on at least one of the antennas exceeds an amplitude threshold over a period of time that exceeds a time duration threshold.
  • the controller may be configured to produce a notification indicative of a position or location on the patient support structure or patient where an excessive force is being exerted.
  • the controller may be configured to transmit a notification via at least one of the antennas in response to the force asserted on at least one of the antennas exceeding a defined threshold.
  • a method of operating a system in a medical facility including a plurality of antennas and a controller communicatively coupled to the antennas, at least some of the antennas responsive to a force asserted thereon, may be summarized as including from time-to-time, transmitting a wideband interrogation signals from at least one of the antennas; determining whether a response to the interrogation signal was received via at least one of the antennas from a transponder that marks an object used in medical procedures; from time-to-time, receiving signals from at least some of the antennas indicative of the force asserted on the antenna.
  • the method may further include producing a notification by the controller which may be configured to produce a notification if the force exerted on at least one of the antenna exceeds at least one of an amplitude threshold or a time duration threshold.
  • the method may further include producing a notification by the controller if the force exerted on at least one of the antenna exceeds an amplitude threshold over a period of time that exceeds a time duration threshold.
  • the method may further include producing a notification by the controller indicative of a position or location on the patient support structure or patient where an excessive force is being exerted.
  • the method may include transmitting a notification via at least one of the antennas in response to the force asserted on at least one of the antennas exceeding a defined threshold.
  • FIG. 1 is a schematic diagram showing an environment in which a medical procedure is performed, for example a surgical environment including a table, bed or other structure to carry or support at least a portion of a patient, that includes a plurality of antennas, and a controller communicatively coupled to the antennas an interrogation and detection system to detect an object tagged with a transponder in a patient, according to one illustrated embodiment.
  • a surgical environment including a table, bed or other structure to carry or support at least a portion of a patient, that includes a plurality of antennas, and a controller communicatively coupled to the antennas an interrogation and detection system to detect an object tagged with a transponder in a patient, according to one illustrated embodiment.
  • FIG. 2 a top plan view of the table, bed or other structure of FIG. 1 showing the plurality of antennas, according to one illustrated embodiment.
  • FIG. 3 is a top plan view of the table, bed or other structure of FIG. 1 showing approximate ranges of each of the antennas of FIG. 2 .
  • FIG. 4 is a top plan view of a patient support structure showing a number of antennas on a patient support surface and a number of antennas on an opposed surface, according to another illustrated embodiment.
  • FIG. 5A is a side elevational view of the patient support structure of FIG. 4 .
  • FIG. 5B is a cross-sectional view of the patient support structure of FIG. 4 taken along section line 6 of FIG. 4 .
  • FIG. 6A is a top plan view of a support structure showing a number of antennas on a patient support surface and a number of antennas on an opposed surface, according to yet another illustrated embodiment.
  • FIG. 6B is a cross-sectional view of the patient support structure of FIG. 6A taken along section line 7 of FIG. 6A .
  • FIG. 6C is a partial isometric view of the patient support structure of FIGS. 6A and 6B , enlarged to illustrated electrically conductive paths or traces of the antennas.
  • FIG. 7 is a cross-sectional view of a patient support structure having recesses in which the antennas are received, according to another illustrated embodiment.
  • FIG. 8A is a top plan view of a patient support structure in the form of a bed or an operating table showing a number of antennas arranged in a non-overlapping relationship, according to another illustrated embodiment.
  • FIG. 8B is a top plan view of a patient support structure in the form of a mattress or pad showing a number of antennas arranged in a non-overlapping relationship, according to another illustrated embodiment.
  • FIG. 8C is a top plan view of a patient support structure in the form of a sheet showing a number of antennas arranged in a non-overlapping relationship, according to another illustrated embodiment.
  • FIG. 9 is an enlarged top plan view of an antenna according to one illustrated embodiment, where the antenna is formed from multiple coils of a conductive material that is radiolucent.
  • FIG. 10A is an enlarged top plan view of an antenna according to one illustrated embodiment, wherein the antenna is formed of a top coil of conductive material and a bottom coil of conductive material.
  • FIG. 10B is an enlarged top plan view of the top coil of the antenna FIG. 10A .
  • FIG. 10C is an enlarged top plan view of the bottom coil of the antenna FIG. 10A .
  • FIG. 10D is a cross-sectional view of a portion of a patient support structure carrying the top and bottom coils of the antenna of FIG. 10A according to one illustrated embodiment.
  • FIG. 10E is a cross-sectional view of a patient support structure with a plurality of antennas according to another illustrated embodiment.
  • FIG. 10F is a top plan view of a patient support structure comprising a plurality of antennas according to still another illustrated embodiment.
  • FIG. 11 is a cross-sectional view of a portion of a patient support structure with an antenna carried in opposed surfaces thereof, according to yet still another illustrated embodiment.
  • FIG. 12 is a cross-sectional view of a portion of a patient support structure an antenna of FIG. 10A carried on opposed surfaced thereof, according to even another illustrated embodiment.
  • FIG. 13A is a schematic diagram showing a surgical table with a plurality of antennas and a controller positioned in a pedestal of the surgical table, according to another illustrated embodiment.
  • FIG. 13B is a schematic diagram showing a bed such as a patient bed used in an environment where medical procedures are preformed, the bed including a plurality of antennas and a controller positioned on a frame of the bed, according to another illustrated embodiment.
  • FIG. 14A is a side elevational view of an overhead light fixture for use in a medical procedure and a light shade with several antennas supported by the light fixture, according to one embodiment in which the light shade is shown in a retracted position or configuration of FIG. 10A .
  • FIG. 14B is a side elevational view of the light fixture and a light shade in which the light shade is shown in an extended position or configuration.
  • FIG. 14C is a side elevational view of a light fixture for use in a medical procedure and a light shade with several antennas according to another illustrated embodiment.
  • FIG. 15A is an isometric view of a track and a curtain or drape containing several antennas, according to one illustrated embodiment.
  • FIG. 15B is a side elevational view of a sheet containing several antennas and configured to be hung from a support according to one embodiment.
  • FIG. 16 is a schematic diagram of a controller, according to one illustrated embodiment, including a motherboard and a plurality of plug-in boards, one for each of the antennas.
  • FIG. 17 is a schematic diagram of a portion of a control system of the interrogation and detection system, according to one illustrated embodiment.
  • FIG. 18 is a schematic diagram of a software configuration of the interrogation and detection system, according to one illustrated embodiment.
  • FIGS. 19A-19I are an electrical schematic diagram of the interrogation and detection system including a control circuit and antenna, according to one illustrated embodiment.
  • FIG. 20 is a timing diagram illustrating a method of frequency hopping, according to one illustrated embodiment.
  • FIG. 21A is a timing diagram illustrating pulsed timing, according to one illustrated embodiment.
  • FIG. 21B is a timing diagram illustrating pulsed timing, according to another illustrated embodiment.
  • FIG. 22 is a timing diagram showing activation of a pair of transistors of the control circuit in a push-pull configuration to drive the antenna, according to one illustrated embodiment.
  • FIG. 23A is a flow diagram of a method of operating an interrogation and detection system, according to one illustrated embodiment.
  • FIG. 23B is a flow diagram of a method of monitoring all antennas for a response to an interrogation signal, according to one illustrated embodiment.
  • FIG. 23C is a flow diagram of a method of monitoring all antennas except a transmitting antenna for a response to an interrogation signal, according to one illustrated embodiment.
  • FIG. 24A is a high level flow diagram of a method of operating an interrogation and detection system to detect transponders, according to one illustrated embodiment.
  • FIG. 24B is a low level flow diagram of a method of operating an interrogation and detection system to sample noise and responses and to adjust sampling times and perform noise correction, according to one illustrated embodiment, the method useful with the method of FIG. 24A .
  • FIG. 24C is a flow diagram of a method of operating an interrogation and detection system to determine whether a transponder has been detected, according to one illustrated embodiment, the method useful with the method of FIG. 24A .
  • FIGS. 25A-25F are flow diagrams of methods of operating an interrogation and detection system by measuring and/or compensating for noise, according to various illustrated embodiments, the methods useful with the method of FIG. 24A .
  • FIG. 26A is a graph showing a measured or sampled response versus time without noise cancellation where a noise source is present but no transponder is present, according to one illustrated embodiment.
  • FIG. 26B is a graph showing a measured or sampled response versus time with noise cancellation where a noise source is present but not transponder is present, according to one illustrated embodiment.
  • FIG. 26C is a graph showing a measured or sampled response versus frequency without noise cancellation where a noise source is present but no transponder is present, according to one illustrated embodiment.
  • FIG. 26D is a graph showing a measured or sampled response versus frequency with noise cancellation where a noise source is present but not transponder is present, according to one illustrated embodiment.
  • FIG. 27A is a graph showing a measured or sampled response versus time without noise cancellation where a noise source and a transponder are present, according to one illustrated embodiment.
  • FIG. 27B is a graph showing a measured or sampled response versus time with noise cancellation where a noise source and a transponder are present, according to one illustrated embodiment.
  • FIG. 27C is a graph showing a measured or sampled response versus frequency without noise cancellation where a noise source and a transponder are present, according to one illustrated embodiment.
  • FIG. 27D is a graph showing a measured or sampled response versus frequency with noise cancellation where a noise source and a transponder are present, according to one illustrated embodiment.
  • FIG. 28 is an isometric view of a surgical environment including an operating table that carries a plurality of antennas, a hand held wand antenna, and a controller according to one illustrated embodiment.
  • FIG. 29 is an isometric view of a surgical environment including a patient support structure in the form of a surgical table that includes a plurality of antennas, and a controller communicatively coupled to the antennas and to a display screen and user input.
  • FIG. 30A is a top plan view of a wireless electrode, according to one illustrated embodiment.
  • FIG. 30B is top plan view of a plurality of wireless electrode attached to a patient on a patient support structure.
  • FIG. 30C is a top plan view of two wireless electrodes connected by one wire.
  • FIG. 31 is a top plan view of a plurality of leads attached to a patient, each lead extending to an intermediary relay which wirelessly communicates with at least one antenna of an interrogation and detection system.
  • FIG. 32 is a side elevational view of a wireless pulse oximeter attached to the finger of a patient
  • FIG. 33 is a side elevational view of a wireless intra-cranial pressure monitor attached to a patient's head.
  • FIG. 34 is a side elevational view of an infusion pump with a radio attached thereto.
  • FIG. 35 is a side elevation view of an intra-aortal balloon pump with a radio attached thereto.
  • FIG. 36 is a schematic diagram of a controller, according to one illustrated embodiment, including a motherboard and a plurality of plug-in boards, one for each of the antennas, as well as additional plug-in boards to enable communication with medical telemetry devices.
  • antennas e.g., six antennas. Successive ones of the antennas may be used to transmit an interrogation signal, while two or more antennas are monitored for a response to the interrogation signal.
  • Such may provide significant advantages over more conventional methods, for example motion based methods that employ motion (e.g., sweeping) of an antenna (e.g., wand) over a patient. For instance, this allows the transmit and receive paths to the transponder to be different from one another (e.g., transmit path is from a first antenna to a transponder, while the receive path is from the transponder to a second antenna).
  • the path length to the transponder may be shortened in many configurations, thus improving the signal. For instance, when using a single antenna to both transmit an interrogation signal and to receive a response to the interrogation signal, the power of the received signal is equal to about the 6 th root of the input power. However, when using multiple antennas to transmit and receive over the same area, interrogation path length in one direction may be shorter. Another advantage is that all scan time is averaged, allowing a longer noise time averaging (e.g., 10 seconds) as opposed to motion based scanning, where integration time may be limited (e.g., about 0.25 seconds per sample).
  • a representative value of noise samples measured over a plurality of antennas may be employed to determine noise to be removed from noise plus signals received at one of the antennas, thereby advantageously lowering a noise floor and/or increasing range or performance.
  • the various disclosed embodiments may provide significantly better performance.
  • FIGS. 1 and 2 show a medical procedure environment 10 in which medical procedures are performed, for example a surgical environment in which surgeries are performed, a patient room in which child birth deliveries or other medical procedures are performed or a physician's office, etc.
  • the medical procedure environment 10 includes a table (e.g., surgical table), bed, or other structure 12 which can carry a patient or portion thereof and an interrogation and detection system 14 .
  • the interrogation and detection system 14 includes a plurality of antennas 16 a - 16 f (collectively 16 , shown in broken line in FIG. 1 to indicate that such are hidden in that view) which are carried by the patient support surface 12 .
  • the interrogation and detection system 14 also includes a controller 18 communicatively coupleable to the antennas 16 by one or more wired or wireless communication paths, for example coaxial cable 20 . As discussed in detail below, the interrogation and detection system 14 is operable to ascertain the presence or absence of objects 22 a, 22 b (collectively 22 ) tagged with transponders 24 a, 24 b (collectively 24 ), which may be in or on a patient (not shown).
  • the table, bed or other structure 12 may include a patient support structure 26 and a pedestal or base 28 which supports the patient support structure 26 .
  • the patient support structure 26 should have dimensions sufficient to support at least a portion of a patient during a medical procedure, for instance during surgery, child birth, etc. Hence, the patient support structure 26 may have a length of six feet or more and a width of two feet or more.
  • the patient support structure 26 may have two or more articulated sections 26 a - 26 c, as illustrated in FIG. 1 or 2 , or may be an unarticulated or unitary structure as illustrated in FIGS. 4, 7 and 9 .
  • Hinges 30 a, 30 b (collectively 30 ) or other coupling structures may couple the articulated sections 26 a - 26 c.
  • the hinges 30 may, for example, be located along a longitudinal axis 32 of the patient support structure 26 at locations that would approximate the anticipated position of a between a patient's legs and torso and between the patient's torso and head.
  • the patient support structure 26 is preferably made of a rigid material and is preferably radiolucent.
  • Various radiolucent materials may be employed, for instance carbon fiber or radiolucent plastics.
  • the patient support structure 26 may be molded from plastics such as an acrylic or a phenolic resin (e.g., commercially available under the trademark SPAULDITE®).
  • the patient support structure 26 may include a frame.
  • the frame may be made of a metal which may not be radiolucent. In such embodiments, the frame preferably makes up a small percentage of the total area of the patient support structure 26 .
  • the patient support structure 26 may be capable of withstanding multiple cycles of sterilization (e.g., chemical, heat, radiation, etc.).
  • sterilization e.g., chemical, heat, radiation, etc.
  • a large variety of surgical tables, patient beds and other structures capable of carrying a patient or a portion of a patient are commercially available. Many of these commercially available structures include electric motors and electronics. Typically, there is no or minimum regulation of non-ionizing electromagnetic radiation generated by such electric motors and electronics. Hence, many environments 10 in which medical procedures are performed tend to be electromagnetically noisy environments.
  • the table, bed or other structure 12 may include one or more mattresses or pads 34 a - 34 c (collectively 34 ), and/or may include one or more sheets (not shown in FIG. 1 for sake of clarity of illustration).
  • the mattresses or pads 34 and/or sheets may overlie the antennas 16 .
  • the mattresses or pads 34 may take a variety of forms, and may be disposable, or may be capable of withstanding multiple cycles of sterilization (e.g., chemical, heat, radiation, etc.).
  • the mattresses or pads 34 are preferably radiolucent.
  • the mattresses or pads 34 may take a conventional form, for example cotton, open cell or a closed cell foam rubber, with or without an appropriate cover.
  • the mattresses or pads 34 may include one or more bladders (e.g., dual layer urethane envelope) to receive a fluid (e.g., air, water, etc.) to selectively inflate one or more portions of the mattresses or pads 34 , and/or to control a temperature of one or more portions of the mattresses or pads 34 .
  • the fluid should be radiolucent.
  • the mattresses or pads 34 may be detachably secured to the patient support structure 26 via various fasteners, for instance ties, or hook and loop fastener commonly available under the trademark VELCRO®.
  • the pedestal or base 28 may be fixed, or may be moveable.
  • the pedestal or base 28 may include one or more actuators (e.g., motors, pumps, hydraulics, etc.) and/or drive mechanisms (e.g., gears, mechanical couplings) or linkages (not shown) that allow a position and/or orientation of the patient support structure 26 to be adjusted.
  • the pedestal or base 28 may telescope to allow the patient support structure 26 to be mechanically raised and lowered.
  • the pedestal or base 28 may allow the patient support structure 26 to be mechanically tilted or rotated about an axis that is perpendicular to a patient support surface 37 of the patient support structure 26 .
  • portions of one or more of the antennas 16 may overlap.
  • the antennas are coil antennas, each formed of one or more coils
  • a portion of an area enclosed by an outermost coil of each antenna 16 may overlap a portion of an area enclosed by an outermost coil of a neighboring antenna 16 .
  • the area enclosed or enclosed area may be an area enclosed by a normal or perpendicular projection of a perimeter defined the outermost coil of the respective antenna 16 .
  • neighboring antennas 16 may be electrically insulated from one another by one or more electrically insulating layers or substrates.
  • successively adjacent antennas 16 may be carried one opposite surfaces (e.g., opposed outer surfaces, or multiple inner surfaces, or one or more outer and inner surfaces) of a single substrate.
  • the antennas may advantageously be radiolucent, for example being formed of a radiolucent material (e.g., substantially transparent to X-ray or Gamma ray radiation) or a material that at a thickness employed is substantially radiolucent.
  • a radiolucent material e.g., substantially transparent to X-ray or Gamma ray radiation
  • a material that at a thickness employed is substantially radiolucent.
  • an electrically conductive trace of aluminum having a thickness of 200 microns or less sufficiently passes X-rays to be considered radiolucent. More preferably, an aluminum trace having a thickness of 30 microns sufficiently passes X-rays such that even a stack or overlapping portions of three coils (combined thickness under 100 microns) to be radiolucent.
  • An antenna may be considered radiolucent if it is not detectable by a radiologist in an X-ray produced via 10 kV to 120 kV X-ray machine, or preferably a 40 KV X-ray machine in conjunction with a standard 12 inch X-ray image intensifier.
  • An antenna may be considered radiolucent if a coil includes thirty turns or windings and is not detectable by a radiologist in an X-ray.
  • the patient support structure 26 may include one or more film receiving receptacles 29 (only one called out in FIG. 1 ).
  • the film receiving receptacles 29 may be spaced relatively below a patient support surface 37 of the patient support structure 26 .
  • the film receiving receptacles 29 are sized, dimensioned and/or positioned to receive film, for example X-ray film.
  • the film receiving receptacles 29 my be sized and/or dimensioned to receive a film tray or other film holder (not illustrated) which holds the film.
  • radiolucent materials such advantageously allows a patient X-ray images or other radiological images of the patient to be produced, generated or made, while the patient is supported by the patient support structure 26 .
  • the term radiolucent means substantially transmissive to energy in the X-ray portion of the electromagnetic spectrum, that is passing sufficient X-ray energy to produce an X-ray image at standard power levels and standard conditions employed in conventional medical imaging.
  • the table (e.g., surgical table), bed or other structure 12 may include an interrogation and detection system interface 36 .
  • the interrogation and detection system interface 36 may include one or more communications ports 38 that allow communicative coupling to be selectively or detachably made between the antennas 16 and the controller 18 .
  • Such communications ports 38 may, for example, take the form of coaxial connectors, or other communications connectors.
  • Interrogation and detection system interface 36 may include one or more output devices to provide indications to a user.
  • the interrogation and detection system interface 36 may include one or more visual indicators 40 (only one called out in FIGS. 1 and 2 ) to provide indications of a presence and/or an absence of an object.
  • Such may also provide a visual indication that is indicative of a status of a scanning operation by the interrogation and detection system 14 , for instance scanning started, scanning completed, and/or occurrence of an error condition.
  • the visual indicators 40 may take a variety of forms, for example light sources of one or more colors. Light sources may include incandescent lights, light emitting diodes (LEDs), organic light emitting diodes (OLEDs), and/or liquid crystal displays (LCDs).
  • the interrogation and detection system interface 36 may include one or more aural indicators 42 to provide aural indications of a presence and/or an absence of an object and/or a status of a scan operation or occurrence of an error condition.
  • the aural indicator 42 may, for example, take the form of one or more speakers.
  • the interrogation and detection system interface 36 may include one or more switches 44 that allow input to be provided to the controller 18 . Switches 44 may, for example, allow a user to turn ON the interrogation and detection system 14 , start a scan operation, stop a scan operation, adjust a sensitivity of the scanning, adjust one or more frequencies, select or adjust an output type (e.g., type of visual alert, type of aural alert) or level (e.g., brightness, sound level or volume, etc.).
  • an output type e.g., type of visual alert, type of aural alert
  • level e.g., brightness, sound level or volume, etc.
  • the objects 22 may take a variety of forms, for example instruments, accessories and/or disposable objects useful in performing medical procedures, for example surgical procedures, child birth delivery procedures, and/or other medically related procedures.
  • some objects 16 a may take the form of scalpels, scissors, forceps, hemostats, and/or clamps.
  • some objects 22 b may take the form of sponges (e.g., surgical sponges), gauze and/or padding.
  • the objects 22 are tagged, carrying, attached or otherwise coupled to a respective transponder 24 .
  • Some embodiments of the interrogation and detection system 14 disclosed herein are particularly suited to operate with transponders 26 which are not accurately tuned to a chosen or selected resonant frequency. Consequently, the transponders 24 do not require high manufacturing tolerances or expensive materials, and thus may be inexpensive to manufacture.
  • Transponders 24 may include a miniature ferrite rod with a conductive coil wrapped about an exterior surface thereof to form an inductor (L), and a capacitor (C) coupled to the conductive coil to form a series LC circuit.
  • the conductive coil may, for example, take the form of a spiral wound conductive wire with an electrically insulative sheath or sleeve.
  • the transponder 24 may include an encapsulation that encapsulates the ferrite rod, conductive coil, and capacitor.
  • the encapsulant may be a bio-inert plastic, that protects the ferrite rod, conductive coil and/or capacitor from pressure and/or from fluids, for example bodily fluids.
  • the ferrite rod may include a passage sized to receive a physical coupler, for example a bonding tie or string.
  • the bonding tie or string may take the form of an elastomeric x-ray opaque flexible elongated member, that may be used to attach the transponder 24 to various types of objects 22 , for example surgical sponges.
  • the transponder 24 may have a length of about 8 millimeters and a diameter of about 2 millimeters. Employing such small dimensions ensures that the transponder 24 does not impede deformation of objects 16 such as sponges.
  • the transponder 24 may include an optional diode (not shown), to protect against over-voltage occurrences caused by other electronic instruments.
  • the transponders 24 may be attached to hemostats, scissors, certain forms of forceps, and the like. In some embodiments, the transponders 24 may be coupled to the object 22 by way of a clamp or holder. In some embodiments, the transponders 24 may be retained within a cavity of the holder. In some embodiments, the holder may be fashioned of a durable deformable material, such as surgical grade polymer, which may be deformed to clamp securely onto the finger or thumbhole of an instrument. In other embodiments, the transponders 24 may be attached to objects 22 by way of pouches fashioned of sheet material (e.g., surgical fabric) surrounding the transponder 24 . The transponder 24 is retained within the pouch, and in some embodiments the pouch may be sewn or otherwise sealed.
  • a durable deformable material such as surgical grade polymer
  • the medical provider 12 may use the switches 44 to cause a scan of the patient 18 , for instance jut before closing during surgery, in order to detect the presence or absence of the transponder 26 , and hence an object 16 .
  • FIG. 3 shows approximate ranges R 1 -R 6 for the six antennas 16 of the embodiment of FIGS. 1 and 2 .
  • FIG. 3 is illustrative and does not necessarily represent actual ranges.
  • the illustrated ranges R 1 -R 6 (collectively R) show that the ranges R 1 -R 6 are typically larger than the area of the antennas 16 .
  • Ranges R 1 -R 6 may be affected by a variety of factors, including the power of the interrogation signal, distance between the transponders 24 and the antennas 16 , and/or the sensitivity and/or impedance matching between the transponders 24 and interrogation and detection system 14 .
  • Many of the ranges R 1 -R 5 overlap neighboring ranges R 1 -R 5 , although in this illustrated embodiment one range R 6 does not overlap any other range R 1 -R 5 . In other embodiments, all ranges overlap. Alternatively, none of the ranges may overlap.
  • Other arrangements of antennas 16 and/or ranges R are of course possible.
  • FIGS. 4, 5A and 5B show a patient support structure 626 , according to another illustrated embodiment.
  • the patient support structure 626 may, for example, be part of a table, for instance a surgical table, part of a bed or another structure designed to carry a patient or portion of a patient.
  • the patient support structure 626 is a non-articulated, single piece or unitary structure. While illustrated as a single, unitary construction, the patient support structure 626 may be formed of two or more sections, which may or may not be articulated.
  • the patient support structure 626 is formed as a substrate 650 having a patient support surface 637 and an opposed surface 652 that is opposed from the patient support surface 637 .
  • the substrate 650 may be formed of one or more layers.
  • the substrate 650 may be a composite material.
  • the substrate 650 may, for example, be formed as a resin impregnated carbon fiber structure, which may advantageously omit any metal or ferrous metal structural elements. Alternatively, the substrate 650 may minimize the use of any metal or ferrous metal structural elements and locate any metal or ferrous metal structural elements at the peripheries of the substrate 650 .
  • a first set of antennas 616 a, 616 c, 616 e, 616 g are positioned on the patient support surface 637 , while a second set of antennas 616 b, 616 d, 616 f are positioned on the opposed surface 652 .
  • Such allows neighboring ones of the antennas (collectively 616 ), or portions thereof, to overlap, while electrically insulating each antenna 616 from one another.
  • one or more of the antennas 616 could be carried on one or more inner layers of the patient support structure 650 where the patient support structure 650 is formed of two or more layers, for instance as a laminate structure.
  • FIGS. 6A-6C show a patient support structure 626 and antennas 616 a - 616 h (collectively 616 ), according to another illustrated embodiment, wherein individual ones of the electrically conductive paths or traces of the antennas 616 are visible.
  • the patient support structure 626 may, for example, be part of a table, for instance a surgical table, part of a bed (e.g., patient or hospital bed) or another structure designed to carry a patient or portion of a patient on which a medical procedure may be performed.
  • the patient support structure 626 is a non-articulated, single piece or unitary structure. While illustrated as a single, unitary construction, the patient support structure 626 may be formed of two or more sections, which may or may not be articulated.
  • the patient support structure 626 is formed as a substrate 650 having a patient support surface 637 and an opposed surface 652 that is opposed from the patient support surface 637 .
  • the substrate 650 may be formed of one or more layers.
  • the substrate 650 may be a composite material.
  • the substrate 650 may, for example, be formed as a resin impregnated carbon fiber structure, which may advantageously omit any metal or ferrous metal structural elements. Alternatively, the substrate 650 may minimize the use of any metal or ferrous metal structural elements and locate any metal or ferrous metal structural elements at the peripheries of the substrate 650 .
  • the patient support structure 626 carries antennas 616 thereon and/or therein. As best illustrated in FIGS. 6A and 6B , the antennas can be treated as two sets. A first set of antennas 616 a - 616 f arranged generally adjacent one another in an array of two rows on either side of a longitudinal axis 630 and three columns spaced along the longitudinal axis 630 . These antennas 616 a - 616 f do not overlap with one another. These antennas 616 a - 616 f substantially extend the full length and width of the patient support structure 628 .
  • these antennas 616 a - 616 f may be spaced inwardly from a perimeter of the patient support structure, for example where the range of the antennas 616 a - 616 f sufficiently covers the area of the patient support structure 626 .
  • a second set of antennas 616 g, 616 h are arranged generally adjacent one another in an array of one row and two columns. These antennas 616 g, 616 h do not overlap with one another, however these antennas 616 g, 616 h overlap the antennas 616 a - 616 f of the first set when viewed from above the patient support structure 626 .
  • These antennas 616 g, 616 h enhance the overall coverage of the entire area of the patient support structure 626 and volume spaced generally there above.
  • one or more of the antennas 616 could be carried on a lower outer surface 652 and/or on one or more inner layers of the patient support structure 626 , for instance where the patient support structure 626 is a laminate structure.
  • FIG. 6C shows one embodiment of the antennas 616 , which may allow relatively simple and low cost manufacturing, and which prevents the antennas 616 from electrically shorting one another.
  • each antenna may be formed as electrically conductive paths or traces on one or more layers of an electrically non-conductive or insulative substrate, for instance a flexible substrate of circuit board material (e.g. FR4, Kapton).
  • the electrically conductive path or trace may form a coil pattern, hence a coil antenna with multiple windings, as illustrated in FIG. 6C .
  • Portions of the electrically conductive path on one end or half of the substrate may be electrically coupled to respective portions of the electrically conductive path on the other end or half of the substrate via electrically conductive material received in a via that extends through a portion or all of the substrate.
  • the electrically conductive paths appear to terminate at a centerline 647 of each antenna, the electrically conductive paths are in fact electrically coupled to adjacent portions across the centerline 647 by way of respective vias.
  • the electrically conductive path may have change in direction (e.g., 45 degree turn), such that the electrically conductive path spirals inwardly (or outwardly) with each half turn or half winding.
  • an electrically non-conductive or electrically insulative material may overlie the electrically conductive path on a lower surface or side and/or an upper surface or side of the substrate, to provide electrical insulation between overlying substrates.
  • FIG. 7 shows a patient support structure 726 , according to another illustrated embodiment.
  • the patient support structure 726 is formed as a substrate 750 having a patient support surface 737 and an opposed surface 752 that is opposed from the patient support surface 737 .
  • the substrate 750 may be formed of one or more layers.
  • the substrate 750 may be a composite material.
  • the substrate 750 may, for example, be formed as a resin impregnated carbon fiber structure, which may advantageously omit any metal or ferrous metal structural elements.
  • the substrate 750 may minimize the use of any metal or ferrous metal structural elements and locate any metal or ferrous metal structural elements at the peripheries of the substrate 750 . While illustrated as a single, unitary construction, the patient support structure 726 may be formed of two or more sections, which may or may not be articulated.
  • a first set of antennas 716 a, 716 c, 716 e, 716 g are positioned in respective recesses formed in the patient support surface 737
  • a second set of antennas 716 b, 716 d, 716 f are positioned in respective recesses formed in the opposed surface 752 .
  • Such allows neighboring ones of the antennas (collectively 716 ) to overlap, while electrically insulating each antenna 716 from one another.
  • Such also advantageously spaced the antennas 716 of the first and second sets closer together with respect to one another, which may produce more consistent results or performance between the various antennas 716 .
  • one or more of the antennas 716 could be carried on one or more inner layers of the patient support structure 750 where the patient support structure 750 is formed of two or more layers, for instance as a laminate structure.
  • FIG. 8A shows a patient support structure 826 A, according to another illustrated embodiment.
  • the patient support structure 826 A is a non-articulated, single piece or unitary structure. While illustrated as a single, unitary construction, the patient support structure 826 A may be formed of two or more sections, which may or may not be articulated. The patient support structure 826 A may be formed of a variety of materials, for example, the materials of the above described embodiments.
  • the patient support structure 826 A carries a set of antennas 816 Aa- 816 Af (collectively 816 A), which are positioned along a longitudinal axis 830 of the patient support structure 826 A. While illustrated as positioned in non-overlapping fashioned, in some embodiments the antennas 816 A may be positioned in overlapping fashion. While five antennas 816 B are illustrated, the patient support structure 826 A may include a greater or lesser number of antennas 816 A. Consequently, the antennas 816 A may all be carried on the same outer surface (e.g., patient support surface) or inner surface or layer. Thus, may advantageously provide more consistent results or performance between the respective antennas 816 , and/or may simply manufacturing and/or maintenance.
  • FIG. 8B shows a patient support structure, according to another illustrated embodiment.
  • the patient support structure takes the form of a mattress or pad 826 B which may, for example, be used on a table or bed when performing a medical procedure. While illustrated as an articulated structure with two joints or hinges 830 Ba, 830 Bb (collectively 830 B), the mattress or pad 826 B may be formed of a unitary, single piece non-articulated structure.
  • the mattress or pad 826 B may be reusable, and hence should be capable of withstanding repeated sterilization procedures (e.g., heat, chemical, radiation, etc.). Alternatively, the mattress or pad 826 B may be disposable after a single use.
  • the mattress or pad 826 B may be formed of a variety of materials, for example, the materials of the above described embodiments of mattresses or pads.
  • the mattress or pad 826 B may include an outer layer or cover 892 B and an interior 890 B (visible through broken portion of outer layer 892 B).
  • the outer layer or cover 892 B provides environmental protection to the interior 890 B.
  • the interior 890 B may, for example, take the form of a conformable interior, which may be made of any variety of materials. Suitable material may, for example, include cotton or a foam material such as a closed or an open cell foam rubber or LATEX®. Alternatively, the conformable interior may take the form of a fluid (e.g., a liquid or a gas).
  • the outer layer or cover 892 B may be made of cotton, nylon, rayon or other natural or synthetic materials.
  • the outer layer or cover 892 B may, for example, be impervious to liquids.
  • the outer layer or cover 892 B may include one or more layers of a rubber, LATEX®, polyvinyl chloride, plastic or other material that is impervious to fluids, for example bodily fluids.
  • the mattress or pad 826 B carries a set of antennas 816 Ba- 816 Be (collectively 816 B), which are positioned along a longitudinal axis 832 B of the mattress or pad 826 B. While illustrated as positioned in overlapping fashioned, in some embodiments the antennas 816 B may be positioned in non-overlapping fashion. While five antennas 816 B are illustrated, the mattress or pad 826 B may include a greater or lesser number of antennas 816 B. For example, the mattress or pad 826 B may have antennas 816 arranged in a similar fashion to that illustrated in FIGS. 6A-6C .
  • the antennas 816 B may on opposite sides of a layer on or in the mattress or pad 826 B, or on two or more different layers on or in the mattress or pad 826 B.
  • the layer or layers may be an outer surface (e.g., patient support surface) or an inner surface or layer.
  • the mattress or pad 826 B includes an interface, such as a connector 894 B, to allow the antennas 816 B to be communicatively coupled to the controller 18 ( FIG. 1 ).
  • FIG. 8C shows a patient support structure, according to another illustrated embodiment.
  • the patient support structure takes the form of a sheet 826 C.
  • the sheet 826 C may, for example, be used on, over, or in conjunction with a table, bed, frame or other structure during a medical procedure.
  • the sheet 826 C may be formed of a unitary, single piece of material or a cloth, for example a fabric.
  • the cloth may, for example, be woven, knitted, felted, pressed, etc.
  • the sheet 826 C may be reusable, and hence should be capable of withstanding repeated sterilization procedures (e.g., heat, chemical, radiation, etc.).
  • the sheet 826 C may be disposable after a single use.
  • the sheet 826 C may be absorbent or may be impermeable to fluids, for example bodily fluids.
  • the sheet 826 C may be formed of a variety of materials, for example, cotton, nylon, rayon, or other natural or synthetic fibers.
  • the sheet 826 C may include one or more layers of a rubber, LATEX®, polyvinyl chloride, plastic or other material that is impervious to fluids, for example bodily fluids.
  • the sheet 826 C carries a set of antennas 816 Ca- 816 Ce (collectively 816 C), which are positioned along a longitudinal axis 832 C of the sheet 826 C. While illustrated as positioned in overlapping fashioned, in some embodiments the antennas 816 C may be positioned in non-overlapping fashion. While six antennas 816 C are illustrated, the sheet 826 C may include a greater or lesser number of antennas 816 C. For example, the antennas 816 may be arranged on the sheet 826 in an identical or similar fashion as illustrated in FIGS. 6A-6C . The antennas 816 C may be on opposite sides of the sheet 826 C, or on two or more different layers of the sheet 826 C.
  • the layer or layers may be an outer surface (e.g., patient support surface) or an inner surface or layer.
  • the sheet 826 C includes an interface, such as a connector 894 C, to allow the antennas 816 C to be communicatively coupled to the controller 18 ( FIG. 1 ).
  • FIG. 9 shows an antenna 916 , according to one illustrated embodiment.
  • the antenna 916 may, for example, be suitable for use in any of the previously described embodiments.
  • the antenna 916 may, for example, take the form of an annulus or air-coil formed of coils of conductive material.
  • the conductive material may, for example, take the form of wire or may take the form of a conductive trace printed or otherwise deposited on an inner layer or an outer surface 952 of a substrate 950 .
  • the antenna 916 includes ten turns evenly spaced between an inner diameter of about 11 inches and an outer diameter of about 14 inches.
  • the antenna 916 acts as an inductor. While being formed of a conductive material, the antenna 916 is preferably formed of a radiolucent material.
  • the antenna 916 may be formed as a thin (e.g., thickness, width) strip line aluminum antenna.
  • the antenna 816 includes a pair of terminals 854 a, 854 b that provide electrical coupling to the controller 18 ( FIG. 1 ), for example via the ports 38 of interrogation and detection system interface 36 ( FIGS. 1 and 2 ) and the coaxial cable 20 .
  • FIGS. 10A-10C illustrate a coil antenna 1016 according to one embodiment.
  • the coil antenna 1016 comprises a top coil 1017 (illustrated in isolation in FIG. 10B ) and a bottom coil 1019 (illustrated in isolation in FIG. 10C ).
  • the top and bottom coils 1017 , 1019 are carried by the patient support surface 26 , the top coil 1017 carried on one layer 1021 a and positioned relatively above the bottom coil 1019 carried on another layer 1021 b.
  • the top coil 1017 is electrically coupled to the bottom coil 1019 , for example, by a plug of electrically conductive material 1015 in a via.
  • the via connecting the top coil 1017 to the bottom coil 1019 may comprise a vertical connector of the same material as the coils 1017 , 1019 .
  • any suitable conductor may be used to connect the top coil to the bottom coil at the via point.
  • the individual windings of the two coils are also offset from each other laterally along two perpendicular axes in a horizontal plane (i.e., the plane of the drawing sheet FIG. 10A ) that is perpendicular to the longitudinal axis.
  • the layers 1021 a, 1021 b may be opposed outer surfaces of an electrically insulative substrate, one or more inner surfaces of the electrically insulative substrate, or a combination thereof.
  • the electrically insulative substrate may be a unitary part of the patient support surface, integral part of the patient support surface or attach or carried by the patient support surface.
  • FIG. 10D shows the coil antenna 1016 carried by a patient support structure 26 , according to one illustrated embodiment.
  • Top coil 1017 is positioned relatively above the bottom coil 1019 in an interior of the patient support structure 26 .
  • the bottom coil 1019 is offset from the top coil 1017 vertically along a longitudinal axis 1018 as well as laterally in a horizontal plane which is perpendicular to the longitudinal axis 1018 .
  • the individual windings 1021 of the top coil 1017 are spaced apart leaving gaps between each winding 1021 .
  • the individual windings 1023 of the bottom coil 1019 are spaced directly below the gaps between the windings 1021 of the top coil 1017 .
  • the windings 1021 , 1023 are thus spread in such a way to provide a more even distribution of radiolucence.
  • FIG. 10D illustrates an embodiment in which the windings 1023 are spaced directly below the gaps between windings 1021 without overlapping the windings 1021 in a lateral direction in the horizontal plane. In other embodiments the windings 1023 may instead slightly overlap the windings 1021 . In some embodiments the windings 1021 , 1023 may cross over each other although such crossings may have an adverse effect on radio transparency. Many other configurations of the coils 1017 , 1019 and the windings 1021 , 1023 will be apparent to those of skill in the art and fall within the scope of this disclosure.
  • FIG. 10D The configuration of windings illustrated in FIG. 10D are given only by way of example and do not limit the scope of the disclosure.
  • the patient support structure 26 and antenna 1016 are not drawn to scale. Relative heights, widths, and separations of the patient support structure 26 and antenna coils 1017 , 1019 may be different in practice than what is shown in FIG. 10D .
  • This design may minimize interference with radiological imagery sources (e.g., X-rays, CAT scans, MRIs) which may be employed while a patient is on the patient support structure 26 .
  • Radiological imaging is commonly employed while patients are on the patient support structure 26 , for example during surgery. This may, for example, be performed by positioning an X-ray machine above the patient support structure 26 and positioning an X-ray sensitive film below the patient support structure 26 .
  • An X-ray image is formed by exposing the film to the X-rays through the patient and patient support structure 26 . Any object or material that absorbs or reflects X-rays more than its surroundings will cause an area of contrast in the developed X-ray image.
  • portions of the patient support 26 structure that absorb more or less than other portions of the patient support structure 26 will appear as a high level of contrast in the developed X-ray image. This can make it difficult to interpret the X-ray image. For this reason it may be beneficial to spread the coils of an antenna, even where nominally radio transparent to reduce the contrast which the antenna may otherwise cause in an X-ray image.
  • a coil antenna with many windings which are stacked or layered are above others may produce a relatively high contrast and appear in an X-ray image even if a single layer of coil is nominally radio transparent.
  • a coil whose windings are spread apart, spread laterally from one another, may also produce relatively large changes in contrast, even where nominally radio transparent.
  • the windings of the coils are positioned to be in adjacent non-overlapping relationship to one another when viewed along the longitudinal axis 1018 .
  • Such creates an area having a very uniform distribution of antenna material, and hence a very uniform radiological attenuation distribution across that area.
  • Such advantageously may cause any attenuation to be uniform, reducing the antenna's effect on the radiological image.
  • FIGS. 10E and 10F show a patient support structure 26 according to one embodiment.
  • the patient support structure carries six antennas 1016 a - 1016 f.
  • Each of the antennas 1016 a - 1016 f may be similar or identical in form to the antenna 1016 illustrated in FIG. 10A-10D .
  • the antennas 1016 a - 1016 f are positioned to provide little or no gap between antennas in the lateral directions of the horizontal plane of the patient support surface 26 , while not overlapping. As described above, this configuration may help to reduce areas of sharp contrast in radiological images.
  • FIG. 10E shows the antennas 1016 a - 1016 f embedded within the patient support structure 26 .
  • the antennas 1016 a - 1016 f may not actually be visible from a top view of the support structure 26 .
  • 10 F shows the antennas 1016 a - 1016 f from the top view to illustrate the relative positions of the antennas 1016 a - 1016 f.
  • the number and configuration of coils, as well as the number and configuration of the winding forming those coils, shown in FIG. 10F is not meant to be limiting. In practice there may be a greater or lesser number of coils and/or a greater or lesser number of windings. In practice, the windings are typically not independent loops, but are illustrated as such in FIG. 10F for ease of illustration.
  • FIG. 11 shows a patient support structure carrying an antenna 1116 , according to another illustrated embodiment.
  • the antenna 1116 comprises a top coil 1117 and a bottom coil 1119 as previously described.
  • the top coil 1117 comprises windings 1121
  • the bottom coil comprises windings 1123 .
  • the windings 1121 , 1123 are laterally offset from each other in two perpendicular directions in a horizontal plane that is perpendicular to a longitudinal axis of the antenna 1116 .
  • the top coil 1117 is formed adjacent to and below a top surface 1137 of the support structure 26 , for example in a channel or recess formed in the top section 1137 .
  • the bottom coil 1119 is formed above and adjacent to a bottom surface 1152 of the support structure 26 , for example, in a channel or recess formed in the bottom section 1152 .
  • FIG. 12 illustrates a patient support structure that carries an antenna 1126 , according to yet another illustrated embodiment.
  • the antenna 1216 comprises a top coil 1217 and a bottom coil 1219 .
  • the top coil 1217 comprises windings 1221
  • the bottom coil comprises windings 1223 .
  • the windings 1221 , 1223 are laterally offset from each other in a horizontal plane that is perpendicular to a longitudinal axis of the antenna 1216 .
  • the top coil 1217 is carried directly on a top surface 1237 of the support structure 26 .
  • the bottom coil 1219 is carried directly on a bottom surface 1252 of the support structure 26 .
  • the top and/or bottom coils 1217 , 1219 may be adhered or otherwise physically coupled to the respective surfaces 1237 , 1252 .
  • the relative dimensions of the features shown in FIG. 12 may not be accurate.
  • the antenna windings 1221 , 1223 may not, in practice, protrude from the surfaces 1237 , 1252 to the same extent as illustrated.
  • Many other configurations for the antennas are possible and the preceding embodiments are given only by way of non-limiting example.
  • FIG. 13A shows a surgical environment 1310 that includes a surgical table 1312 and an interrogation and detection system 1314 , according to another illustrated embodiment.
  • the embodiment of FIG. 13A is similar in some respects to one or more of the previously described embodiments, hence only significant differences in structure and operation will be discussed.
  • the surgical table 1310 may include a patient support structure 1326 and a pedestal or base 1328 .
  • the patient support structure 1326 may be a laminate structure having multiple layers.
  • the patient support structure 1326 may be a shell type structure or housing having an open interior.
  • the patient support structure 1326 may be a solid structure, for example a roto-molded structure.
  • the plurality of antennas 1316 a - 1316 f (collectively 1316 ) of the interrogation and detection system 1314 are carried by the surgical table 1312 , for example carried by inner layers of the patient support structure 1326 or positioned in an interior of a shell or housing forming the patient support structure 1326 . While illustrated as being in overlapping relationship, in some embodiments the antennas 1316 may not overlap.
  • the controller 1318 of the interrogation and detection system 1314 may be positioned in the pedestal or base 1328 , for example in an interior 1330 of the pedestal or base 1328 .
  • One or more wired or wireless communication paths may communicatively couple the controller 1318 to the antennas 1316 and/or to an interrogation and detection system interface 1336 , for example coaxial cable 1320 .
  • the interrogation and detection system 1314 may receive power for a variety of sources, for example from a wall outlet or receptacle via a conventional power cord and plug 1332 .
  • the antennas of the interrogation and detection system 14 are not limited to being implemented in a patient support structure 26 .
  • Previous embodiments have, by way of example, described various ways of implementing antennas within a patient support structure. These embodiments have been given purely by way of example and are not intended to be limiting. Those of skill in the art will recognize that the antennas may be implemented in many configurations throughout the environment in which medical procedures are performed.
  • FIG. 13B shows an environment in which medical procedures are performed 1340 that includes a bed (e.g., patient bed) 1342 and an interrogation and detection system 1344 , according to another illustrated embodiment.
  • the embodiment of FIG. 13B is similar in some respects to one or more of the previously described embodiments, hence only significant differences in structure and operation will be discussed.
  • the environment 1310 may for example, take the form of a hospital room, clinic room, or examination room of a medical practitioner's office.
  • the bed 1342 may include a patient support structure 1346 and a frame or base 1348 .
  • the patient support structure 1346 may support one or more mattresses, for example a segmented mattress 1347 .
  • the frame 1348 may be made of plastic, metal, composite, reinforced composited, and/or roto-molded materials. Various commercially available designs of frames for patient beds are suitable.
  • the frame 1348 may include a set of wheels 1350 (only one called out in FIG. 13B ) allowing the bed 1342 to be easily moved.
  • the frame 1348 may include one or more rails 1352 , which may, or may not, be removable or which may, or may not, fold down.
  • the bed 1342 may include one or more electric motors 1354 (only one called out in FIG. 13B ) and linkages 1356 (only one called out in FIG. 13B ) which are selectively actuated to move or articulate portions of the bed 1342 or mattress 1346 . Other mechanisms may be used to move portions of the mattress 1346 .
  • Commercially available patient or hospital beds 1342 typically include one or more pieces of electrical or electronic equipment (e.g., electric motors 1354 ) which are sources of radio noise which may interfere with the interrogation and detection system 1344 . Such equipment typically produce very consistent or periodic (i.e., non-random) noise.
  • Some embodiments of the interrogation and detection system 1344 discussed herein employ various techniques to address such non-random noise.
  • the interrogation and detection system 1344 includes a plurality of antennas 1366 a - 1366 f (collectively 1366 ) of the interrogation and detection system 1344 are carried by the patient support structure 1346 , mattress 1347 or frame 1348 .
  • the antennas 1366 may be carried by inner layers of the mattress 1347 or positioned in an interior of a shell or housing forming the patient support structure 1346 . While illustrated as being in non-overlapping relationship, in some embodiments the antennas 1366 may overlap.
  • a controller 1368 of the interrogation and detection system 1344 may be carried by the frame or base 1348 .
  • One or more wired or wireless communication paths may communicatively couple the controller 1368 to the antennas 1366 and/or to an interrogation and detection system interface, for example coaxial cable 1370 .
  • the interrogation and detection system 1314 may receive power for a variety of sources, for example from a wall outlet or receptacle via a conventional power cord and plug (not shown in FIG. 13B ).
  • antennas may form strain sensors as part of a strain gauge.
  • the antennas may be carried by flexible substrate, for instance a flexible printed circuit board such as a polyimide (Kapton®) or polyester (Mylar®) printed circuit board.
  • the resistance of the antenna varies as the substrate flexes in response to an asserted force. The change in resistance may be measured to determine strain, and hence force applied.
  • the antennas may be configured and coupled in groups of fours to form full Wheatstone bridges.
  • the antennas may additionally, or alternatively, be oriented along various axes or dimensions to detect strain in different directions.
  • Multiple layers of antennas may be employed to detect flex in two opposite directions, normal to the plane of the substrate.
  • dedicated strain sensors or gauges may be employed, which function only to sense force (e.g., strain or pressure) and which do not function as antennas.
  • Sensing strain may be useful in detecting excessive and/or prolonged pressure asserted between a patient and the patient support surface. Excess and/or prolonged pressure may cause the patient to develop “bed sores” or ulcers. Tracking or monitoring pressure may allow the medical care provider to intervene before the “bed sores” or ulcers occur.
  • the control system may be configured to provide a warning or alert (e.g., visual, aural and/or tactile) when pressure or strain exceeds some threshold in amplitude and/or time.
  • the controller may produce a notification if the force exerted on at least one of the antenna exceeds an amplitude threshold over a period of time that exceeds a time duration threshold.
  • the control system may additionally, or alternatively, provide an indication of a position or location on the patient support surface or patient where the excessive pressure is occurring or being asserted.
  • the controller may display a map of the patient support structure and/or patient, with icons or alphanumeric indications indicative of various locations where excessive force is being asserted and/or an amplitude of force being asserted at respective locations on the map.
  • FIG. 14A shows a number of antennas 1416 carried by a lightshade 1432 of a light fixture 1434 used in medical procedures, according to one illustrated embodiment, in which the lightshade is shown in a retracted or undeployed position or configuration.
  • the light fixture 1434 may house one or more lights to be used during surgery, birth delivery or other medical procedure, including dental procedures.
  • the patient laying on a patient support structure is typically illuminated brightly by an overhead light fixture 1434 .
  • the light fixture 1434 may be situated directly above the operating table or slightly offset as desired.
  • the light fixture 1434 is also generally positioned as close to the patient as possible without impeding the medical services providers (e.g., surgeons and staff) during the medical procedure (e.g., surgery, birth delivery).
  • the proximal overhead position allows the light fixture 1434 to brightly illuminate the patient.
  • the light fixture 1434 is positioned so as to reduce or eliminate any shadows on the patient's body during the surgery.
  • the proximal overhead position of the light fixture 1434 provides an excellent location for the antennas 1416 of an interrogation and detection system.
  • the number of antennas 1416 located on the lightshade 1432 may be any number suitable for the interrogation process.
  • the lightshade 1432 may be attached to the light fixture 1434 by extendable and retractable support arms 1436 .
  • FIG. 14A illustrates the lightshade 1432 in a retracted or undeployed position or configuration, raised relative to the light fixture 1434 .
  • the support arms 1436 may include hinges 1438 or other linkages. The hinges 1436 or other linkages enable the lightshade 1432 to be moved to an extended or deployed position or configuration, lowered relative to the light fixture 1434 and the patient support surface, for example, as illustrated in FIG. 14B .
  • the antennas 1416 of the lightshade 1432 may be operable in the raised position.
  • the antennas 1416 may be attached to the light fixture 1434 in a form other than that of a lightshade 1432 .
  • FIG. 14C shows a lightshade 1432 is coupled to the light fixture 1434 without the use of supporting arms 1436 , according to yet another illustrated embodiment.
  • the lightshade 1432 may be a flexible sheet carrying a number of antennas 1416 .
  • the flexible sheet is coupleable to the light fixture 1434 by wrapping the flexible sheet around the light fixture 1434 and securing the flexible sheet thereto.
  • the lightshade 1432 may be attached to the light fixture 1434 by hooks, hook-and-loop fasteners (e.g., VELCRO®), clips, or any other suitable fasteners or adhesives. Two ends of the lightshade 1432 may be attached to each other to create an opening sized to securely receive a portion of the light fixture 1434 therein. In this configuration the lightshade 1432 remains on the light fixture by virtue of having a smaller diameter opening than a diameter of the portion of the light fixture.
  • the lightshade 1432 may alternatively be an integral part of the light.
  • the antennas 1416 of the lightshade 1432 are communicatively coupled to an interrogation and detection system interface 36 .
  • the interrogation and detection system interface 36 may be located at any suitable position in the room or in another room.
  • the antennas 1416 may be connected to the system interface 36 by a wired connection (e.g., wire bundle 1450 ) or a wireless connection.
  • the wire bundle 1450 may run along a ceiling, wall and/or floor of the operating room to communicatively couple with a controller 18 .
  • the light fixture 1434 is attached to a mobile support which can be moved about the room or even from one room to another.
  • the system interface 36 is also attached to the light fixture 1434 .
  • the controller 18 may be attached to the mobile support of the light fixture 1434 with the antennas 16 directly connected to the controller by 1450 .
  • the function and operation of the interrogation and detection system 14 in embodiments in which the antennas 1416 are coupled to a light fixture 1434 may be substantially the same as those embodiments in which the antennas 1416 are coupled to the patient support structure 26 .
  • FIG. 15A shows a drape or curtain 1542 that carries a number of antennas 1516 according to one illustrated embodiment.
  • the terms drape and curtain are used interchangeably herein and in the claims.
  • the drape or curtain 1542 may, for example, be used on, over, or in conjunction with a table, bed, frame or other structure during a medical procedure.
  • the drape or curtain 1542 may be coupled to a track 1540 which surrounds a patient support structure 26 .
  • the track 1540 is typically in close proximity to the patient support structure and affords a suitable location for the antennas 1516 of the interrogation and detection system 14 .
  • the track may be fastened to a ceiling of a room, for example an operating room, patient room or physician's office or examination room.
  • a wire bundle 1550 may also be attached to the ceiling as the wire bundle runs to the system interface 36 or controller 18 situated elsewhere in the surgical environment.
  • the antennas 1516 may be carried on either exterior surface of the drape or curtain 1542 or be situated (e.g., laminated) within the drape or curtain 1542 . While FIG. 15A shows the antennas 1516 on two opposing sides of the patient support structure 26 , the antennas 1516 may be positioned on a few or greater number sides of the patient support structure 26 while in use.
  • the drape or curtain 1542 may be selectively deployed and retracted along the track 1540 during use. For example, the drape or curtain 1542 may be retained in a retracted, undeployed position or configuration during times or periods when scanning or interrogation is not being performed.
  • the drape or curtain 1542 may be moved to an extended, deployed position or configuration in preparation for scanning or interrogation, for example, just prior to completing the medical procedures (e.g., surgery) and, for example closing the patient. In other embodiments, the drape or curtain 1542 may be retained in the extended or deployed position or configuration throughout the surgical procedure.
  • the antennas 1516 may be connected to system interface 36 by means of the wire bundle 1550 extending from the curtain 1540 .
  • FIG. 15B shows a sheet 1544 carrying a number of antennas 1516 which sheet 1544 may be quickly hung on a rack or frame 1540 .
  • the term sheet is used interchangeably herein and in the claims the terms drape or curtain.
  • the term rack is used herein and in the claims interchangeably with the term frame.
  • the sheet 1544 can be hung from the rack 1540 by connectors 1546 . More than one sheet 1544 may be hung from the rack 1540 on one or more sides of the patient support structure 26 .
  • the antennas 1516 may be attached on either exterior surface of the sheet 1544 or be situated (e.g., laminated or woven) within the sheet 1544 .
  • FIG. 16 shows a controller 1618 , according to one illustrated embodiment.
  • the motherboard 1672 may also include one or more ports 1679 to receive control signals, for example from the interrogation and detection system interface 36 , 1336 ( FIG. 1 , FIG. 13A ).
  • the motherboard 1672 may also include one or more synchronization circuits 1680 configured to control and synchronize the operation of the various plug-in boards 1678 .
  • the synchronization circuit 1680 may be configured to cause one of the plug-in boards 1678 to transmit an interrogation signal from a first antenna, and cause one or more of the other plug-in boards to monitor for a response by a transponder to the interrogation signal.
  • the synchronization circuit 1680 may cause the plug-in boards 1678 to have all of the antennas monitor for a response to the interrogation signal.
  • the synchronization circuit 1680 may cause the plug-in boards 1678 to have all of the antennas other than the antenna that transmitted a most recent interrogation signal monitor for a response. Such may advantageously allow monitoring sooner than would otherwise be possible since such can avoid the need to allow the transmitting antenna to return to a quiescent state after transmitting before monitoring for a response.
  • the synchronization circuit 1680 may synchronize the plug-in boards 1678 to successively cause the various antennas to transmit, for example starting with an antenna at one end, and successively transmitting from each of the antennas in order along the longitudinal axis 30 ( FIGS. 1 and 2 ).
  • the synchronization circuit may synchronize the plug-in boards 1678 to cause the various antennas to transmit, but not in order along the longitudinal axis 30 .
  • the synchronization circuit 1680 may synchronize the plug-in boards 1678 to cause the transmission of interrogations signals from a subset of the total set of antennas.
  • the various antennas may be controlled by respective circuits integrated into a signal circuit board.
  • the various antennas may be controlled by a single circuit.
  • FIG. 17 shows a control system 1700 of a controller of an interrogation and detection system, according to one illustrated embodiment.
  • the control system 1700 includes a field programmable gate array (FPGA) board 1702 , one or more analog boards 1704 , and a display board 1706 , communicatively coupled to one another.
  • the analog board(s) 1704 may take the form of one or more plug-in boards 1678 , as discussed in reference to FIG. 16 . Hence, there may be a respective analog board 1704 for each of the antennas 16 ( FIGS. 1 and 2 ).
  • the FPGA board includes an FPGA 1708 , configuration jumpers 1710 , RS-232 drivers 1712 , oscillator 1714 , random access memory (RAM) 1716 , flash memory 1718 , and voltage monitoring (VMON) analog-to-digital converter (ADC) 1720 .
  • FPGA 1708 configuration jumpers 1710 , RS-232 drivers 1712 , oscillator 1714 , random access memory (RAM) 1716 , flash memory 1718 , and voltage monitoring (VMON) analog-to-digital converter (ADC) 1720 .
  • the FPGA 108 may take the form of a Xilinx Spartan 3 FPGA, which runs FPGA and application software. As explained below, on power up, the FPGA reads the configuration information and application software program from the flash memory 1718 .
  • the configuration jumpers 1710 are used to select the application software configuration.
  • the RS-232 drivers 1712 are used to allow the application software to communicate using serial RS-232 data for factory test and diagnostics.
  • the oscillator 1714 sets the clock frequency for the operation of the FPGA 1708 .
  • the oscillator 1714 may, for example, take the form of 40 MHz oscillator, although other frequencies are possible.
  • the RAM 1716 is connected to the FPGA 1708 and is available for use by the application software.
  • the application software uses this memory space for storage of both the executable program and program data.
  • the RAM 1716 may, for example, have a capacity of 1 MB.
  • the flash memory 1718 contains both the FPGA configuration data and the binary application program. On power up the FPGA 1708 reads the flash memory to configure the FPGA 1708 and to copy the application program binary data from the flash memory 1718 to the RAM 1702 .
  • the voltage monitor ADC 1720 is connected to the FPGA 1708 and controlled by the application software to monitor a power supply and regulated voltage forms in controller electronics.
  • the analog board 1704 includes transmit control circuits 1722 , capacitor selection circuits 1724 , an antenna detection circuit 1726 , signal ADC 1728 , audible beeper 1730 and self-test signal 1732 .
  • Optional capacitor selection circuits 1724 on the analog board 1704 are controlled by the signals from the FPGA 1708 to tune the drive circuit to match an inductance of the antenna 16 ( FIGS. 1 and 2 ).
  • the antenna detection circuit 1726 detects when an antenna 16 ( FIGS. 1 and 2 ) is connected to the controller 20 .
  • the output of the antenna detection circuit 1726 drives a signal denominated as the LOOP_LEVEL_OUT signal, which is an input to the FPGA 1708 .
  • the signal ADC 1728 is used to sample the signals received at the antenna 16 from the transponders 24 ( FIG. 1 ).
  • the signal ADC 1728 may, for example, operate at a 1 MHz sample rate and may have 12-bits of resolution.
  • the FPGA board 1702 generates the timing and control signals for the signal ADC 1728 , which signal are denominated as ADC_CTRL, CS1, SCLK, SDO.
  • the aural indicator (e.g., speaker or beeper) 42 ( FIGS. 1 and 2 ) can be controlled by the FPGA 1708 to emit sounds to indicate various states, modes or operating conditions to the medical provider.
  • the aural indicator e.g., speaker or beeper 42 ( FIGS. 1 and 2 ) can be controlled by the FPGA 1708 to emit sounds to indicate various states, modes or operating conditions to the medical provider.
  • the FPGA 1708 can cause the generation of the self test signal 1732 on the analog board 1704 at the signal ADC 1728 .
  • Self-testing may be performed at start up, and/or at other times, for example periodically or in response to the occurrence of certain conditions or exceptions.
  • the display board 1706 includes user interface elements, for example a number of visual indicators (e.g., LEDs, LCDs, etc.) 40 ( FIGS. 1 and 2 ).
  • the FPGA board 1702 can control the visual indicators 40 on the display board 1706 .
  • the display board 1706 also includes a user selectable activation switch 44 , denominated as front panel button 1736 .
  • the front panel button 1736 is connected to the display board 1706 which allow the FPGA 1708 to monitor when the front panel button 1736 is activated (e.g., pressed).
  • FIG. 18 shows a software configuration 1800 of the interrogation and detection system 14 , according to one illustrated embodiment.
  • the boot loader 1904 is automatically loaded when the FPGA 1708 is configured, and starts execution after a processor core 1806 is reset.
  • the boot loader 1804 is responsible for transferring the application software 1802 from the flash memory 1718 to the external RAM 1716 .
  • the processor platform 1808 is configured into the FPGA 1708 ( FIG. 17 ) on power up from the configuration information stored in the flash memory 1718 .
  • the processor platform 1808 implements a custom microprocessor with a processor core 1806 , peripherals 1810 a - 1810 n, and custom logic 1812 .
  • the processor core 1806 may take the form of a soft processor core supplied by XILINX under the name MICROBLAZETM, that implements a 32-bit processor including memory caches and a floating point unit.
  • a soft core processor is one that is implemented by interconnected FPGA logic cells instead of by a traditional processor logic.
  • the processor core 1806 is connected to the internal FPGA peripherals 1810 a - 1810 n using a 32-bit processor bus 1811 called the On-Chip Peripheral Bus.
  • the XILINX supplied peripherals for the MICROBLAZETM processor core 1806 include external memory interfaces, timers, and general purpose I/O.
  • the custom logic 1812 to create the transmit signals, sample the ADC, and accumulate the transponder return signals is designed as a peripheral to the processor core 1806 .
  • the custom logic 1812 is the part of the design of the FPGA 1708 .
  • Some embodiments may substitute a full microprocessor for the soft processor core.
  • a microprocessor such as the ATOMTM processor, commercially available from Intel Corporation, may be employed in place of the MICROBLAZETM processor core.
  • the full microprocessor may be communicatively coupled to multiple analog antenna channels via one or more FPGAs and one or more suitable buses.
  • the FPGA may, for example, act as a co-processor and/or cache.
  • a higher bandwidth bus architecture may be employed.
  • a PCI expressTM or PCIeTM bus architecture may be employed, rather than an ISA bus architecture.
  • Suitable FPGAs may include those from ATMEL Corporation.
  • Such FPGAs may advantageously have built in PCIe bus architecture, allowing easy integration. This approach may enable more I/O ports, such as USB ports, may provide more or better video options, and may provide faster data rates from the analog antenna channels that otherwise possible using the ISA bus architecture and soft processor core approach.
  • FIGS. 19A-19I show a control circuit 1900 according to one illustrated embodiment.
  • the control circuit 1900 is used to drive the antenna 16 ( FIGS. 1 and 2 ) to excite or interrogate transponders 24 ( FIGS. 1 and 2 ), and to detect and process signals received by the antenna 16 from the transponders 24 .
  • there may be a respective control circuit 1900 for each of the antennas 16 or a single control circuit may be configured to control multiple antennas.
  • the control circuit 1900 includes a transmitter circuit 1902 formed by a pair of drive transistors (e.g., field effect transistors) Q 1 , Q 2 operated in a push-pull configuration between a high voltage rail (e.g., 24 V) and a low voltage rail (e.g., GND).
  • the drive transistors Q 1 , Q 2 are responsive to respective drive signals DRIVE_HI, DRIVE_LO, which are applied to the gates of the respective drive transistors Q 1 , Q 2 .
  • the drive transistors Q 1 , Q 2 are coupled to the antenna 16 by a non-switched capacitor C 8 and the coaxial cable 20 .
  • the antenna 16 and capacitor C 8 as well as capacitance provided by the coaxial cable 20 , form an LC circuit.
  • control circuit 1900 may also include a dynamic tuning circuit 1904 .
  • the dynamic tuning circuit 1904 selectively adjusts the capacitance of the LC circuit.
  • the dynamic tuning circuit 1904 includes a number of switched capacitors C 33 -C 36 and relays U 9 , U 10 .
  • the relays U 9 , U 10 are operated to selectively couple the switched capacitors C 33 -C 36 in series with the non-switched capacitor C 8 , thereby adjusting the LC characteristics of the LC circuit, and allowing fine tuning of the LC circuit around center frequencies or center channels of a number of wide band frequency bands, as described in more detail below.
  • FIG. 20 illustrates a detection cycle 2000 that employs an approach that optimizes signal to noise ratio (SNR), according to one illustrated embodiment. Such may, for example, advantageously increase range or increase sensitivity at a given range.
  • SNR signal to noise ratio
  • One embodiment is optimized based on having an overall detection cycle that performs well for transponders with resonant frequencies from approximately 136 KHz to approximately 154 KHz, and which has a pulse timing that is consistent with hardware limitations.
  • An optimal SNR may be achieved by, for example, transmitting a single wideband frequency pulse.
  • the application software 1802 ( FIG. 18 ) implements the detection cycle 2000 using transmission or interrogation in a frequency band centered around a center channel or frequency.
  • the application software 1802 sequences through a non-measurement portion (i.e., gap) 2000 a, and two distinct measurement portions, denominated as a noise detection portion 2000 b and an interrogation or signal detection portion 2000 c, each detection cycle 2000 .
  • the detection cycle 2000 may, for example, be approximately 275 milliseconds
  • the gap portion may be approximately 10 milliseconds
  • the noise portion approximately 37 milliseconds
  • the interrogation or signal portion approximately 228 milliseconds.
  • the noise detection portion 2000 b which may, for example be a first measurement portion of each detection cycle 2000 , ambient or background noise is measured or sampled, providing a value indicative of a level of ambient or background noise for the particular environment.
  • the noise measurements or samples are taken or captured at a time sufficiently after excitement of the transponders 24 ( FIG. 1 ) by the interrogation signal emitted by the transmitter such that the transponders 24 are substantially not resonating or responding to any previous excitation by interrogation signals.
  • a number N of measurements or samples are taken during the noise detection or first measurement portion 2000 b.
  • the interrogation portion 2000 c which may, for example take the form of the second measurement portion of each detection cycle 2000 .
  • responses by transponders 24 are measured or sampled.
  • the response measurements or samples are taken with the transmitter transmitting or at a time sufficiently close to excitement of the transponders 24 by the interrogation signal emitted by the transmitter such that the transponders 24 are still substantially resonating or responding to the interrogation signal.
  • a number M of measurements or samples are taken during the interrogation or second measurement portion 2000 c.
  • the interrogation portion 2000 c is illustrated as one contiguous or continuous portion 2000 c, in some embodiments the interrogation portion 2000 c may take the form of two or more separate portions or intervals. Each of the portions 2000 c may employ the same transmit frequency band, for example centered around 145 KHz. Other center channels or frequencies may for example be 136 KHz, 139 KHz, 142 KHz, 145 KHz, 148 KHz, 151 KHZ and/or 154 KHz, or any other frequency suitable for exciting the transponder to resonate. Some embodiments may employ frequency hopping, for example transmitting a different center channel or frequency for each of a plurality of interrogation portions 2000 c of each detection cycle 2000 . Such is discussed further in U.S. provisional patent application Ser. No. 60/892,208, filed Feb. 28, 2007 and U.S. non-provisional application Ser. No. 11/743,104, filed May 1, 2007.
  • the gap portion 2000 a may provide time for the response of the transponders 24 to the interrogation signal to decay sufficiently to allow measurement of noise.
  • Some embodiments may arrange the gap 2000 a, the noise detection portion 2000 b and/or the interrogation portion 2000 c, or parts thereof, in a different order.
  • the time to accumulate the noise sample or value indicative of a noise level may, for example, be approximately 37 milliseconds, and the time to accumulate the transponder signal measurement approximately 228 milliseconds. Along with a gap 2000 a of approximately 10 milliseconds between the signal and noise portions, the time for a single detection cycle 2000 would be approximately 275 milliseconds.
  • the transmitter is OFF during the noise measurement portion 2010 b of each detection cycle to measure ambient noise, and the signal measurement portion 2010 c is taken with the transmitter transmitting a wideband interrogation signal about the particular center channel or frequency.
  • the noise samples may be accumulated and a highest one or more of multiple samples or measurements over one or more detection cycles selected or used to prevent unwarranted fluctuations.
  • the response signals from the transponder 26 may be accumulated and/or averaged or integrated over one detection cycle or over multiple detection cycles.
  • the number N of noise measurements or samples and/or the number M of response measurements or samples may be selected to achieve a desired ratio of N to M, in order to achieve or maintain a desired signal to noise ratio. For example, obtaining 200 noise measurements or samples and 800 response measurements or samples each detection cycle results in an SNR of approximately 2 (e.g., the square root of the 800 divided by 200). While an SNR as low as 1.1:1 may be sufficient in some embodiments, an SNR approaching 2:1 ensures sufficient differentiation to eliminate or reduce the possibility of false positives to an acceptable level for the particular applications envisioned herein. Any known hardware and software accumulators, summer, integrators and/or other hardware or software may be suitable.
  • FIG. 21A illustrates pulse timing, according to one illustrated embodiment.
  • the custom logic in the FPGA 1708 ( FIG. 17 ) generates the timing and control signals for each pulse 2110 .
  • the logic of the FPGA 1708 drives the drive transistor control lines to generate the transmit signal.
  • the FPGA logic controls the frequency of the transmit signal.
  • the logic of the FPGA 1708 drives the gate of the dump TRIAC T1 to quickly drain the transmit energy from the antenna 21 in order to allow detection of the response signal form the transponder 24 , if any.
  • a recovery portion 2110 c of the pulse 2110 allows receiver filters and amplifiers to recover from the transmitted pulse before detecting the response signal from the transponder 24 , if any.
  • the FPGA 1708 controls the signal ADC 1728 to sample the response signal from the transponder 24 , if any.
  • the signal ADC 1728 may, for example, sample at a 1 MHz sample rate with a 12-bit resolution.
  • a dither portion 2110 e of the pulse 2110 has a random variable length of time, and may, for example be generated by a pseudo-noise (PN) sequence generator. Adding a random length of time between pulses de-correlates the response signal received from the transponder 24 from constant frequency sources of interference, if any.
  • PN pseudo-noise
  • the custom logic of the FPGA 1708 ( FIG. 17 ) accumulates the received signals from, for example 800 pulses.
  • FIG. 21B illustrates pulse timing, according to one illustrated embodiment.
  • the pulse timing is similar in some respects to that illustrated in FIG. 21A , hence similar or identical structures, acts or features are identified using the same reference numbers. Only significant differences between the two are discussed below.
  • the embodiment of FIG. 21B may advantageously eliminate the dump portion 2110 b of the pulse 2110 . Such may be omitted, for example, where the antenna 21 that transmitted the most recent interrogation signal is not being used to monitor for a response to the interrogation signal. Such may advantageously allow monitoring for the response to occur sooner than would otherwise be possible if the dump portion 2110 b were needed.
  • the embodiment of FIG. 21B may advantageously eliminate the recovery portion 2110 c of the pulse 2110 . Such may be omitted, for example, where the antenna 16 that transmitted the most recent interrogation signal is not being used to monitor for a response to the interrogation signal. Such may advantageously allow monitoring for the response to occur sooner than would otherwise be possible if the recovery portion 2110 c were needed.
  • Removal of the dump portion 2110 b and/or recovery portion 2110 c may allow for a more favorable sampling rate or better resolution or may allow a longer noise detection portion, which may significantly enhance performance.
  • FIG. 22 shows signal timing for driving the drive transistors Q 1 , Q 2 ( FIG. 19A ), according to one illustrated embodiment.
  • the custom logic in the FPGA 1708 ( FIG. 17 ) generates the signals 2220 a, 2220 b to drive the drive transistors Q 1 , Q 2 ( FIG. 19A ) during the transmit portion 2110 a ( FIG. 21 ) of the pulse 2110 .
  • a transmit (TX) period value is used by the logic of the FPGA 1708 to set the transmit frequency.
  • the low transistor (e.g., Low FET) Q 2 turns ON at the beginning of the transmit period.
  • the Low FET off value controls when the low transistor (e.g., Low FET) Q 2 is turned OFF.
  • the low transistor Q 2 is turned OFF before the high transistor (e.g., High FET) Q 1 is turned ON to avoid a short circuit through the transistors Q 1 , Q 2 .
  • the High FET on value controls when the high transistor (e.g., High FET) Q 1 is turned ON.
  • the High FET Off value controls when the high transistor Q 1 is turned OFF.
  • the high transistor is turned OFF before the low transistor Q 2 is turned ON to avoid a short circuit through the transistors Q 1 , Q 2 .
  • the transmit period should be set to 6.9 ⁇ sec.
  • a suitable duration that both the low and high transistors Q 1 , Q 2 are OFF may be set to 400 nsec.
  • the ADC converts the signal received from the transponder 24 , if any, from analog to digital. Such conversion may, for example, be performed at a sampling rate of 1 MHz with a 12-bit data resolution.
  • the sampled ADC data is then accumulated together or integrated, for example over 800 measurements or samples, to compute the total summed response signal received from the transponder 24 , if any.
  • the accumulated or integrated received signal may be match filtered with both in-phase and quadrature reference signals to determine the signal magnitude.
  • the received receive signal is matched filtered with a plurality of reference signals, for example with the seven reference signals, for instance as shown in Table 1 below.
  • Some embodiments, may employ match filtering before accumulating or integrating the received signal.
  • the maximum value for the matched filters (e.g., seven matched filters) with active transmit is compared with an adjusted detection threshold. If the maximum value is greater than the detection threshold, then a response signal from a transponder 26 is considered as having been detected, and appropriate action is taken.
  • Noise faults may be detected as well as antenna transmit voltage faults.
  • Noise faults may be detected when the matched filter output during the noise detection portion is greater than a noise fault threshold (e.g., a threshold magnitude 2.7 mV over a threshold time, e.g., 7 seconds or threshold magnitude 7 mV over a time threshold of 7 seconds).
  • Antenna transmit voltage faults may be detected when the antenna transmit voltage drops below an antenna voltage fault threshold (e.g., 270 V Peak-to-Peak ).
  • Two environmental faults in a row such as the above, may trigger an Environmental Error Mode, while two normal measurements in a row may return to a normal Scan Mode. Faults in general are discussed in more detail below.
  • the interrogation and detection system may employ a fast Fourier transform approach in lieu of match filtering.
  • FIG. 23A shows a method 2300 of operating the interrogation and detection system 14 , according to one illustrated embodiment.
  • the method 2300 starts at 2302 .
  • the method 2300 may start on application of power to the interrogation and detection system 12 or in response to activation of a switch by a user such as a clinician, surgeon
  • the interrogation and detection system 14 may enter a Power-Up mode.
  • the Power UP mode 502 may, for example, in response to the application of power to the controller 18 and turning ON the switch on the controller 18 .
  • a Power indicator e.g., LED
  • the software 1800 may perform software initialization, built in tests, and an audio/visual test. If a fault is detected, the software 1800 may progress to a System Fault Mode.
  • the software 1800 may turn a System Ready indicator (e.g., LED green), and enter an antenna Detection Mode.
  • a System Ready indicator e.g., LED green
  • the software 1800 may cause an indication of the detection of a system fault by blinking a System Ready indicator (e.g., LED) yellow, and/or issuing a sequence of rapid beeps or other sounds.
  • the corrective action for the System Fault Mode may be to cycle power to reinitiate the Power Up mode. Continued failure indicates a failed controller 18 .
  • the software 1800 checks for antennas 16 connected to the controller 18 .
  • the Antenna Detection Mode may be indicated by turning the System Ready indicator (e.g., LED) green and turning the Antenna Ready indicator (e.g., LED) OFF. If no antenna 16 is detected, the software 1800 remains in the Antenna Detection Mode. If one or more antennas 16 are detected, the software 1800 makes note of the total number of antennas and progresses to the Antenna Initialization Mode.
  • the software 1800 may turn the Antenna Ready indicator (e.g., LED) yellow and optionally check for the presence of a respective fuse coupled to antennas 16 . If a fuse is found, the software 1800 may attempt to blow the fuse and verify that the fuse was correctly blown. After the fuse is blown the software 1800 may verify that respective antenna 16 is operating within tolerances. The software 1800 may indicate that the antenna 16 is ready by turning the Antenna Ready indicator green. The software 1800 may also start a timer which will allow the antenna 16 to be disconnected and reconnected to the controller for a period to time (e.g., 5 hours) after the fuse is blown.
  • a timer which will allow the antenna 16 to be disconnected and reconnected to the controller for a period to time (e.g., 5 hours) after the fuse is blown.
  • the controller 18 may determine the adjustments or fine tuning to be made about the center frequencies or channels during Antenna Initialization Mode.
  • the controller 18 may determine the particular frequency in each of the frequency bands that elicits the response with the highest voltage.
  • the controller 18 may determine such be varying the capacitance of the LC circuit using the switched capacitors C 33 -C 36 during the Antenna Initialization Mode.
  • the particular combination of switched capacitors C 33 -C 36 which achieved the response with the highest voltage may then be automatically employed during the Scan Mode (discussed below) to adjust or fine tune about the center frequency or channel in each broad band of transmission.
  • Other approaches to determining the fine tuning may be employed.
  • the software 1800 If the software 1800 does not successfully complete the Antenna Initialization Mode, the software 1800 enters an Invalid Antenna Mode. If the software 1800 successfully completes the Antenna Initialization Mode, the software 1800 progresses to the Scan Mode to automatically start scanning. In the Invalid Antenna Mode, the software 1800 may blink the Antenna Ready indicator yellow and issues a slow beep pattern.
  • the Invalid Antenna Mode may be entered in response to any of the following conditions: 1) the antenna 16 connected to the controller 18 is out of tolerance; 2) the controller 18 is unable to blow the fuse of the antenna 16 ; 3) the antenna 16 does not have a fuse and more than the set time period has past (e.g., 5 hours) since a fuse was blown; 4) the antenna 16 does not have a fuse and the controller 18 has been restarted; 5) the antenna 16 has been connected to the controller 18 for more than the set time period (e.g., 5 hours); 6) the antenna 16 is detuned due to close proximity to metal.
  • the corrective action for the Invalid Antenna Mode is to remove the invalid antenna 16 and attach a new antenna 16 to the controller 18 that contains a fuse or to reconnect the antenna 16 while holding it in the air at least 2 feet away from large metallic objects.
  • the software 1800 enters the Scan Mode when the antennas 16 are ready and the operator presses a Start/Stop button.
  • the software 1800 may issue a short three beep pattern via the speaker or beeper when entering the Scan Mode to identify the entry to the user.
  • the software 1800 may continuously or periodically perform the following functions: 1) look for response signals from transponders 24 ; 2) monitor the noise level; 3) insure the antennas 16 are connected and operating correctly; and 4) blink the appropriate indicator in a circular pattern.
  • the interrogation and monitoring for response may be performed using a detection cycle, such as that set out in FIGS. 21A, 21B and the description related to those Figures. While, not specifically set out in FIG. 18 , such may also include optimization of signal to noise ratio, such as set out in FIG. 20 and the description related thereto.
  • a timer starts.
  • the timer allows a limit to be set on the amount of time spent scanning for a transponder 24 (i.e., scan maximum time interval).
  • a counter could be employed to set a limit of the number of iterations that the antennas 16 are successively employed to transmit interrogation signals.
  • an antenna counter i is set, for example set to 1.
  • the antenna counter allows the method 2300 to successively iterate through each of a number N of antennas 16 to transmit the interrogation signal.
  • the number N of antennas 16 may have been determined during the Antenna Detection Mode.
  • an interrogation signal is transmitted from an i th antenna 16 .
  • the FPGA 1708 FIG. 17
  • the interrogation signal may advantageously take the form of an unmodulated interrogation signal, for example in the radio or microwave portions of the electromagnetic spectrum.
  • one or more antennas 16 are monitored for a response to the interrogation signal.
  • a number of the plug-in boards may monitor the respective antenna coupled thereto for the response to the interrogation signal.
  • all of the antennas 16 may be monitored to a response to the interrogation signal.
  • all except the antenna 16 that transmitted the most recent interrogation signal i.e., i th antenna
  • some subset of all of the antennas 16 may be monitored for a response to the interrogation signal.
  • the response may advantageously take the form of an unmodulated response signal, for example in the radio or microwave portions of the electromagnetic spectrum.
  • the FPGA 1708 may poll or otherwise monitor each of a number of plug-in or analog boards to determine if a response signal was detected via any of the antennas coupled to those plug-in or analog boards. If a response to the interrogation signal was received, a suitable indication is provided at 2314 , and the method 2300 terminates at 2316 . For example, when an appropriate response signal from a transponder 24 is detected while in Scan Mode, the software 1800 may turn ON an amber DETECT indicator (e.g., LEDs) and/or provide an audible alarm.
  • an amber DETECT indicator e.g., LEDs
  • the alarm may, for example, beep a continuous solid tone as long as the transponder is detected, with a minimum of beep duration of, for instance 0.5 second. If a response to the interrogation signal was not received, it is determined whether there are additional antennas to transmit the interrogation signal from at 2318 .
  • antennas 16 may be operated to transmit an interrogation signal in an order of appearance along a longitudinal axis of the patient support surface or may be operated in any other order. Also as previously noted, all or some lesser number of antennas may be employed to transmit the interrogation signal in any single pass or iteration through the set or subset of antennas 16 .
  • a time limit i.e., scan maximum time interval
  • the method 2300 terminates at 2316 . If the time limit has not been exceeded, the counter is reset at 2306 . This allows multiple passes through the use of each antenna in a set or subset of antennas 16 as the interrogating antenna 16 .
  • the software 1800 may issue a short three beep pattern and return to the Antenna Ready Mode.
  • the software 1800 If the software 1800 detects that one of the antennas 16 is disconnected while in the Scan Mode, the software 1800 enters the Scan Fault Mode. In the Scan Fault Mode, the software 1800 may issue a sequence of rapid beeps and blink ON and OFF the amber DETECT indicator. The Scan Fault Mode can be cleared by pushing the Start/Stop button. The software 1800 will automatically clear the scan fault mode after 10 beeps.
  • the software 1800 may progress to the Environment Error Mode.
  • the software 1800 may issue or produce an appropriate indication.
  • the software 1800 may cause the production of a sequence of slow beeps and the blinking ON and OFF the green circle indicator.
  • the corrective action for the Environment Error Mode is to reposition the antenna with respect to any large metal objects or sources of electrical interference.
  • the software 1800 may automatically stop the scan if the environment error condition lasts for more than a set time or number of beeps (e.g., 5 beeps).
  • FIG. 23B shows a method 2310 b of monitoring all antennas for a response to an interrogation signal, according to one illustrated embodiment.
  • an interrogation and detection system monitors all antennas 16 for a response to the interrogation signal.
  • FIG. 23C shows a method 2310 c of monitoring all antennas except a transmitting antenna for a response to an interrogation signal, according to one illustrated embodiment.
  • an interrogation and detection system monitors all antennas 16 for a response to the interrogation signal, except the antenna 16 the transmitted the most recent interrogation signal.
  • FIG. 24A shows a method of operating an interrogation and detection system to detect transponders 2400 a, according to one illustrated embodiment.
  • the method 2400 a starts at 2401 .
  • the method 2400 a may start when the interrogation of detection system is turned ON, or when power is supplied, or in response to a call from a procedure or function.
  • an antenna counter I is set, allowing the method 2400 a to iterate through one or more antennas (n) of the interrogation and detection system.
  • the interrogation and detection system iterates through the antennas by transmitting interrogations signals successively from each of a number of the antennas, typically one antenna at a time, and monitoring or listening for response signals on one or more of the antennas.
  • the interrogation and detection system measures averaged noise and averaged signals.
  • the interrogation and detection system processes the averaged noise and averaged signal, and at 2405 determines whether a transponder (i.e., return or response signal from transponder) has been detected.
  • the interrogation and detection system requires more than one (e.g., two) successive detections of the transponder to conclude that the signal detected indicates the presence of a transponder. Such prevents against false positive determinations.
  • the interrogation and detection system again measures averaged noise and averaged signals.
  • the interrogation and detection system again processes the averaged noise and averaged signal and at 2408 determines whether a transponder (i.e., return or response signal from transponder) has been detected.
  • the interrogation and detection system provides notification at 2409 .
  • Notification may, for example, include sending an electrical or optical signal and/or producing a visual, aural or tactile alert to a user (e.g., medical service provider). If the interrogation and detection system determines that a transponder has not been detected at either 2405 , 2407 , control passes to 2410 .
  • the interrogation and detection system determines whether there are further antennas to iterate through. If so, the antenna counter is iterated, and control returns to 2403 . If not, the method 2400 a, may terminate at 2412 . Alternatively, the method 2400 a may return to 2402 and continuously repeat as long as power is supplied to the interrogation and detection system.
  • FIG. 24B shows a method of operating an interrogation and detection system to sample noise and responses and to adjust sampling times and perform noise correction 2400 b, according to one illustrated embodiment, the method useful with the method of FIG. 24A .
  • the method 2400 b starts at 2420 .
  • the method 2400 b may start in response to a call from a procedure that implements the method 2400 a.
  • the method 2400 b may, for example, be employed in measuring averaged noise and averaged signal 2403 ( FIG. 24A ).
  • a transmitter of the interrogation and detection system is OFF (i.e., not transmitting interrogation signals) or is turned OFF if not already OFF. This starts a noise detection portion of a transponder detection cycle.
  • ambient noise received by the antennas is sampled. For example, ambient noise detected by all of the antennas may be sampled by the interrogation and detection system.
  • the interrogation and detection system determines noise cancellation factors for each antenna.
  • the interrogation and detection system may employ a variety of approaches for determining the noise cancellation factors, for example computing a noise cancellation factor for each antenna based on ambient noise detected on all of the other antennas except the antenna for which the respective noise cancellation factor is being computed.
  • the interrogation and detection system determines a sample averaging time for sampling nose based on the measured ambient noise level.
  • the interrogation and detection system determines a sample response averaging time based on the measured ambient noise level.
  • the sample averaging times determine how long samples of noise or response will be averaged in determining noise or response measurements or levels.
  • Such dynamic determination of sample averaging times allows the interrogation and detection system to accommodate a changing noise environment. For example when a piece of equipment is introduced or removed from the environment or a piece of equipment turns ON or OFF, or otherwise changes amount or frequency distribution of noise it generates in the environment.
  • the interrogation and detection system may obtain adjust the noise floor to increase range in real time or almost real time in response to the actual noise in the environment.
  • the interrogation and detection system averages noise corrected noise samples for the noise sample averaging time.
  • the noise sample averaging time may be determined dynamically.
  • the noise samples may be corrected, for example, using the determined nose cancellation factors.
  • the interrogation and detection system transmits interrogation signal(s) from one of the antennas.
  • the interrogation and detection system may iterate through the antennas one at a time, for example using an antenna counter I.
  • the interrogation and detection system averages noise corrected responses for the response averaging time.
  • the response sample averaging time may be determined dynamically.
  • the response samples may be corrected, for example, using the determined nose cancellation factors. It is noted that as received, the response signals typically contain a mix of signal and noise, hence is generally referred to herein as responses. After noise correction, the result is theoretically pure signal. In practice there may be some still be some amount of noise remaining, however the signal will typically dominate the noise after noise correction.
  • the method 2400 b may terminate at 2429 , for example until called again by the procedure that implements 2400 a ( FIG. 24A ) to transmit interrogation signals from a next antenna.
  • FIG. 24C shows a method of operating an interrogation and detection system to determine whether a transponder has been detected 2400 c, according to one illustrated embodiment, the method useful with the method of FIG. 24A .
  • the method 2400 c starts at 2440 .
  • the method 2400 c may start in response to a call from a procedure that implement the method 2400 a ( FIG. 24A ).
  • the method 2400 c may, for example, be employed in processing transponder detection 2404 ( FIG. 24A ).
  • FIGS. 25A-25E are flow diagrams of methods of operating an interrogation and detection system by measuring and/or compensating for noise, according to various illustrated embodiments, the methods useful with the method of FIG. 24A .
  • the interrogation and detection system transforms the averaged noise and response samples from a time domain to a frequency domain.
  • the interrogation and detection system may, for example, perform fast Fourier transforms on the averaged samples.
  • the interrogation and detection system may find a peak of response fast Fourier transformed spectrum data.
  • the interrogation and detection system determines an amplitude threshold based on the averaged noise level.
  • the interrogation and detection system determines whether the response amplitude is equal or exceeds the determined amplitude threshold. If so, control passes to 2445 . If not, control passes to 2448 where a signal may optionally be produced indicative of no tag being detected.
  • the interrogation and detection system determines whether the signal is in appropriate frequency range. While the frequency range is illustrated as being between 137 KHz and 165 KHz, inclusive, other frequency ranges may be employed depending on the specific structure and frequency of the transponders. The disclosed embodiments are particular suited for use with low Q transponders in which the response frequencies of various transponders are not closely controlled, advantageously allowing large manufacturing tolerances to reduce cost. If the signal is in the appropriate frequency range, control passes to 2446 , otherwise control goes to 2448 .
  • the interrogation and detection system determines the Q value of the response. For example, the interrogation and detection system may compute the slope of the received signal decay at a number of windows (e.g., 5 windows).
  • the interrogation and detection system determines if the determined Q value is greater than or equal to a threshold Q value (e.g., 35). While the threshold Q value is illustrated as being 35, other Q values may be employed depending on the Q value(s) of the specific transponders. If the tag response Q value below the Q value threshold, the interrogation and detection system determines that a transponder has been detected at 2450 . If the tag response Q value is equal or above the Q value threshold, the interrogation and detection system determines that a tag has not been detected 2448 .
  • a threshold Q value e.g. 35
  • the method 2400 c may terminate at 2449 , for example until called again by the procedure that implements the method 2400 a ( FIG. 24A ).
  • FIG. 25A shows a method 2500 a of measuring or sampling responses, according to one illustrated embodiment.
  • the interrogation and detection system measures or samples response on all antennas or antenna channels.
  • FIG. 25B shows a method 2500 b of determining noise estimates, according to one illustrated embodiment.
  • the interrogation and detection system determines noise estimates based on measures or samples from all antennas or antenna channels other than the respective antenna or antenna channel for which the noise estimate will provide the compensation factors.
  • FIG. 25C shows a method 2500 c of determining noise estimates, according to one illustrated embodiment.
  • the interrogation and detection system determines an average noise estimate based on averaging of measures or samples from all antennas or antenna channels other than the respective antenna or antenna channel for which the noise estimate will provide the compensation factors.
  • FIG. 25D shows a method 2500 d of determining noise estimates, according to one illustrated embodiment.
  • the interrogation and detection system determines an average noise estimate based on averaging of measures or samples from all antennas or antenna channels other than the respective antenna or antenna channel for which the noise estimate will provide the compensation factors.
  • the averaging includes averaging of noise detection portions which occur both before and after an interrogation portion of a transponder detection cycle. Such allows the interrogation and detection system to essentially determine whether the noise is consistent, periodic, or non-random.
  • FIG. 25E shows a method 2500 e of determining noise estimates, according to one illustrated embodiment.
  • the interrogation and detection system determines an average noise estimate by determining a decomposed least squares average of noise measurements or samples. While a decomposed least squares approach is illustrated, a wide variety of other approaches may be employed (e.g., Bayesian averaging).
  • FIG. 25F shows a method 2500 f of determining noise estimates, according to one illustrated embodiment.
  • the interrogation and detection system compares noise measured from before an interrogation portion of the transponder detection to noise measured after the interrogation portion of the transponder detection cycle.
  • a difference between the noise measurements may represent variation in noise.
  • the interrogation and detection system may increase the sample averaging time for sampling responses to interrogation signals if a determined difference (i.e., variation in noise) is greater than a variation threshold. Such may allow the interrogation and detection system to accommodate different noise sources, such as those that produce periodic or non-random versus those that produce random noise.
  • FIG. 26A shows a measured or sampled response 2600 a, according to one illustrated embodiment.
  • the response 2600 a in the time domain was measured in an environment which contained a noise source (e.g., fluoroscope) but no transponder.
  • the response 2600 a has not been subjected to noise cancellation or adjustment.
  • the amplitude (Y-axis) is in mV, while the time (X-axis) is in ps.
  • FIG. 26B shows a measured or sampled response 2600 b, according to one illustrated embodiment.
  • the response 2600 b is the response 2600 a having been subjected to noise cancellation or adjustment. Most of the peaks have noticeably been diminished.
  • FIG. 26C shows a measured or sampled response 2600 c, according to one illustrated embodiment.
  • the response 2600 c is the response 2600 a after a fast Fourier transformation to the frequency domain.
  • the amplitude (Y-axis) is in mV, while the time (X-axis) is in frequency. There are three distinctive peaks of noise.
  • FIG. 26D shows a measured or sampled response 2600 d, according to one illustrated embodiment.
  • the response 2600 d is the noise cancelled response 2600 b after a fast Fourier transformation to the frequency domain.
  • the peaks have been noticeable diminished, indicating that almost all noise has been removed by the noise cancelation.
  • FIG. 27A shows a sampled or measured response 2700 a, according to one illustrated embodiment.
  • the response 2700 a in the time domain was measured in an environment which contained a noise source (e.g., fluoroscope) and a transponder.
  • the response 2700 a has not been subjected to noise cancellation or adjustment.
  • the amplitude (Y-axis) is in mV, while the time (X-axis) is in ps.
  • FIG. 27B shows a measured or sampled response 2700 b, according to one illustrated embodiment.
  • the response 2700 b is the response 2700 a after being subjected to noise cancellation. While many the peaks (associated with noise) have noticeably been diminished, other distinctive peaks remain.
  • FIG. 27C shows a measured or sampled response 2700 c, according to one illustrated embodiment.
  • the response 2700 c is the response 2700 a after a fast Fourier transformation to the frequency domain.
  • the amplitude (Y-axis) is in mV, while the time (X-axis) is in frequency. There are three distinctive peaks.
  • FIG. 27D shows a measured or sampled response 2700 d, according to one illustrated embodiment.
  • the response 2700 d is the noise cancelled response 2700 b after a fast Fourier transformation to the frequency domain. Two of the three peaks have been noticeable diminished, indicating that almost all noise has been removed by the noise cancelation, and leaving a single distinctive peak at the resonant frequency of the transponder.
  • the above described embodiments may improve a detection range versus noise performance over other more conventional approaches.
  • the embodiment of the present disclosure may be capable of achieving far superior performance, having greater detection range in even mildly noisy environments. Such is particularly advantageous in environments such as operating theaters, and substantially helps reduce false readings (e.g., false positives, false negatives). Thus, such may provide the level of performance demanded by hospitals and doctors.
  • the interrogation and detection system performs a number of acts or operations.
  • the interrogation and detection system receives unmodulated electromagnetic signals during a noise detection portion of the detection cycle.
  • the interrogation and detection system determines a noise value indicative of a noise level that corresponds to a highest one of a number N of samples or measurements of the unmodulated electromagnetic signals received during the noise detection portion of the detection cycle, where the number N is greater than one.
  • the interrogation and detection system may determine a noise value indicative of a noise level based at least in part on the unmodulated electromagnetic signals received during the noise detection portion of the detection cycle by setting the noise value based on the highest one of six samples or measurements of the unmodulated electromagnetic signal received during the noise detection portion of the detection cycle.
  • the interrogation and detection system adjusts a signal detection threshold based at least in part on the determined noise value of at least one of the detection cycles.
  • the interrogation and detection system may adjust the signal detection threshold by adjusting the signal detection threshold based at least in part on a first number of determined noise values indicative of a noise level during at least one noise detection portion that occurred before the receive response portion of a first one of the detection cycles and a second number of determined noise values indicative of a noise level during at least one noise detection portion that occurred after the receive response portion of the first one of the detection cycles.
  • the interrogation and detection system may adjust the signal detection threshold based at least in part on the determined noise value of at least one of the detection cycles by adjusting the signal detection threshold to be approximately twice an average of at least one of the first and the second number of determined noise values.
  • the interrogation and detection system may, for example, adjust the signal detection threshold based at least in part on the determined noise value of at least one of the detection cycles by adjusting the signal detection threshold to be approximately twice a greatest one of at least one of the first and the second number of determined noise values.
  • the interrogation and detection system emits at least one electromagnetic interrogation signal during a transmit portion of the detection cycle.
  • the interrogation and detection system receives unmodulated electromagnetic signals during a receive response portion of the detection cycle that follows the transmit portion of the detection cycle.
  • the interrogation and detection system determines the presence or absence of a transponder based at least in part on a number M of samples or measurements of the unmodulated electromagnetic signals received during the detection cycle and the adjusted signal detection threshold, where the number M is greater than one.
  • a ratio of N:M may be at least equal to 4.
  • N may be equal to about 200 and M may be equal to about 800.
  • the interrogation and detection system may determine the presence or absence of a transponder by comparing a maximum value of a plurality of matched filter outputs with the adjusted signal threshold.
  • the interrogation and detection system determines if an output of at least one matched filter during the noise detection portion of the detection cycle exceeds a noise fault threshold indicative of a noise fault. Such may be employed to prevent extraneous objects (e.g., metal table, EKG leads, etc.) from producing a positive result. For example, the interrogation and detection system may determine if the output of the at least one matched filter during the noise detection portion of the detection cycle exceeds the noise fault threshold for a defined period of time. The interrogation and detection system may then terminate the detection cycle in response to the output of the at least one matched filter exceeding the noise fault threshold for the defined period of time.
  • a noise fault threshold indicative of a noise fault.
  • the interrogation and detection system may convert the received signal(s) from the time domain to the frequency domain spectrum. Such may be employed, for example in lieu of the match filtering.
  • the interrogation and detection system may, for example, perform a Fourier transform, for instance a fast Fourier transform such as a 256 point fast Fourier transform. Suitable algorithms and/or sets of software code for performing such are available or can be written.
  • the interrogation and detection system may search the frequency domain spectrum to determine the object with the strongest resonance in a defined frequency band. For example, the interrogation and detection system may search the frequency domain spectrum from about 120 KHz to about 175 KHz.
  • An amplitude of the resonant object may be computed as the sum of the resonant power plus and minus 2 fast Fourier transform bins from the peak resonance frequency. This approach may provide a more accurate measurement of power than simply using the peak value.
  • the frequency of the resonant object may be computed using an interpolation approach. This approach may provide a more accurate determination of resonant frequency than simply using the fast Fourier bin number.
  • the interrogation and detection system may determine the presence or absence of a transponder based at least in part on a frequency of the unmodulated electromagnetic signals received during the detection cycle being within a defined frequency range. The defined frequency range may extend from about 137 KHz to about 160 KHz.
  • the interrogation and detection system may ignore any unmodulated electromagnetic signals received during a recovery portion (if any) of the detection cycle that precedes the receive response portion of the detection cycle. Such may be useful in preventing false positives (i.e., tag detections) from being triggered by the transmission of the interrogation or excitement signals.
  • the interrogation and detection system may determine a Q value (i.e., Quality factor) of the resonant object from a signal decay slope for the received unmodulated electromagnetic signal(s) returned by the resonant object. For example, the interrogation and detection system may determine a Q value of the unmodulated electromagnetic signals received during the detection cycle being at least equal to a threshold Q value.
  • the threshold Q value may, for example, be 35.
  • the interrogation and detection system may, for example, use multiple windows, for instance five (5) window positions may provide suitable results.
  • the interrogation and detection system may determine the presence or absence of a transponder based at least in part on a Q value of the unmodulated electromagnetic signal(s) received during the detection cycle.
  • the interrogation and detection system may preferably employ the Q value determination in conjunction with determination based on the frequency and on the determination based on the adjusted signal detection threshold.
  • the tag detection may advantageously be based on the received unmodulated electromagnetic signal(s) satisfying all three conditions: 1) measured amplitude is above a threshold, which may be an adjustable threshold, 2) measured frequency is between a lower limit and an upper limit, and 3) measured Q value is above a minimum Q threshold. Interference, for example from RFID tags or EKG cables, are rejected when any of the following three conditions are satisfied: a) measured frequency is below the lower frequency limit, b) measured frequency is above the upper frequency limit, or c) measured Q value is below the threshold Q value.
  • a threshold which may be an adjustable threshold
  • measured frequency is between a lower limit and an upper limit
  • measured Q value is above a minimum Q threshold.
  • the interrogation and detection system herein described may further implement a handheld wand 2802 as illustrated in FIG. 28 .
  • Wand 2802 comprises a loop antenna 2806 , a handle 2808 , and a cord 2810 .
  • the wand 2802 may be configured to interface with the interrogation and detection system.
  • the wand 2802 may be connected to the controller 18 by means of the chord 2810 .
  • the wand 2802 may be waved over the patient on the patient support structure 26 while emitting an interrogation signal to excite any transponder 24 which may be in or near the patient.
  • the antennas 16 a - 16 f may then all be used to detect a signal from the transponder as previously described.
  • the controller 18 controls the wand 2802 .
  • the wand 2802 emits an interrogation signal and monitors for a response from a transponder 24 .
  • the wand 2802 operates independent of the antennas 16 and the controller 18 .
  • the wand 2802 is wirelessly operated.
  • the wand 2802 only detects a transponder and does not emit an interrogation signal.
  • the wand 2802 may be implemented in a form other than a loop antenna. The illustrated embodiments are given only by way of non-limiting example.
  • the wand 2802 may interact (e.g., inductively) with the other antennas 16 and/or the transponders to, for example, advantageously increase sensitivity and/or range.
  • the antennas 16 may emit interrogation signals and the wand 2802 may be used to detect return or response signals from the transponders.
  • the wand 2802 may emit interrogation signals and the antennas 16 may be used to detect return or response signals from the transponders.
  • an electromagnetic field may be set up between the wand 2602 and one or more of the antennas 16 , and disturbances of the electromagnetic field caused by the presence of a transponder therein detected. Other approaches that combined the wand 2802 and one or more of the antennas 16 may be advantageously employed.
  • the above-described interrogation and detection system 14 may additionally be utilized to reduce the total number of wired devices used in a medical procedure environment such as a surgical environment and attendant clutter associated with such wired devices.
  • a medical procedure environment such as a surgical environment and attendant clutter associated with such wired devices.
  • electronic instruments and equipment used to aid in surgery.
  • This may include various medical instruments which monitor the vital signs or other characteristics or aspects of the patient and hence which may provide telemetry (telemetry medical instruments).
  • telemetry medical instruments includes EKG machines, other types of electrogram devices, pulse oximeters, intracranial pressure monitors, blood pressure monitors, thermometers or other temperature sensitive devices, pH sensors, electrical conductivity sensors, etc.
  • life support equipment for example, cardiopulmonary bypass machines, ventilators, intra-aortic balloon pumps, an infusion pumps, etc. All of these instruments may comprise one or more wires including power cords and wires that extend between the patient and the instrument and/or monitors or displays. These wires may be an obstacle to medical personnel performing or assisting in the surgery. This may put the patient at risk, as well as increase the risk of damaging the equipment. Additionally, many of these cords and wires must be sterilized after each use. Sterilizing a wire can be extremely expensive since inventory control must be maintained, wires are typically difficult to sterilize, and repeated sterilization may shorten the useful life of the wire.
  • the interrogation and detection system 14 described herein may advantageously enable the wireless operation of many systems and instruments in a surgical environment.
  • the interrogation and detection system 14 may comprise antennas 16 embedded in a patient support structure 26 , or situated in other configurations throughout the operating room.
  • the interrogation and detection system 14 may further comprise a controller 18 configured to control the operation of the antennas 16 .
  • the antennas 16 and controller 18 comprise a useful infrastructure which reduces a total number of wires used in the vicinity of a patient. The reduction of wires can reduce complications and costs of surgery.
  • FIG. 29 shows an environment in which medical procedures (e.g., therapeutic and/or diagnostic medical procedures) are performed, according to one illustrated embodiment.
  • the medical procedure environment may take a variety of forms such as an operating room or theater, a patient room, examination room, a clinician's office, etc.
  • the medical procedure environment includes a plurality of antennas 2916 a - 2916 f (collectively 2916 ). As illustrated, some or all of the antennas 2916 may be carried by a patient support structure 2926 (e.g., operating table, bed, pads, mattress). Alternatively, one or more of the antennas 2916 may be located elsewhere in the medical procedure environment, for example carried by a light fixture or associated shade, a curtain or drape, etc.
  • a patient support structure 2926 e.g., operating table, bed, pads, mattress.
  • the antennas 2916 may be located elsewhere in the medical procedure environment, for example carried by a light fixture or associated shade, a curtain or drape, etc.
  • the medical procedure environment may include a controller 2918 communicatively coupled to one or more of the antennas 2916 .
  • the controller 2918 is preferably communicatively coupled to the antenna(s) 2916 via one or more wired communications channels, for example via one or more cables, for instance shielded coaxial cables (not shown in FIG. 29 ).
  • the controller 2918 may, for example, be positioned on or within a pedestal 2928 which supports the patient support structure 2926 .
  • one or more of the antennas 2916 may emit interrogation signals and receive responses to interrogation signals in order to detect a presence or absence of transponders which mark various types of objects used in medical procedures, for instance instruments, implements, and various other supplies such as sponges, pads, gauze.
  • the controller 2918 may provide a notification (e.g., visual, aural, tactile) in response to a detection of a presence or absence of a transponder in the range of one or more of the antennas 2916 .
  • one or more of the antennas 2916 may also be used to provide wireless communications with one or more pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 2959 a, 2059 b (collectively 2959 ).
  • the dedicated medical diagnostic, therapeutic or monitoring equipment 2959 may include one or more antennas 2961 a, 2961 b, receivers, transmitters and/or transceivers (not shown in FIG. 29 ) to provide wireless communications to and/or from the dedicated medical diagnostic, therapeutic or monitoring equipment 2959 .
  • the antennas 2916 may serve as a relay between pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 2959 , for example as a relay between sensors (not illustrated in FIG. 29 ) and a dedicated controller or control system of a piece of dedicated medical diagnostic, therapeutic or monitoring equipment 2959 , remotely located from the sensors.
  • the controller 2918 of the interrogation and detection system 2914 may serve as a user interface to display information from and/or to interact with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 2959 , for instance as described directly below.
  • a display 2950 and a user input device 2952 may be communicatively coupled to the controller 2918 .
  • the display 2950 may be any screen or monitor (e.g., LCD panel, CRT) suitable to display information and/or a user interface (e.g., graphical user interface).
  • the display 2950 may be a touch-sensitive display device, capable of functioning as a user input device of a user interface.
  • the display 2950 may be a stand alone, separate piece of equipment. Alternatively, the display 2950 may be integrated into the controller 2918 or the patient support structure 2926 .
  • the display 2950 and/or user input device 2952 may be a dedicated medical telemetry terminal or part of a piece of dedicated medical diagnostic, therapeutic or monitoring equipment 2959 .
  • the display 2950 and/or user input device 2952 may be general purpose equipment capable of providing display of information from, and/or control over, a variety of pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 2959 .
  • the display 2950 may be configured to display medical telemetry or data received via antennas 2916 .
  • the medical telemetry or data may be received by one or more of the antennas 2916 from one or more of a variety of medical telemetry devices such as dedicated medical diagnostic, therapeutic or monitoring equipment 2959 (e.g., EKG sensors or electrodes, intra-cranial pressure sensors, pulse oximetry sensors or pulse oximeters, or any other of numerous medical measurement or sensor devices).
  • the medical telemetry or data may be related to a characteristic or physiological condition of a patient.
  • the telemetry or data may be related to one or more operational characteristics of the dedicated medical diagnostic, therapeutic, or monitoring equipment themselves, whether equipment dedicated to medically related measurement or sensing, or equipment that performs a therapeutic function on the patient.
  • the telemetry or data may be conveniently displayed by the display 2928 , either in processed and/or raw form. Processing may be preformed by the dedicated medical diagnostic, therapeutic or monitoring equipment 2959 or by the controller 2918 of the interrogation and detection system 2914 . Telemetry or data from multiple pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 2959 may be displayed sequentially or concurrently (e.g., substantially simultaneously) on the display 2950 .
  • One or more of the antennas 2916 of the interrogation and detection system 2914 may communicate with the dedicated medical diagnostic, therapeutic or monitoring equipment, for example receiving data from, and/or providing data, instructions and/or new programs to the dedicated medical diagnostic, therapeutic or monitoring equipment.
  • one or more of the antennas 2916 may relay commands to the dedicated medical diagnostic, therapeutic or monitoring equipment such as a cardiopulmonary bypass machine, ventilator, intra-aortic balloon pump, infusion pump, etc.
  • one or more of the antennas 2916 may relay data or telemetry from the dedicated medical diagnostic, therapeutic or monitoring equipment, such as an EKG electrodes, pulse oximetry sensors, blood pressure sensors, intracranial pressure monitor sensors, etc.
  • the user input device e.g., keyboard, keypad, pointer device, and/or graphical user interface
  • the controller 2918 can be used to instruct the controller 2918 to control one or more of the dedicated medical diagnostic, therapeutic or monitoring equipment in wireless communication with the interrogation and detection system 2914 .
  • These pieces of dedicated medical diagnostic, therapeutic or monitoring equipment or instruments are not shown in FIG. 29 , but one or more may be present in the environment in which medically related diagnostic, therapeutic and/or monitoring procedures are performed. Exemplary embodiments of dedicated medical diagnostic, therapeutic or monitoring equipment which can communicate via one or more of the antennas 2916 are described below.
  • the medical procedure environment may include one or more automatic data collection readers 2990 a, 2990 b (collectively 2990 , only two illustrated).
  • the automatic data collection readers 2990 are dedicated to reading and/or writing data to one or more data carriers 2924 a - 2924 d (collectively 2924 , only three illustrated), hence may be denominated as dedicated automatic data collection readers herein and in the claims.
  • Such denomination means that the dedicated automatic data collection readers 2990 perform only reading and/or writing to data carriers 2924 , and are not otherwise used to measure or sense physiological conditions of a patient or therapeutically interact with a patient.
  • the dedicated automatic data collection readers 2990 may, for example, take the form of, or include, a machine-readable symbol reader 2990 a, for instance a scanner or imager capability of optically reading machine-readable symbols 2924 c (e.g., barcode, area or matrix code or stacked code symbols). Also for example, the dedicated automatic data collection readers 2990 may take the form of, or include, a radio frequency identification (RFID) reader 2990 b, for instance an RFID interrogator capability of wirelessly reading information from an RFID data carrier such as an RFID tag 2924 b.
  • RFID radio frequency identification
  • the dedicated automatic data collection readers 2990 may combine machine-readable symbol and RFID reading capabilities. Suitable dedicated automatic data collection readers 2990 may be commercially available from Intermec Technologies or Symbol Technologies. Additionally, or alternatively, the dedicated automatic data collection readers 2990 may be capable of reading or writing to other data carriers such as optical memories, touch memories (e.g., available from Dallas Semiconductor), magnetic stripes, etc.
  • the data carriers 2924 may take a large variety of forms, including but not limited to labels or tags that carry machine-readable symbols or that otherwise encode machine-readable information (e.g., RFID, optical memories, touch memories, magnetic stripes).
  • the data carrier 2924 may advantageously encode information in two or more forms, for example an RFID transponder that carries or bears a machine-readable symbol.
  • the data carrier 2924 may include a transponder and an RFID transponder. Details of such are discussed in U.S. patent application Ser. No. 12/472,199 filed May 26, 2009, as well as in U.S. provisional patent applications Ser. Nos. 61/056,299 and 61/102,749, filed May 27, 2008 and Oct. 3, 2008, respectively, and which are incorporated by reference herein in their entireties.
  • the dedicated automatic data collection readers 2990 may include one or more processors and/or memory.
  • the dedicated automatic data collection readers 2990 may be configured to process or pre-process information read from the data carrier.
  • the dedicated automatic data collection readers 2990 may be configured to automatically recognize symbols from various symbologies and decode the same.
  • the dedicated automatic data collection readers 2990 may be configured to write data to a data carrier 2924 .
  • the dedicated automatic data collection reader 2990 b may be configured to automatically write information to an RFID data carrier 2924 .
  • the dedicated automatic data collection readers 2990 may be communicatively coupled to the controller 2918 , either via a physical or wired channel (e.g., electrical or optical) as illustrated for the reader 2990 a or wirelessly as illustrated for the reader 2990 b.
  • Wireless communications may occur via one or more of the antennas 2916 of the interrogation and detection system. While FIG. 29 illustrates all antennas 2916 of the interrogation and detection system as being carried by the patient support structure, one, more or all of the antennas of the interrogation and detection system may be carried by other structures, for example a shade associated with a light fixture or a drape.
  • the dedicated automatic data collection readers 2990 may form part of a network, along with the communications channel(s) and controller 2918 .
  • the dedicated automatic data collection readers 2990 may be employed to read information from data carriers 2924 physically associated with various objects (e.g., implements 2922 a, tools, machines 2922 d, devices, sponges 2922 b, pads, gauze, articles and/or other supplies), and/or a patient and/or one or more medical care providers (e.g., doctors, nurses, anesthesiologist, radiology technician), for instance from a data carrier of a wrist band 2922 c, anklet or badge worn by the patient or medical care provider.
  • medical care providers e.g., doctors, nurses, anesthesiologist, radiology technician
  • Such can be integrated with other automatically collected information, such as information indicative of a physiological condition of the patient or subject, or information indicative of an operational parameter of a piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • one or more of the antennas 2916 of the interrogation and detection system may be used to reader from, and/or write to, data carriers 2924 .
  • the controller 2918 may be configured to cause one or more of the antennas 2916 to emit interrogation signals in a frequency band employed by RFID transponders or tags, and to receive response signals encoding information from the RFID transponder's memory.
  • Information received from the RFID transponder may, for example, include an identifier, such as a unique identifier that uniquely identifies the RFID transponder or tag.
  • a database stored on a computer-readable medium may associate the identifier with information that identifies the object to which the RFID transponder or tag is attached, as well as information about the object.
  • the information may include identity of the object such as manufacturer, model, type, classification, lot number and/or date of manufacture.
  • the information may include a history of the object, for instance number of uses, number and/or type of sterilization cycles, number and/or date of refurbishment, dates and/or times of use, dates of inspection and/or identity of inspector.
  • the information may be accessible (e.g., read, write) by the controller 2918 of the interrogation and detection system, and/or by one or more pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • An EKG machine may be used to monitor the heart activity of a patient during surgery.
  • a plurality of electrodes or sensors are attached to a patient at various locations on the patient.
  • Each electrode or sensor is electrically coupled to the EKG machine by a respective electrically conductive wire.
  • Each EKG electrode and wire is commonly referred to as a lead.
  • As many as twelve or more electrodes may be attached to the patient simultaneously, each electrode having its own wire coupled to an EKG machine.
  • EKG lead wires can be particularly obtrusive during surgery. The EKG lead wires frequently become tangled. Medical personnel moving about the patient are impeded by the wires. Medical personnel may bump into the wires and either break a wire or detach one or more of the EKG electrodes.
  • the electrodes may be difficult to reattach as there may be bodily fluid covering the area where the detached electrode was previously attached. If more than one electrode becomes detached, the electrodes are particularly susceptible to being replaced in the wrong location. Also, fluid on the electrodes may cover a distinguishing mark meant to indicate the proper location of the electrodes. Reattaching the electrodes wastes valuable time and can lead to improper placement of the electrodes and faulty EKG data. Reducing the amount of wires leading from the EKG electrodes to an EKG machine is desirable.
  • FIG. 30A shows a piece of dedicated medical diagnostic, therapeutic or monitoring equipment in the form of wireless sensor or transducer 3054 , according to one embodiment.
  • the wireless sensor or transducer may take the form of an electrode 3054 a, for instance an electrode suitable for measuring EKGs. While such may be referred to as a “wireless lead,” applicants understand that such term is somewhat a misnomer since the “lead” or electrical wire is eliminated and all that remains of the original “lead” is the electrode (i.e., electrically sensitive sensor or transducer).
  • the wireless sensor or transducer 3054 carries a battery 3056 and a radio 3058 .
  • the radio 3058 comprises at least a transmitter and may include a receiver as well, and may be formed as a transceiver.
  • the wireless sensor or transducer 3054 may also include an inscription or marker indicating a proper position of the wireless sensor or transducer 3054 on the body of the patient.
  • the individual wireless electrodes 3054 a may sense activity of the heart or other physiological activity (e.g., electrical) in any suitable manner.
  • the wireless sensor or transducer 3054 may take a passive form, deriving power from a wireless interrogation signal, similar to radio frequency identification (RFID) transponders. While discussed in terms of an electrode 3054 a to sense electrical physiological characteristics (e.g., conductivity, impedance, resistivity, capacitance), a wireless sensor or transducer 3054 can be employed which is responsive to other physiological characteristics (e.g., temperature, moisture, pH, salt, pressure, stress, strain or force).
  • RFID radio frequency identification
  • FIG. 30B shows a plurality of “wireless leads” or electrodes 3054 a attached to a patient 3060 according to one embodiment.
  • a patient may have twelve or more EKG electrodes positioned on the torso, back, limbs, or any suitable location.
  • the configuration of the wireless electrodes 3054 a in FIG. 30B is given only by way of broad example of the number and positioning of the wireless electrodes 3054 a. In practice, the number and positioning of wireless electrodes 3054 a may be different from that shown in FIG. 30B .
  • Each wireless electrode 3054 a comprises a radio 3058 configured to transmit EKG data to an antenna 16 coupled to the interrogation and detection system 14 .
  • the controller 18 processes the data received from the wireless electrodes 3054 a and displays the resulting EKG waveform on the display 2950 ( FIG. 29 ).
  • Each wireless electrode 3054 a may transmit a unique identifier to the controller 18 so that the controller 18 may know which data came from which wireless electrode 3054 a.
  • the identifier may also indicate the position of an individual wireless electrode on the patient's body.
  • the electrodes 3054 a may bear a marking which identifies the wireless electrode 3054 a and/or a location on the body at which the wireless electrode 3054 a should be placed or is placed.
  • Two or more electrodes 3054 a may be wirelessly communicatively coupled to each other. Two wireless electrodes 3054 a are wirelessly coupled when at least one of the wireless electrodes 3054 a is configured to transmit data to the other wireless electrode 3054 a. One wireless electrode 3054 a can send a signal to a second wireless electrode 3054 a and the second wireless electrode 3054 a can then transmit data to the antenna 16 representing the data gathered by one or both wirelessly coupled wireless electrodes 3054 a. The controller 18 may receive wireless transmissions from only one or from both wireless electrodes 3054 a.
  • the configuration shown in FIG. 30B greatly reduces the number of wires in the vicinity of the patient. Medical personnel moving about the patient support structure 2726 will face a much lower risk of bumping a wire and either detaching an electrode 2854 or stumbling themselves. There are fewer wires on the body of the patient to impede surgeons performing delicate and precise operations on the body of the patient. In addition to this, the EKG machine no longer needs to be present in the surgical environment.
  • the controller 18 may process the data sent from the electrodes 3054 a and displays the data (e.g., EKG waveform) on the display 2950 ( FIG. 29 ).
  • the wireless electrodes 3054 may wirelessly transmit telemetry or data to a piece of dedicated medical diagnostic, therapeutic or monitoring equipment (e.g., an EKG machine).
  • the piece of dedicated medical diagnostic, therapeutic or monitoring equipment may in turn transmit data to the controller 18 of the interrogation and detection system, for example via the antennas 16 or via one or more wired connections (e.g., electrically conductive cables or optical fiber cables).
  • the controller 18 may also transmit instructions to the piece of piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the controller 18 may transmit operating instructions which cause the piece of piece of dedicated medical diagnostic, therapeutic or monitoring equipment to operate in a certain fashion, or may transmit new software or firmware instructions or upgrades of existing software or firmware instructions, to reconfigure the piece of piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • one or more of the antennas 2916 may provide wireless communications between the display 2950 , user input device 2952 and the piece of piece of dedicated medical diagnostic, therapeutic or monitoring equipment, which may employ conventional wired electrodes (not shown).
  • FIG. 30C shows sensor or transducer 3054 according to an alternative embodiment.
  • One electrode 3054 a may be connected by a wire 3062 to another wireless lead or electrode 3054 a.
  • One or both of the electrodes 3054 a comprises a radio 3058 (i.e., transmitter and/or receiver or transceiver that communicates via portions of the electromagnetic spectrum typically associated with radio communications such as the radio and microwave portions of the electromagnetic spectrum) and optionally a discrete consumable power source such as battery 3056 or fuel cell.
  • At least one of the pair of wireless electrodes 3054 a transmits telemetry or data (e.g., EKG signals) to one or more of the antennas 16 of the interrogation and detection system 14 .
  • FIG. 31 shows a plurality of sensors or transducers 3154 in the form of leads or electrodes 3154 a and an intermediary relay 3164 , according to one illustrated embodiment.
  • the leads 3154 a may, for example, include an electrode, sensor or other transducer, and a physical communications conduit, for example an electrically conductive or optical wire or cable.
  • Each of the leads 3154 a is attached to a patient 3160 at various locations on the patient to sense a physiological characteristic of the patient.
  • Each lead 3154 a is also communicatively attached or coupled to the intermediate relay 3164 .
  • the intermediate relay 3164 is a commonly shared communications device 2964 (i.e., common communications device shared by two or more of the leads 3154 a ), and is interchangeably referred to as such herein.
  • the intermediate relay or common communications device 3164 may take the form of, or include, a multiplexer and/or demultiplexer.
  • the common communications device 2964 includes a radio 3158 operable to transmit telemetry or data (e.g., signals) detected by the leads 3154 a to one or more of the antennas 16 of the interrogation and detection system 14 .
  • the radio 3158 includes one or more antennas, a transmitter and may also include a receiver, and may be formed as transceiver.
  • the common communications device 3164 may be powered by a battery 3156 or other power source.
  • the leads 3154 a may be powered by respective batteries located at the electrode portions of the leads 3154 a.
  • the leads 3154 a may receive power from the intermediate relay or common communications device 3164 via the respective wires.
  • the leads 3154 a may wirelessly receive power via an interrogation signal.
  • the intermediate relay or common communications device 3164 wireless transmits telemetry or data (e.g., EKG signals) to the controller 18 of the interrogation and detection system via one or more antennas 16 .
  • the controller 18 may displays the telemetry or data on the display 2950 ( FIG. 29 ), either in processed or raw form.
  • the controller 18 may communicate the telemetry or data to a piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the controller 18 may relay the telemetry or data to an EKG machine for processing and display or printing. Such may take place over a physical media, such as electrical wires or optical fibers. This advantageously eliminates many of the wires around the patient 3160 which would have connected the leads 3154 a directly to an EKG machine.
  • the EKG machine likewise may not be needed as the common communications device 3164 and the controller 18 may process the EKG data.
  • a typical pulse oximeter sensor is attached to a finger of a patient to measure the blood-oxygen level of a patient.
  • the pulse oximeter sensor is normally connected by one or more wires to a pulse oximeter processing system to process raw data from pulse oximeter sensor.
  • the pulse oximeter processing system includes or is coupled to a display to display processed data.
  • FIG. 32 shows a wireless pulse oximeter sensor 3266 , according to one embodiment.
  • the pulse oximeter sensor 3266 may be used to monitor the oxygen content of a patient's blood.
  • the wireless pulse oximeter sensor 3266 is physically attached to a portion of the patient, for example a finger 3268 of the patient.
  • the wireless pulse oximeter sensor 3266 comprises a transducer 3257 and a radio 3258 transmitter and/or receiver or transceiver).
  • the radio 3258 includes an antenna (now shown) and is configured to wirelessly transmit data sensed by the transducer 3257 to at least one antenna 16 coupled to the interrogation and detection system 14 .
  • the controller 18 may process the data received via the at least one antenna.
  • the controller 18 may display the patient's blood-oxygen data on the display 2950 ( FIG. 29 ) in processed or raw form. The data may advantageously be displayed simultaneously with EKG data on a single display 2950 ( FIG. 29 ).
  • the controller 18 may relay the sensed measurements to a dedicated pulse oximeter processing system or controller, either via wireless or wired communications.
  • the interrogation and detection system 14 may advantageously be utilized to eliminate extraneous wire, and/or an extra display or processor.
  • some embodiments may take advantage of the proximity of antennas 16 to the patient to wirelessly collect data from various sensors or transducers, and to relay that data directly to associated processing equipment dedicated to a particular function or task.
  • the controller 18 of the interrogation and detection system 14 may itself implement some or all of the processing usually performed by the associated dedicated processing system.
  • FIG. 33 illustrates an intracranial pressure monitor 3370 according to one embodiment.
  • the intracranial pressure monitor 3370 is a dedicated piece of medical diagnostic, therapeutic or monitoring equipment which is attached to a head of the patient to monitor pressure in the head.
  • the intracranial pressure monitor 3370 may include one or more pressure sensors or transducers (e.g., piezo-electric or resistance based strain gauge) 3371 and a radio 3372 (i.e., transmitter and/or receiver or transceiver) that includes an antenna (not shown).
  • the pressure sensors or transducers 3371 may be implemented in a MEMS device or other suitable mechanism.
  • the radio 3172 is communicatively coupled to the pressure sensor 3371 .
  • the radio 333172 transmits data from the pressure sensor or transducer 3371 to an antenna 16 of the interrogation and detection system 14 .
  • the controller 18 may process the data and display the processed data on the display 2950 ( FIG. 29 ). Alternatively, the controller 18 may simply display raw, unprocessed data via the display 2950 . Additionally, or alternatively, the controller 18 may relay the raw or partially processed data to a controller of a dedicated intracranial pressure monitor processing system or controller.
  • the display 2950 FIG. 29 ) advantageously displays intracranial pressure monitor sensor data along with pulse oximetry and/or EKG data collected from one or both of the pulse oximeter 3266 ( FIG. 32 ) and/or electrodes 3054 ( FIG. 30A ).
  • dedicated medical diagnostic, therapeutic or monitoring equipment may relay processed data back to the interrogation and detection system 14 , via antennas 16 , for display on display 2950 , possibly with other processed data.
  • the dedicated medical diagnostic, therapeutic or monitoring equipment may be communicatively coupled directly to the display 2950 , for example via one or more wired or wireless connections.
  • the interrogation and detection system 14 can further be utilized to communicate with and issue commands to other dedicated medical diagnostic, therapeutic or monitoring equipment, for example dedicated medical therapeutic equipment used to perform a therapeutic function on the patient or dedicated medical diagnostic equipment used to collect diagnostic information from the patient.
  • dedicated medical diagnostic, therapeutic or monitoring equipment for example dedicated medical therapeutic equipment used to perform a therapeutic function on the patient or dedicated medical diagnostic equipment used to collect diagnostic information from the patient.
  • FIG. 34 illustrates an infusion pump 3474 according to one illustrated embodiment.
  • the infusion pump 3474 is a piece of dedicated medical diagnostic, therapeutic or monitoring equipment that may be used to inject fluid (e.g., intravenously) into a patient.
  • the fluid may be one or more drugs, anesthetic, blood, plasma, saline, food or sucrose, etc.
  • the infusion pump 3474 may be programmed to introduce fluid into the patient at a desired rate.
  • the infusion pump 3474 may include a radio (e.g., transmitter and/or receiver, or transceiver) 3458 configured to communicate wirelessly with an antenna 16 of the interrogation and detection system 14 .
  • the radio 3458 may receive wireless control signals from a remotely located controller, for instance the controller 18 .
  • the control signals may indicate, for example, an infusion rate at which to pump the fluid into the patient, a start time, a stop time, a duration, a delivery profile indicating various rates over time.
  • the radio 3458 may additionally or alternatively, transmit monitoring signals to a remotely located controller, for instance the controller 18 .
  • the monitoring signals may indicate various operational characteristics of the infusion pump 3474 , for instance, amount and/or rate of actual fluid delivery, an amount of fluid remaining, and whether a battery of the infusion pump 3474 is nearing depletion.
  • the data from the infusion pump 3474 may be displayed on the display 2950 ( FIG. 29 ) along with other medical telemetry or data described in relation to FIGS. 30-33 . Additionally, or alternatively, the medical telemetry or data may be relayed by the controller 18 of the interrogation and detection system 14 to a dedicated controller of an infusion pump system. Such may be done over one or more wired or wireless communications channels.
  • a user may use the input device 2952 and/or touch screen of the display 2950 ( FIG. 29 ) to enter a new fluid infusion rate for the infusion pump 3474 .
  • the controller 18 then sends a control signal to the infusion pump 3474 via an antenna 16 of the interrogation and detection system 14 .
  • the user may enter a new rate via a user input device of a dedicated infusion pump system, which relays control instructions to the interrogation and detection system 14 .
  • the signal is received at the radio 3458 of the infusion pump 3474 and the infusion pump 3474 adjusts the fluid infusion rate accordingly.
  • the controller 18 may be configured to communicate with remotely located equipment, such as a display at a nurse's station outside of the room in which the medical procedure is preformed. Any of the data received by the controller 18 can be displayed at the nurse's station. In this way medical personnel remote to the patient's room may monitor any of the equipment communicating with the interrogation and detection system 14 .
  • remotely located equipment such as a display at a nurse's station outside of the room in which the medical procedure is preformed. Any of the data received by the controller 18 can be displayed at the nurse's station. In this way medical personnel remote to the patient's room may monitor any of the equipment communicating with the interrogation and detection system 14 .
  • the controller 18 may be configured to receive commands from the nurse's station to adjust the fluid infusion rate of the infusion pump 3474 .
  • the controller 18 may be configured to receive commands from the nurse's station to adjust a function of any of the equipment coupled to the interrogation and detection system.
  • FIG. 35 illustrates an intra-aortic balloon pump system 3576 , according to one illustrated embodiment.
  • a balloon pump system is a dedicated piece of medical diagnostic, therapeutic or monitoring equipment used to inflate or deflate catheter balloons.
  • the balloon pump system is typically controlled by a computer coupled to an EKG machine.
  • the computer controls the pulsation of the balloon pump according to data from the EKG.
  • the intra-aortic balloon pump system 3576 comprises a pump 3577 operable to selectively inflate and deflate an intra-aortic balloon.
  • the intra-aortic balloon pump system 3576 may include a user interface 3578 including a display 3578 a and one or more user input devices (e.g., keys, switches, knobs, pointer devices) 3578 b.
  • the display 3578 a and user input devices 3578 b are dedicated to the display of information related to operation of the aortic balloon pump system 3576 and control thereof, respectively.
  • the intra-aortic balloon pump system 3576 may include a radio (e.g., transmitter and/or receiver or transceiver) 3558 configured to communicate with an antenna 16 of the interrogation and detection system 14 .
  • the controller 18 may be configured to control the balloon pump 3576 from a remote location, for example in response to EKG data.
  • the controller 18 may transmit data, for instance EKG data, to the balloon pump system 3576 and allow the balloon pump system 3576 to process the data and control the pump 3577 accordingly.
  • the balloon pump system 3576 does not need to be connected by wire to another piece of dedicated medical diagnostic, therapeutic or monitoring equipment (e.g., EKG machine), thus enhancing the environment in which the medical procedure is preformed.
  • the interrogation and detection system 14 may function as a relay between sensors or transducers (e.g., electrodes), pumps (e.g., pump of inter-aortic balloon system) and other dedicated medical diagnostic, therapeutic or monitoring equipment or dedicated medical diagnostic, therapeutic or monitoring control systems of such dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the interrogation and detection system 14 may be further utilized to interact with a balloon pump during or after surgery.
  • FIG. 36 illustrates a controller 3618 , according to one illustrated embodiment.
  • the controller 3618 is similar to that of FIG. 16 but has been adapted to enable operation of the antennas 16 to communicate with pieces of dedicated medical diagnostic, therapeutic or monitoring equipment as described in relation to FIGS. 29-34 .
  • the controller 3618 comprises a motherboard 3672 .
  • the motherboard 3672 includes or is communicatively coupled to a plurality of ports or connectors 3674 to communicatively couple the motherboard 3672 to respective antennas 16 as previously described in relation to FIG. 16 .
  • the motherboard 3672 may also include slot connectors 3676 to receive plug-in boards 3678 as previously described in relation to FIG. 16 .
  • the controller 3618 has been expanded to include one or more additional slot connectors 3676 for receiving one or more additional plug-in boards 3678 for enabling communication through the antennas 16 or additional antenna(s) with one or more medical telemetry or data and support or control pieces of dedicated medical diagnostic, therapeutic or monitoring equipment, for example equipment such as EKG electrodes 3054 , pulse oximeter sensor 3266 , intracranial pressure monitor 3370 , fusion pump 3474 , and balloon pump system 3576 .
  • dedicated medical diagnostic, therapeutic or monitoring equipment which may be used during and after a medical procedures (e.g., operation), any or all of which may be fitted with radios (e.g., transmitter and/or receiver, or transceiver) and configured to interface with the interrogation and detection system.
  • the one or more additional plug-in boards 3676 enable the controller 3618 to operate the interrogation and detection antennas 16 in a mode for interacting with pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • a single antenna 16 of the interrogation and detection antennas may be dedicated to communicate with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • more than one antenna 16 of the interrogation and detection system 14 may be configured to communicate with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • all of the antennas 16 of the interrogation and detection system 14 are configured to communicate with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • one or more of the antennas 16 of the interrogation and detection system 14 are dedicated to communications with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment, the plug-in boards being different from the plug-in board used with antennas 16 that perform interrogations to locate transponders 24 .
  • one or more antennas 16 are used to perform all of interrogation, detection of transponders and to communicate with sensors, pumps, and/or other instruments or equipment, and/or with dedicated control systems of the same.
  • one or more additional antennas 16 may be connected to ports 3674 of the motherboard 3672 dedicated solely to interface with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the controller 18 of the interrogation and detection system may be operable to communicate with radios 3058 , 3258 , 3372 , 3458 , 3558 of the various pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 3054 , 3266 , 3370 , 3474 , 3576 .
  • Radios 3058 , 3258 , 3372 , 3458 , 3558 may operate in more precise frequency bands than the transponders 24 .
  • Antennas of the interrogation and detection system 14 may be configured to operate in a first mode to detect transponders 24 and in a second mode to communicate with the pieces of dedicated medical equipment.
  • the first mode may include operating in a first broad frequency range as previously described with regards to the interrogation and detection process.
  • the second mode may include operating in a second frequency range, more narrow than the first frequency range.
  • the first and second frequency ranges may overlap. In other embodiments, the first and second frequency ranges do not overlap.
  • the radios may be passive, employing passive RFID type technology.
  • Such radios may employ a first antenna dedicated solely to receiving a first signal to charge a charge pump of the radio to power the radio.
  • the second antenna operates at a different frequency than the first antenna and is configured to communicate with an antenna 16 of the interrogation and detection system 14 .
  • a dedicated power antenna may be installed in the interrogation and detection system 14 to supply a constant signal to power EKG wireless leads or electrodes 3054 .
  • the power antenna could be installed in the operating room independent of the interrogation and detection system 14 . In either case, the power antenna should be near the patient support structure 26 in order to supply an adequately strong signal to the radios.
  • the power generated by the charge pump supplements the battery 3056 to extend the life thereof in the case of a long medical procedure which may last several hours. Otherwise, the battery 3056 of the wireless leads or electrodes 3054 may run out of power. Thus, the power generated by the charge pump from the power antenna signal may advantageously prolong the life of the battery 3056 .
  • the radios may also comprise two antennas to supplement the batteries of the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • the teachings herein may employ any variety of other electrodes, sensors or transducers and diagnostic, therapeutic or monitoring equipment.
  • photo-electric pulse plethysmograph transducers for example, photo-electric pulse plethysmograph transducers, respiratory effort transducers, GSR finger electrode transducers, physiological sounds microphone, active electrodes, air flow transducers, blood pressure transducers, blood pressure cuff transducers, hand dynamometers, variable range force transducer, twin axis goniometer, torsion meter, laser Doppler surface flow probe, skin surface temperature, fast response temperature probe, surface temperature banjo probe, liquid immersion probe, digit surface temperature probe, accelerometer, pulse oximeters transducer.
  • signal bearing media include, but are not limited to, the following: recordable type media such as floppy disks, hard disk drives, CD ROMs, digital tape, and computer memory.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Electromagnetism (AREA)
  • Neurosurgery (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

The presence or absence of objects tagged with transponders may be determined in an environment in which medical procedures are performed via an interrogation and detection system which includes a controller and a plurality of antennas positioned along a patient support structure. The antennas may be positioned along an operating table, bed, mattress or pad, sheet, or may be positioned on a drape, or shade. Respective antennas may successively be activated to transmit interrogation signals. Multiple antennas may be monitored for responses from transponders to the interrogation signals. For example, all antennas other than the antenna that transmitted the most recent interrogation signal may be monitored. Antennas may be responsive to force, a signal indicative of such force being produced. A wireless physiological condition monitor may detect patient physiological conditions and wirelessly transmit signals indicative of such.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a divisional patent application of U.S. patent application Ser. No. 12/606,963, now U.S. Pat. No. 9,792,408, and claims benefit under 35 U.S.C. 119(e) to U.S. provisional patent application Ser. No. 61/222,847 filed Jul. 2, 2009; and U.S. provisional patent application Ser. No. 61/242,699 filed Sep. 15, 2009, both of which are incorporated herein by reference in their entireties.
  • BACKGROUND Technical Field
  • The present disclosure generally relates to a wireless medical procedure environment, and more particularly detection of transponder tagged objects and communications with various pieces of medical equipment in an environment in which medical procedures are performed.
  • Description of the Related Art
  • It is often useful or important to be able to determine the presence or absence of an object.
  • For example, it is important to determine whether objects associated with a medical procedure, for instance surgery or child birth delivery, are present in a patient's body before completion of the medical procedure. Such objects may take a variety of forms used in medical procedures. For example, the objects may take the form of instruments, for instance scalpels, scissors, forceps, hemostats, and/or clamps. Also for example, the objects may take the form of related accessories and/or disposable objects, for instance surgical sponges, gauzes, and/or absorbent pads. When used in surgery, failure to locate an object before closing the patient may require additional surgery, and in some instances may have serious adverse medical consequences. In other medical procedures, such as vaginal child birth deliveries, failure to remove objects, for instance gauze or absorbent pads can lead to infections.
  • Some hospitals have instituted procedures which include checklists or requiring multiple counts to be performed to track the use and return of objects during surgery. Such a manual approach is inefficient, requiring the time of highly trained personnel, and is prone to error.
  • Another approach employs transponders and a wireless interrogation and detection system. Such an approach employs wireless transponders which are attached to various objects used during surgery. The interrogation and detection system includes a transmitter that emits pulsed wideband wireless signals (e.g., radio or microwave frequency) and a detector for detecting wireless signals returned by the transponders in response to the emitted pulsed wideband signals. Such an automated system may advantageously increase accuracy while reducing the amount of time required of highly trained and highly compensated personnel. Examples of such an approach are discussed in U.S. Pat. No. 6,026,818, issued Feb. 22, 2000, and U.S. Patent Publication No. US 2004/0250819, published Dec. 16, 2004.
  • Commercial implementation of such an automated system requires that the overall system be cost competitive and highly accurate. In particular, false negatives must be avoided to ensure that objects are not mistakenly left in the patient. Some facilities may wish to install a single interrogation and detection system in each surgery theater or room in which medical procedures are conducted, while other facilities may move an interrogation and detection system between multiple surgical theaters or other rooms. In either case, the overall system will require a large number of transponders, since at least one transponder is carried, attached or otherwise coupled to each object which may or will be introduced into a patient or subject during the medical procedure. Consequently, the transponders must be inexpensive. However, inexpensive transponders typically have a relatively large variation in the frequency of signals they emit, making it difficult to accurately detect the signals returned by the transponders. This may be particularly difficult in some environments which are noisy with respect to the particular resonant frequencies of the transponders. Rooms in hospitals in which medical procedures are performed tend to have increasingly larger amounts of electronic equipment, and hence are becoming notoriously noisy environments. Consequently, a new approach to detection of the presence and absence of transponder that facilitates the use of inexpensive transponders is highly desirable.
  • BRIEF SUMMARY
  • A system for use in a medical facility may be summarized as including a number of antennas and a controller communicatively coupled to the antennas and configured to selectively cause at least one of the antennas to emit an interrogation signal and to detect a response signal, if any, from a number of transponders physically coupled to a number of objects used in medical procedures, wherein the controller is further configured to provide wireless communications of at least one of data or instructions with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to emit the interrogation signal or receive the response signal.
  • At least a plurality of the number of antennas may be carried by a patient support structure that carries a patient during a medical procedure. At least one of the number of antennas may be a handheld antenna that inductively cooperates with the plurality of antennas carried by the patient support structure. At least one of the number of antennas may be a handheld antenna, and one of the handheld antenna or the plurality of antennas carried by the patient support structure may transmit an interrogation signal and the other one of the handheld antenna or the plurality of antennas carried by the patient support surface may receive response signals, if any, to the interrogation signal. The number of antennas may include at least three loop antennas spaced along a longitudinal axis of the patient support structure, and the patient support surface may be one of an operating table, a bed, a mattress, or a sheet. At least a plurality of the number of antennas may be carried by a drape that at least partially surrounds a patient support structure that carries a patient during a medical procedure. At least a plurality of the number of antennas may be carried by a shade that extends from a light fixture positioned relatively above a patient support structure that carries a patient during a medical procedure. The controller may be configured to receive data signals from the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the data signals representing physiological characteristics of the patient measured by the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. The controller may be configured to receive data signals from the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the data signals representing operational characteristics of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. The controller may be configured to transmit control signals to the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the control signals representing operational instructions to control operation of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. The controller may be communicatively coupled to a display and may be operable to display information related to at least one of the patient or the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. The controller may be communicatively coupled to a user input device and may be operable to receive user input entered via the user input device and to transmit control signals based on the received user input to the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the control signals representing operational instructions to control operation of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. The controller may be configured to receive data signals from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment and to transmit the data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. A first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may be a transducer coupled to the patient and a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may be a dedicated control system for the transducer. The first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may be one of an electrocardiogram electrode, a pulse oximetry transducer and the second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may be a dedicated electrocardiogram processing system or a pulse oximetry processing system. At least one of the antennas may be responsive to a force exerted thereon and the controller may be configured to receive a signal indicative of the force exerted on the antenna and to produce a notification if the force exceeds at least one of an amplitude threshold or a time duration.
  • A method of operating a system in a medical facility, the system including a plurality of antennas and a controller communicatively coupled to the antennas may be summarized as including from time-to-time, transmitting a number of wideband interrogation signals from at least one of the antennas; determining whether a response to the interrogation signals was received via at least one of the antennas from a transponder that marks an object used in a medical procedure; from time-to-time, providing communications with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to emit the interrogation signal or receive the response signal.
  • Transmitting a number of wideband interrogation signals from at least one of the antennas may include transmitting the wideband interrogation signals from a number of antennas carried by a patient support structure that carries a patient during a medical procedure. Transmitting a number of wideband interrogation signals from at least one of the antennas may include transmitting the wideband interrogation signals from a handheld antenna that inductively cooperates with the plurality of antennas carried by the patient support structure. At least one of the number of antennas may be a handheld antenna, and transmitting the wideband interrogation signals may include transmitting the wideband interrogation signal by one of the handheld antenna or the plurality of antennas carried by the patient support structure, and further may include receiving any response signals to the wideband interrogation signals by the other one of the handheld antenna or the plurality of antennas carried by the patient support structure. Transmitting a number of wideband interrogation signals from at least one of the antennas may include transmitting the wideband interrogation signals from at least three loop antennas spaced along a longitudinal axis of one of an operating table, a bed, a mattress or a sheet. Transmitting a number of wideband interrogation signals from at least one of the antennas may include transmitting the wideband interrogation signals from a plurality of antennas carried by a drape that at least partially surrounds a patient support surface that carries a patient during a medical procedure. Transmitting a number of wideband interrogation signals from at least one of the antennas may include transmitting the wideband interrogation signals from a plurality of antennas carried by a shade that extends from a light fixture positioned relatively above a patient support surface that carries a patient during a medical procedure. Providing communications with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the antennas may include receiving data signals from the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the data signals representing physiological characteristics of the patient measured by the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. Providing communications with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the antennas may include receiving data signals from the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the data signals representing operational characteristics of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. Providing communications with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the antennas may include transmitting control signals to the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the control signals representing operational instructions to control operation of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. The method may further include transmitting information by the controller to a display to display information related to at least one of the patient or the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. The method may further include receiving by the controller user input entered by a user via a user input device; and transmitting control signals by the controller based on the received user input to the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the control signals representing operational instructions to control operation of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. The method may further include receiving data signals by the controller via at least one of the antennas from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment; and transmitting the received data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment. Receiving data signals by the controller via at least one of the antennas from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may include receiving data signals from a transducer coupled to the patient and transmitting the received data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may include transmitting the data signals to a dedicated control system for the transducer. Receiving data signals by the controller via at least one of the antennas from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may include receiving data signals from one of an electrocardiogram electrode, a pulse oximetry transducer and transmitting the received data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment may include transmitting the data signals to one of a dedicated electrocardiogram processing system or a pulse oximetry processing system. At least one of the antennas may be responsive to a force exerted thereon and may further include receiving signals by the controller indicative of the force exerted on the antenna; and may produce a notification if the force exceeds at least one of an amplitude threshold or a time duration.
  • A physiological condition monitor may be summarized as including a transducer coupleable to a patient to sense a physiological condition of the patient; an antenna physically coupled to the transducer; and a transmitter communicatively coupled to the transducer and to the antenna and configured to transmit signals indicative of the sensed physiological condition of the patient via the antenna to a plurality of antennas remote from the device. The antennas may be positioned proximate a patient support surface.
  • The physiological condition monitor may further include an energy storage device electrically coupled to provide power to the transmitter. The physiological condition monitor may further include a circuit configured to transform electromagnetic energy into electrical power, and coupled to supply the electrical power to the transmitter. The physiological condition monitor may further include a circuit that encodes an identifier that uniquely identifiers the physiological condition monitor from other physiological condition monitors. The physiological condition monitor may have a portion that bears an optical marking. The optical marking may encode an identifier which may uniquely identify the physiological condition monitor.
  • A system for use in a medical facility may be summarized as including a number of antennas, at least some of the antennas responsive to a force asserted thereon; and a controller communicatively coupled to the antennas and configured to selectively cause at least one of the antennas to emit an interrogation signal and to detect a response signal, if any, from a number of transponders physically coupled to a number of objects used in medical procedures, wherein the controller is further configured to receive signals from at least some of the antennas indicative of the force asserted on the antenna.
  • The controller may be configured to produce a notification if the force exerted on at least one of the antennas exceeds at least one of an amplitude threshold or a time duration threshold. The controller may be configured to produce a notification if the force exerted on at least one of the antennas exceeds an amplitude threshold over a period of time that exceeds a time duration threshold. The controller may be configured to produce a notification indicative of a position or location on the patient support structure or patient where an excessive force is being exerted. The controller may be configured to transmit a notification via at least one of the antennas in response to the force asserted on at least one of the antennas exceeding a defined threshold.
  • A method of operating a system in a medical facility, the system including a plurality of antennas and a controller communicatively coupled to the antennas, at least some of the antennas responsive to a force asserted thereon, may be summarized as including from time-to-time, transmitting a wideband interrogation signals from at least one of the antennas; determining whether a response to the interrogation signal was received via at least one of the antennas from a transponder that marks an object used in medical procedures; from time-to-time, receiving signals from at least some of the antennas indicative of the force asserted on the antenna.
  • The method may further include producing a notification by the controller which may be configured to produce a notification if the force exerted on at least one of the antenna exceeds at least one of an amplitude threshold or a time duration threshold. The method may further include producing a notification by the controller if the force exerted on at least one of the antenna exceeds an amplitude threshold over a period of time that exceeds a time duration threshold. The method may further include producing a notification by the controller indicative of a position or location on the patient support structure or patient where an excessive force is being exerted. The method may include transmitting a notification via at least one of the antennas in response to the force asserted on at least one of the antennas exceeding a defined threshold.
  • BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
  • In the drawings, identical reference numbers identify similar elements or acts. The sizes and relative positions of elements in the drawings are not necessarily drawn to scale. For example, the shapes of various elements and angles are not drawn to scale, and some of these elements are arbitrarily enlarged and positioned to improve drawing legibility. Further, the particular shapes of the elements as drawn, are not intended to convey any information regarding the actual shape of the particular elements, and have been solely selected for ease of recognition in the drawings.
  • FIG. 1 is a schematic diagram showing an environment in which a medical procedure is performed, for example a surgical environment including a table, bed or other structure to carry or support at least a portion of a patient, that includes a plurality of antennas, and a controller communicatively coupled to the antennas an interrogation and detection system to detect an object tagged with a transponder in a patient, according to one illustrated embodiment.
  • FIG. 2 a top plan view of the table, bed or other structure of FIG. 1 showing the plurality of antennas, according to one illustrated embodiment.
  • FIG. 3 is a top plan view of the table, bed or other structure of FIG. 1 showing approximate ranges of each of the antennas of FIG. 2.
  • FIG. 4 is a top plan view of a patient support structure showing a number of antennas on a patient support surface and a number of antennas on an opposed surface, according to another illustrated embodiment.
  • FIG. 5A is a side elevational view of the patient support structure of FIG. 4.
  • FIG. 5B is a cross-sectional view of the patient support structure of FIG. 4 taken along section line 6 of FIG. 4.
  • FIG. 6A is a top plan view of a support structure showing a number of antennas on a patient support surface and a number of antennas on an opposed surface, according to yet another illustrated embodiment.
  • FIG. 6B is a cross-sectional view of the patient support structure of FIG. 6A taken along section line 7 of FIG. 6A.
  • FIG. 6C is a partial isometric view of the patient support structure of FIGS. 6A and 6B, enlarged to illustrated electrically conductive paths or traces of the antennas.
  • FIG. 7 is a cross-sectional view of a patient support structure having recesses in which the antennas are received, according to another illustrated embodiment.
  • FIG. 8A is a top plan view of a patient support structure in the form of a bed or an operating table showing a number of antennas arranged in a non-overlapping relationship, according to another illustrated embodiment.
  • FIG. 8B is a top plan view of a patient support structure in the form of a mattress or pad showing a number of antennas arranged in a non-overlapping relationship, according to another illustrated embodiment.
  • FIG. 8C is a top plan view of a patient support structure in the form of a sheet showing a number of antennas arranged in a non-overlapping relationship, according to another illustrated embodiment.
  • FIG. 9 is an enlarged top plan view of an antenna according to one illustrated embodiment, where the antenna is formed from multiple coils of a conductive material that is radiolucent.
  • FIG. 10A is an enlarged top plan view of an antenna according to one illustrated embodiment, wherein the antenna is formed of a top coil of conductive material and a bottom coil of conductive material.
  • FIG. 10B is an enlarged top plan view of the top coil of the antenna FIG. 10A.
  • FIG. 10C is an enlarged top plan view of the bottom coil of the antenna FIG. 10A.
  • FIG. 10D is a cross-sectional view of a portion of a patient support structure carrying the top and bottom coils of the antenna of FIG. 10A according to one illustrated embodiment.
  • FIG. 10E is a cross-sectional view of a patient support structure with a plurality of antennas according to another illustrated embodiment.
  • FIG. 10F is a top plan view of a patient support structure comprising a plurality of antennas according to still another illustrated embodiment.
  • FIG. 11 is a cross-sectional view of a portion of a patient support structure with an antenna carried in opposed surfaces thereof, according to yet still another illustrated embodiment.
  • FIG. 12 is a cross-sectional view of a portion of a patient support structure an antenna of FIG. 10A carried on opposed surfaced thereof, according to even another illustrated embodiment.
  • FIG. 13A is a schematic diagram showing a surgical table with a plurality of antennas and a controller positioned in a pedestal of the surgical table, according to another illustrated embodiment.
  • FIG. 13B is a schematic diagram showing a bed such as a patient bed used in an environment where medical procedures are preformed, the bed including a plurality of antennas and a controller positioned on a frame of the bed, according to another illustrated embodiment.
  • FIG. 14A is a side elevational view of an overhead light fixture for use in a medical procedure and a light shade with several antennas supported by the light fixture, according to one embodiment in which the light shade is shown in a retracted position or configuration of FIG. 10A.
  • FIG. 14B is a side elevational view of the light fixture and a light shade in which the light shade is shown in an extended position or configuration.
  • FIG. 14C is a side elevational view of a light fixture for use in a medical procedure and a light shade with several antennas according to another illustrated embodiment.
  • FIG. 15A is an isometric view of a track and a curtain or drape containing several antennas, according to one illustrated embodiment.
  • FIG. 15B is a side elevational view of a sheet containing several antennas and configured to be hung from a support according to one embodiment.
  • FIG. 16 is a schematic diagram of a controller, according to one illustrated embodiment, including a motherboard and a plurality of plug-in boards, one for each of the antennas.
  • FIG. 17 is a schematic diagram of a portion of a control system of the interrogation and detection system, according to one illustrated embodiment.
  • FIG. 18 is a schematic diagram of a software configuration of the interrogation and detection system, according to one illustrated embodiment.
  • FIGS. 19A-19I are an electrical schematic diagram of the interrogation and detection system including a control circuit and antenna, according to one illustrated embodiment.
  • FIG. 20 is a timing diagram illustrating a method of frequency hopping, according to one illustrated embodiment.
  • FIG. 21A is a timing diagram illustrating pulsed timing, according to one illustrated embodiment.
  • FIG. 21B is a timing diagram illustrating pulsed timing, according to another illustrated embodiment.
  • FIG. 22 is a timing diagram showing activation of a pair of transistors of the control circuit in a push-pull configuration to drive the antenna, according to one illustrated embodiment.
  • FIG. 23A is a flow diagram of a method of operating an interrogation and detection system, according to one illustrated embodiment.
  • FIG. 23B is a flow diagram of a method of monitoring all antennas for a response to an interrogation signal, according to one illustrated embodiment.
  • FIG. 23C is a flow diagram of a method of monitoring all antennas except a transmitting antenna for a response to an interrogation signal, according to one illustrated embodiment.
  • FIG. 24A is a high level flow diagram of a method of operating an interrogation and detection system to detect transponders, according to one illustrated embodiment.
  • FIG. 24B is a low level flow diagram of a method of operating an interrogation and detection system to sample noise and responses and to adjust sampling times and perform noise correction, according to one illustrated embodiment, the method useful with the method of FIG. 24A.
  • FIG. 24C is a flow diagram of a method of operating an interrogation and detection system to determine whether a transponder has been detected, according to one illustrated embodiment, the method useful with the method of FIG. 24A.
  • FIGS. 25A-25F are flow diagrams of methods of operating an interrogation and detection system by measuring and/or compensating for noise, according to various illustrated embodiments, the methods useful with the method of FIG. 24A.
  • FIG. 26A is a graph showing a measured or sampled response versus time without noise cancellation where a noise source is present but no transponder is present, according to one illustrated embodiment.
  • FIG. 26B is a graph showing a measured or sampled response versus time with noise cancellation where a noise source is present but not transponder is present, according to one illustrated embodiment.
  • FIG. 26C is a graph showing a measured or sampled response versus frequency without noise cancellation where a noise source is present but no transponder is present, according to one illustrated embodiment.
  • FIG. 26D is a graph showing a measured or sampled response versus frequency with noise cancellation where a noise source is present but not transponder is present, according to one illustrated embodiment.
  • FIG. 27A is a graph showing a measured or sampled response versus time without noise cancellation where a noise source and a transponder are present, according to one illustrated embodiment.
  • FIG. 27B is a graph showing a measured or sampled response versus time with noise cancellation where a noise source and a transponder are present, according to one illustrated embodiment.
  • FIG. 27C is a graph showing a measured or sampled response versus frequency without noise cancellation where a noise source and a transponder are present, according to one illustrated embodiment.
  • FIG. 27D is a graph showing a measured or sampled response versus frequency with noise cancellation where a noise source and a transponder are present, according to one illustrated embodiment.
  • FIG. 28 is an isometric view of a surgical environment including an operating table that carries a plurality of antennas, a hand held wand antenna, and a controller according to one illustrated embodiment.
  • FIG. 29 is an isometric view of a surgical environment including a patient support structure in the form of a surgical table that includes a plurality of antennas, and a controller communicatively coupled to the antennas and to a display screen and user input.
  • FIG. 30A is a top plan view of a wireless electrode, according to one illustrated embodiment.
  • FIG. 30B is top plan view of a plurality of wireless electrode attached to a patient on a patient support structure.
  • FIG. 30C is a top plan view of two wireless electrodes connected by one wire.
  • FIG. 31 is a top plan view of a plurality of leads attached to a patient, each lead extending to an intermediary relay which wirelessly communicates with at least one antenna of an interrogation and detection system.
  • FIG. 32 is a side elevational view of a wireless pulse oximeter attached to the finger of a patient,
  • FIG. 33 is a side elevational view of a wireless intra-cranial pressure monitor attached to a patient's head.
  • FIG. 34 is a side elevational view of an infusion pump with a radio attached thereto.
  • FIG. 35 is a side elevation view of an intra-aortal balloon pump with a radio attached thereto.
  • FIG. 36 is a schematic diagram of a controller, according to one illustrated embodiment, including a motherboard and a plurality of plug-in boards, one for each of the antennas, as well as additional plug-in boards to enable communication with medical telemetry devices.
  • DETAILED DESCRIPTION
  • In the following description, certain specific details are set forth in order to provide a thorough understanding of various disclosed embodiments. However, one skilled in the relevant art will recognize that embodiments may be practiced without one or more of these specific details, or with other methods, components, materials, etc. In other instances, well-known structures associated with transmitters, receivers, or transceivers and/or medical equipment and medical facilities have not been shown or described in detail to avoid unnecessarily obscuring descriptions of the embodiments.
  • Unless the context requires otherwise, throughout the specification and claims which follow, the word “comprise” and variations thereof, such as, “comprises” and “comprising” are to be construed in an open, inclusive sense, that is as “including, but not limited to.”
  • Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Further more, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
  • As used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. It should also be noted that the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
  • The headings and Abstract of the Disclosure provided herein are for convenience only and do not interpret the scope or meaning of the embodiments.
  • Many of the embodiments described herein, perform interrogation and detection of transponder tagged objects using multiple antennas (e.g., six antennas). Successive ones of the antennas may be used to transmit an interrogation signal, while two or more antennas are monitored for a response to the interrogation signal. Such may provide significant advantages over more conventional methods, for example motion based methods that employ motion (e.g., sweeping) of an antenna (e.g., wand) over a patient. For instance, this allows the transmit and receive paths to the transponder to be different from one another (e.g., transmit path is from a first antenna to a transponder, while the receive path is from the transponder to a second antenna). Hence, the path length to the transponder may be shortened in many configurations, thus improving the signal. For instance, when using a single antenna to both transmit an interrogation signal and to receive a response to the interrogation signal, the power of the received signal is equal to about the 6th root of the input power. However, when using multiple antennas to transmit and receive over the same area, interrogation path length in one direction may be shorter. Another advantage is that all scan time is averaged, allowing a longer noise time averaging (e.g., 10 seconds) as opposed to motion based scanning, where integration time may be limited (e.g., about 0.25 seconds per sample). Even further, a representative value of noise samples measured over a plurality of antennas may be employed to determine noise to be removed from noise plus signals received at one of the antennas, thereby advantageously lowering a noise floor and/or increasing range or performance. Thus, the various disclosed embodiments may provide significantly better performance.
  • FIGS. 1 and 2 show a medical procedure environment 10 in which medical procedures are performed, for example a surgical environment in which surgeries are performed, a patient room in which child birth deliveries or other medical procedures are performed or a physician's office, etc. The medical procedure environment 10 includes a table (e.g., surgical table), bed, or other structure 12 which can carry a patient or portion thereof and an interrogation and detection system 14. The interrogation and detection system 14 includes a plurality of antennas 16 a-16 f (collectively 16, shown in broken line in FIG. 1 to indicate that such are hidden in that view) which are carried by the patient support surface 12. The interrogation and detection system 14 also includes a controller 18 communicatively coupleable to the antennas 16 by one or more wired or wireless communication paths, for example coaxial cable 20. As discussed in detail below, the interrogation and detection system 14 is operable to ascertain the presence or absence of objects 22 a, 22 b (collectively 22) tagged with transponders 24 a, 24 b (collectively 24), which may be in or on a patient (not shown).
  • The table, bed or other structure 12 may include a patient support structure 26 and a pedestal or base 28 which supports the patient support structure 26. The patient support structure 26 should have dimensions sufficient to support at least a portion of a patient during a medical procedure, for instance during surgery, child birth, etc. Hence, the patient support structure 26 may have a length of six feet or more and a width of two feet or more. The patient support structure 26 may have two or more articulated sections 26 a-26 c, as illustrated in FIG. 1 or 2, or may be an unarticulated or unitary structure as illustrated in FIGS. 4, 7 and 9. Hinges 30 a, 30 b (collectively 30) or other coupling structures may couple the articulated sections 26 a-26 c. The hinges 30 may, for example, be located along a longitudinal axis 32 of the patient support structure 26 at locations that would approximate the anticipated position of a between a patient's legs and torso and between the patient's torso and head.
  • The patient support structure 26 is preferably made of a rigid material and is preferably radiolucent. Various radiolucent materials may be employed, for instance carbon fiber or radiolucent plastics. Such advantageously allows radiological technologies to be employed, for example X-ray imaging. For example, the patient support structure 26 may be molded from plastics such as an acrylic or a phenolic resin (e.g., commercially available under the trademark SPAULDITE®). In some embodiments, the patient support structure 26 may include a frame. The frame may be made of a metal which may not be radiolucent. In such embodiments, the frame preferably makes up a small percentage of the total area of the patient support structure 26. The patient support structure 26 may be capable of withstanding multiple cycles of sterilization (e.g., chemical, heat, radiation, etc.). A large variety of surgical tables, patient beds and other structures capable of carrying a patient or a portion of a patient are commercially available. Many of these commercially available structures include electric motors and electronics. Typically, there is no or minimum regulation of non-ionizing electromagnetic radiation generated by such electric motors and electronics. Hence, many environments 10 in which medical procedures are performed tend to be electromagnetically noisy environments.
  • The table, bed or other structure 12 may include one or more mattresses or pads 34 a-34 c (collectively 34), and/or may include one or more sheets (not shown in FIG. 1 for sake of clarity of illustration). The mattresses or pads 34 and/or sheets may overlie the antennas 16. The mattresses or pads 34 may take a variety of forms, and may be disposable, or may be capable of withstanding multiple cycles of sterilization (e.g., chemical, heat, radiation, etc.). The mattresses or pads 34 are preferably radiolucent. The mattresses or pads 34 may take a conventional form, for example cotton, open cell or a closed cell foam rubber, with or without an appropriate cover. Alternatively, the mattresses or pads 34 may include one or more bladders (e.g., dual layer urethane envelope) to receive a fluid (e.g., air, water, etc.) to selectively inflate one or more portions of the mattresses or pads 34, and/or to control a temperature of one or more portions of the mattresses or pads 34. In such embodiments, the fluid should be radiolucent. The mattresses or pads 34 may be detachably secured to the patient support structure 26 via various fasteners, for instance ties, or hook and loop fastener commonly available under the trademark VELCRO®.
  • The pedestal or base 28 may be fixed, or may be moveable. The pedestal or base 28 may include one or more actuators (e.g., motors, pumps, hydraulics, etc.) and/or drive mechanisms (e.g., gears, mechanical couplings) or linkages (not shown) that allow a position and/or orientation of the patient support structure 26 to be adjusted. For example, the pedestal or base 28 may telescope to allow the patient support structure 26 to be mechanically raised and lowered. Also for example, the pedestal or base 28 may allow the patient support structure 26 to be mechanically tilted or rotated about an axis that is perpendicular to a patient support surface 37 of the patient support structure 26.
  • As illustrated, portions of one or more of the antennas 16 may overlap. For example, where the antennas are coil antennas, each formed of one or more coils, a portion of an area enclosed by an outermost coil of each antenna 16 may overlap a portion of an area enclosed by an outermost coil of a neighboring antenna 16. The area enclosed or enclosed area may be an area enclosed by a normal or perpendicular projection of a perimeter defined the outermost coil of the respective antenna 16. In such embodiments, neighboring antennas 16 may be electrically insulated from one another by one or more electrically insulating layers or substrates. For example, successively adjacent antennas 16 may be carried one opposite surfaces (e.g., opposed outer surfaces, or multiple inner surfaces, or one or more outer and inner surfaces) of a single substrate. As discussed in more detail below, the antennas may advantageously be radiolucent, for example being formed of a radiolucent material (e.g., substantially transparent to X-ray or Gamma ray radiation) or a material that at a thickness employed is substantially radiolucent. For example, an electrically conductive trace of aluminum having a thickness of 200 microns or less sufficiently passes X-rays to be considered radiolucent. More preferably, an aluminum trace having a thickness of 30 microns sufficiently passes X-rays such that even a stack or overlapping portions of three coils (combined thickness under 100 microns) to be radiolucent. An antenna may be considered radiolucent if it is not detectable by a radiologist in an X-ray produced via 10 kV to 120 kV X-ray machine, or preferably a 40 KV X-ray machine in conjunction with a standard 12 inch X-ray image intensifier. An antenna may be considered radiolucent if a coil includes thirty turns or windings and is not detectable by a radiologist in an X-ray.
  • The patient support structure 26 may include one or more film receiving receptacles 29 (only one called out in FIG. 1). The film receiving receptacles 29 may be spaced relatively below a patient support surface 37 of the patient support structure 26. The film receiving receptacles 29 are sized, dimensioned and/or positioned to receive film, for example X-ray film. The film receiving receptacles 29 my be sized and/or dimensioned to receive a film tray or other film holder (not illustrated) which holds the film. Along with the use of radiolucent materials, such advantageously allows a patient X-ray images or other radiological images of the patient to be produced, generated or made, while the patient is supported by the patient support structure 26. As used herein an in the claims, the term radiolucent means substantially transmissive to energy in the X-ray portion of the electromagnetic spectrum, that is passing sufficient X-ray energy to produce an X-ray image at standard power levels and standard conditions employed in conventional medical imaging.
  • The table (e.g., surgical table), bed or other structure 12 may include an interrogation and detection system interface 36. The interrogation and detection system interface 36 may include one or more communications ports 38 that allow communicative coupling to be selectively or detachably made between the antennas 16 and the controller 18. Such communications ports 38 may, for example, take the form of coaxial connectors, or other communications connectors. Interrogation and detection system interface 36 may include one or more output devices to provide indications to a user. For instance, the interrogation and detection system interface 36 may include one or more visual indicators 40 (only one called out in FIGS. 1 and 2) to provide indications of a presence and/or an absence of an object. Such may also provide a visual indication that is indicative of a status of a scanning operation by the interrogation and detection system 14, for instance scanning started, scanning completed, and/or occurrence of an error condition. The visual indicators 40 may take a variety of forms, for example light sources of one or more colors. Light sources may include incandescent lights, light emitting diodes (LEDs), organic light emitting diodes (OLEDs), and/or liquid crystal displays (LCDs). Also for instance, the interrogation and detection system interface 36 may include one or more aural indicators 42 to provide aural indications of a presence and/or an absence of an object and/or a status of a scan operation or occurrence of an error condition. The aural indicator 42 may, for example, take the form of one or more speakers. The interrogation and detection system interface 36 may include one or more switches 44 that allow input to be provided to the controller 18. Switches 44 may, for example, allow a user to turn ON the interrogation and detection system 14, start a scan operation, stop a scan operation, adjust a sensitivity of the scanning, adjust one or more frequencies, select or adjust an output type (e.g., type of visual alert, type of aural alert) or level (e.g., brightness, sound level or volume, etc.).
  • The objects 22 may take a variety of forms, for example instruments, accessories and/or disposable objects useful in performing medical procedures, for example surgical procedures, child birth delivery procedures, and/or other medically related procedures. For instance, some objects 16 a may take the form of scalpels, scissors, forceps, hemostats, and/or clamps. Also for example, some objects 22 b may take the form of sponges (e.g., surgical sponges), gauze and/or padding. The objects 22 are tagged, carrying, attached or otherwise coupled to a respective transponder 24. Some embodiments of the interrogation and detection system 14 disclosed herein are particularly suited to operate with transponders 26 which are not accurately tuned to a chosen or selected resonant frequency. Consequently, the transponders 24 do not require high manufacturing tolerances or expensive materials, and thus may be inexpensive to manufacture.
  • Transponders 24 may include a miniature ferrite rod with a conductive coil wrapped about an exterior surface thereof to form an inductor (L), and a capacitor (C) coupled to the conductive coil to form a series LC circuit. The conductive coil may, for example, take the form of a spiral wound conductive wire with an electrically insulative sheath or sleeve. The transponder 24 may include an encapsulation that encapsulates the ferrite rod, conductive coil, and capacitor. The encapsulant may be a bio-inert plastic, that protects the ferrite rod, conductive coil and/or capacitor from pressure and/or from fluids, for example bodily fluids. In some embodiments, the ferrite rod may include a passage sized to receive a physical coupler, for example a bonding tie or string. The bonding tie or string may take the form of an elastomeric x-ray opaque flexible elongated member, that may be used to attach the transponder 24 to various types of objects 22, for example surgical sponges. The transponder 24 may have a length of about 8 millimeters and a diameter of about 2 millimeters. Employing such small dimensions ensures that the transponder 24 does not impede deformation of objects 16 such as sponges. The transponder 24 may include an optional diode (not shown), to protect against over-voltage occurrences caused by other electronic instruments. The transponders 24 may be attached to hemostats, scissors, certain forms of forceps, and the like. In some embodiments, the transponders 24 may be coupled to the object 22 by way of a clamp or holder. In some embodiments, the transponders 24 may be retained within a cavity of the holder. In some embodiments, the holder may be fashioned of a durable deformable material, such as surgical grade polymer, which may be deformed to clamp securely onto the finger or thumbhole of an instrument. In other embodiments, the transponders 24 may be attached to objects 22 by way of pouches fashioned of sheet material (e.g., surgical fabric) surrounding the transponder 24. The transponder 24 is retained within the pouch, and in some embodiments the pouch may be sewn or otherwise sealed. Sealing may be done with adhesive, hot glue, clamping, grommeting, or the like. Various embodiments of suitable transponders and retention devices are discussed in U.S. Provisional Patent Application No. 60/811,376 filed Jun. 6, 2006, U.S. Provisional Patent Application No. 61/091,667 filed Aug. 25, 2008, U.S. patent application Ser. No. 11/759141 filed Jun. 6, 2007, U.S. patent application Ser. No. 12/046,396 filed Mar. 11, 2008, U.S. Pat. No. 6,026,818 issued Feb. 22, 2000, U.S. Design patent application Ser. No. 29/322,539 filed Aug. 6, 2008 and U.S. Design Pat. No. D568,186 issued May 6, 2008, all of which are incorporated herein by reference in their entireties.
  • In use, the medical provider 12 may use the switches 44 to cause a scan of the patient 18, for instance jut before closing during surgery, in order to detect the presence or absence of the transponder 26, and hence an object 16.
  • FIG. 3 shows approximate ranges R1-R6 for the six antennas 16 of the embodiment of FIGS. 1 and 2.
  • FIG. 3 is illustrative and does not necessarily represent actual ranges. The illustrated ranges R1-R6 (collectively R) show that the ranges R1-R6 are typically larger than the area of the antennas 16. Ranges R1-R6 may be affected by a variety of factors, including the power of the interrogation signal, distance between the transponders 24 and the antennas 16, and/or the sensitivity and/or impedance matching between the transponders 24 and interrogation and detection system 14. Many of the ranges R1-R5 overlap neighboring ranges R1-R5, although in this illustrated embodiment one range R6 does not overlap any other range R1-R5. In other embodiments, all ranges overlap. Alternatively, none of the ranges may overlap. Other arrangements of antennas 16 and/or ranges R, are of course possible.
  • FIGS. 4, 5A and 5B show a patient support structure 626, according to another illustrated embodiment.
  • The patient support structure 626 may, for example, be part of a table, for instance a surgical table, part of a bed or another structure designed to carry a patient or portion of a patient. The patient support structure 626 is a non-articulated, single piece or unitary structure. While illustrated as a single, unitary construction, the patient support structure 626 may be formed of two or more sections, which may or may not be articulated. The patient support structure 626 is formed as a substrate 650 having a patient support surface 637 and an opposed surface 652 that is opposed from the patient support surface 637. The substrate 650 may be formed of one or more layers. For example, the substrate 650 may be a composite material. The substrate 650 may, for example, be formed as a resin impregnated carbon fiber structure, which may advantageously omit any metal or ferrous metal structural elements. Alternatively, the substrate 650 may minimize the use of any metal or ferrous metal structural elements and locate any metal or ferrous metal structural elements at the peripheries of the substrate 650.
  • A first set of antennas 616 a, 616 c, 616 e, 616 g are positioned on the patient support surface 637, while a second set of antennas 616 b, 616 d, 616 f are positioned on the opposed surface 652. Such allows neighboring ones of the antennas (collectively 616), or portions thereof, to overlap, while electrically insulating each antenna 616 from one another. While illustrated as being carried on outer surfaces of the patient support structure 650 one or more of the antennas 616 could be carried on one or more inner layers of the patient support structure 650 where the patient support structure 650 is formed of two or more layers, for instance as a laminate structure.
  • FIGS. 6A-6C show a patient support structure 626 and antennas 616 a-616 h (collectively 616), according to another illustrated embodiment, wherein individual ones of the electrically conductive paths or traces of the antennas 616 are visible.
  • The patient support structure 626 may, for example, be part of a table, for instance a surgical table, part of a bed (e.g., patient or hospital bed) or another structure designed to carry a patient or portion of a patient on which a medical procedure may be performed. The patient support structure 626 is a non-articulated, single piece or unitary structure. While illustrated as a single, unitary construction, the patient support structure 626 may be formed of two or more sections, which may or may not be articulated. The patient support structure 626 is formed as a substrate 650 having a patient support surface 637 and an opposed surface 652 that is opposed from the patient support surface 637. The substrate 650 may be formed of one or more layers. For example, the substrate 650 may be a composite material. The substrate 650 may, for example, be formed as a resin impregnated carbon fiber structure, which may advantageously omit any metal or ferrous metal structural elements. Alternatively, the substrate 650 may minimize the use of any metal or ferrous metal structural elements and locate any metal or ferrous metal structural elements at the peripheries of the substrate 650.
  • The patient support structure 626 carries antennas 616 thereon and/or therein. As best illustrated in FIGS. 6A and 6B, the antennas can be treated as two sets. A first set of antennas 616 a-616 f arranged generally adjacent one another in an array of two rows on either side of a longitudinal axis 630 and three columns spaced along the longitudinal axis 630. These antennas 616 a-616 f do not overlap with one another. These antennas 616 a-616 f substantially extend the full length and width of the patient support structure 628. Alternatively, these antennas 616 a-616 f may be spaced inwardly from a perimeter of the patient support structure, for example where the range of the antennas 616 a-616 f sufficiently covers the area of the patient support structure 626. A second set of antennas 616 g, 616 h are arranged generally adjacent one another in an array of one row and two columns. These antennas 616 g, 616 h do not overlap with one another, however these antennas 616 g, 616 h overlap the antennas 616 a-616 f of the first set when viewed from above the patient support structure 626. These antennas 616 g, 616 h enhance the overall coverage of the entire area of the patient support structure 626 and volume spaced generally there above.
  • While illustrated as being carried an upper outer surface 637 of the patient support structure 626, one or more of the antennas 616 could be carried on a lower outer surface 652 and/or on one or more inner layers of the patient support structure 626, for instance where the patient support structure 626 is a laminate structure.
  • FIG. 6C shows one embodiment of the antennas 616, which may allow relatively simple and low cost manufacturing, and which prevents the antennas 616 from electrically shorting one another.
  • In particular, each antenna may be formed as electrically conductive paths or traces on one or more layers of an electrically non-conductive or insulative substrate, for instance a flexible substrate of circuit board material (e.g. FR4, Kapton). The electrically conductive path or trace may form a coil pattern, hence a coil antenna with multiple windings, as illustrated in FIG. 6C. Portions of the electrically conductive path on one end or half of the substrate may be electrically coupled to respective portions of the electrically conductive path on the other end or half of the substrate via electrically conductive material received in a via that extends through a portion or all of the substrate. Thus, while the electrically conductive paths appear to terminate at a centerline 647 of each antenna, the electrically conductive paths are in fact electrically coupled to adjacent portions across the centerline 647 by way of respective vias. Alternatively, the electrically conductive path may have change in direction (e.g., 45 degree turn), such that the electrically conductive path spirals inwardly (or outwardly) with each half turn or half winding. Alternatively, or additionally, an electrically non-conductive or electrically insulative material may overlie the electrically conductive path on a lower surface or side and/or an upper surface or side of the substrate, to provide electrical insulation between overlying substrates.
  • FIG. 7 shows a patient support structure 726, according to another illustrated embodiment.
  • The patient support structure 726 is formed as a substrate 750 having a patient support surface 737 and an opposed surface 752 that is opposed from the patient support surface 737. The substrate 750 may be formed of one or more layers. For example, the substrate 750 may be a composite material. The substrate 750 may, for example, be formed as a resin impregnated carbon fiber structure, which may advantageously omit any metal or ferrous metal structural elements. Alternatively, the substrate 750 may minimize the use of any metal or ferrous metal structural elements and locate any metal or ferrous metal structural elements at the peripheries of the substrate 750. While illustrated as a single, unitary construction, the patient support structure 726 may be formed of two or more sections, which may or may not be articulated.
  • A first set of antennas 716 a, 716 c, 716 e, 716 g are positioned in respective recesses formed in the patient support surface 737, while a second set of antennas 716 b, 716 d, 716 f are positioned in respective recesses formed in the opposed surface 752. Such allows neighboring ones of the antennas (collectively 716) to overlap, while electrically insulating each antenna 716 from one another. Such also advantageously spaced the antennas 716 of the first and second sets closer together with respect to one another, which may produce more consistent results or performance between the various antennas 716. While illustrated as being carried on outer surfaces of the patient support structure 750 one or more of the antennas 716 could be carried on one or more inner layers of the patient support structure 750 where the patient support structure 750 is formed of two or more layers, for instance as a laminate structure.
  • FIG. 8A shows a patient support structure 826A, according to another illustrated embodiment.
  • The patient support structure 826A is a non-articulated, single piece or unitary structure. While illustrated as a single, unitary construction, the patient support structure 826A may be formed of two or more sections, which may or may not be articulated. The patient support structure 826A may be formed of a variety of materials, for example, the materials of the above described embodiments.
  • Notably, the patient support structure 826A carries a set of antennas 816Aa-816Af (collectively 816A), which are positioned along a longitudinal axis 830 of the patient support structure 826A. While illustrated as positioned in non-overlapping fashioned, in some embodiments the antennas 816A may be positioned in overlapping fashion. While five antennas 816B are illustrated, the patient support structure 826A may include a greater or lesser number of antennas 816A. Consequently, the antennas 816A may all be carried on the same outer surface (e.g., patient support surface) or inner surface or layer. Thus, may advantageously provide more consistent results or performance between the respective antennas 816, and/or may simply manufacturing and/or maintenance.
  • FIG. 8B shows a patient support structure, according to another illustrated embodiment.
  • The patient support structure takes the form of a mattress or pad 826B which may, for example, be used on a table or bed when performing a medical procedure. While illustrated as an articulated structure with two joints or hinges 830Ba, 830Bb (collectively 830B), the mattress or pad 826B may be formed of a unitary, single piece non-articulated structure. The mattress or pad 826B may be reusable, and hence should be capable of withstanding repeated sterilization procedures (e.g., heat, chemical, radiation, etc.). Alternatively, the mattress or pad 826B may be disposable after a single use. The mattress or pad 826B may be formed of a variety of materials, for example, the materials of the above described embodiments of mattresses or pads. As previously discussed in reference to mattresses or pads, the mattress or pad 826B may include an outer layer or cover 892B and an interior 890B (visible through broken portion of outer layer 892B). The outer layer or cover 892B provides environmental protection to the interior 890B. The interior 890B may, for example, take the form of a conformable interior, which may be made of any variety of materials. Suitable material may, for example, include cotton or a foam material such as a closed or an open cell foam rubber or LATEX®. Alternatively, the conformable interior may take the form of a fluid (e.g., a liquid or a gas). The outer layer or cover 892B may be made of cotton, nylon, rayon or other natural or synthetic materials. The outer layer or cover 892B may, for example, be impervious to liquids. For example, the outer layer or cover 892B may include one or more layers of a rubber, LATEX®, polyvinyl chloride, plastic or other material that is impervious to fluids, for example bodily fluids.
  • Notably, the mattress or pad 826B carries a set of antennas 816Ba-816Be (collectively 816B), which are positioned along a longitudinal axis 832B of the mattress or pad 826B. While illustrated as positioned in overlapping fashioned, in some embodiments the antennas 816B may be positioned in non-overlapping fashion. While five antennas 816B are illustrated, the mattress or pad 826B may include a greater or lesser number of antennas 816B. For example, the mattress or pad 826B may have antennas 816 arranged in a similar fashion to that illustrated in FIGS. 6A-6C. The antennas 816B may on opposite sides of a layer on or in the mattress or pad 826B, or on two or more different layers on or in the mattress or pad 826B. The layer or layers may be an outer surface (e.g., patient support surface) or an inner surface or layer. The mattress or pad 826B includes an interface, such as a connector 894B, to allow the antennas 816B to be communicatively coupled to the controller 18 (FIG. 1).
  • FIG. 8C shows a patient support structure, according to another illustrated embodiment.
  • The patient support structure takes the form of a sheet 826C. The sheet 826C may, for example, be used on, over, or in conjunction with a table, bed, frame or other structure during a medical procedure. The sheet 826C may be formed of a unitary, single piece of material or a cloth, for example a fabric. The cloth may, for example, be woven, knitted, felted, pressed, etc. The sheet 826C may be reusable, and hence should be capable of withstanding repeated sterilization procedures (e.g., heat, chemical, radiation, etc.). Alternatively, the sheet 826C may be disposable after a single use. The sheet 826C may be absorbent or may be impermeable to fluids, for example bodily fluids. The sheet 826C may be formed of a variety of materials, for example, cotton, nylon, rayon, or other natural or synthetic fibers. For example, the sheet 826C may include one or more layers of a rubber, LATEX®, polyvinyl chloride, plastic or other material that is impervious to fluids, for example bodily fluids.
  • Notably, the sheet 826C carries a set of antennas 816Ca-816Ce (collectively 816C), which are positioned along a longitudinal axis 832C of the sheet 826C. While illustrated as positioned in overlapping fashioned, in some embodiments the antennas 816C may be positioned in non-overlapping fashion. While six antennas 816C are illustrated, the sheet 826C may include a greater or lesser number of antennas 816C. For example, the antennas 816 may be arranged on the sheet 826 in an identical or similar fashion as illustrated in FIGS. 6A-6C. The antennas 816C may be on opposite sides of the sheet 826C, or on two or more different layers of the sheet 826C. The layer or layers may be an outer surface (e.g., patient support surface) or an inner surface or layer. The sheet 826C includes an interface, such as a connector 894C, to allow the antennas 816C to be communicatively coupled to the controller 18 (FIG. 1).
  • FIG. 9 shows an antenna 916, according to one illustrated embodiment. The antenna 916 may, for example, be suitable for use in any of the previously described embodiments.
  • The antenna 916 may, for example, take the form of an annulus or air-coil formed of coils of conductive material. The conductive material may, for example, take the form of wire or may take the form of a conductive trace printed or otherwise deposited on an inner layer or an outer surface 952 of a substrate 950. In one embodiment, the antenna 916 includes ten turns evenly spaced between an inner diameter of about 11 inches and an outer diameter of about 14 inches. The antenna 916 acts as an inductor. While being formed of a conductive material, the antenna 916 is preferably formed of a radiolucent material. For example, the antenna 916 may be formed as a thin (e.g., thickness, width) strip line aluminum antenna.
  • The antenna 816 includes a pair of terminals 854 a, 854 b that provide electrical coupling to the controller 18 (FIG. 1), for example via the ports 38 of interrogation and detection system interface 36 (FIGS. 1 and 2) and the coaxial cable 20.
  • FIGS. 10A-10C illustrate a coil antenna 1016 according to one embodiment.
  • The coil antenna 1016 comprises a top coil 1017 (illustrated in isolation in FIG. 10B) and a bottom coil 1019 (illustrated in isolation in FIG. 10C). The top and bottom coils 1017, 1019 are carried by the patient support surface 26, the top coil 1017 carried on one layer 1021 a and positioned relatively above the bottom coil 1019 carried on another layer 1021 b. The top coil 1017 is electrically coupled to the bottom coil 1019, for example, by a plug of electrically conductive material 1015 in a via. In practice the via connecting the top coil 1017 to the bottom coil 1019 may comprise a vertical connector of the same material as the coils 1017, 1019. Any suitable conductor may be used to connect the top coil to the bottom coil at the via point. In addition to being offset from each other vertically along a longitudinal axis 1018 of the coils (see FIG. 10D), the individual windings of the two coils are also offset from each other laterally along two perpendicular axes in a horizontal plane (i.e., the plane of the drawing sheet FIG. 10A) that is perpendicular to the longitudinal axis. The layers 1021 a, 1021 b may be opposed outer surfaces of an electrically insulative substrate, one or more inner surfaces of the electrically insulative substrate, or a combination thereof. The electrically insulative substrate may be a unitary part of the patient support surface, integral part of the patient support surface or attach or carried by the patient support surface.
  • FIG. 10D shows the coil antenna 1016 carried by a patient support structure 26, according to one illustrated embodiment.
  • Top coil 1017 is positioned relatively above the bottom coil 1019 in an interior of the patient support structure 26. As noted above, the bottom coil 1019 is offset from the top coil 1017 vertically along a longitudinal axis 1018 as well as laterally in a horizontal plane which is perpendicular to the longitudinal axis 1018. The individual windings 1021 of the top coil 1017 are spaced apart leaving gaps between each winding 1021. The individual windings 1023 of the bottom coil 1019 are spaced directly below the gaps between the windings 1021 of the top coil 1017. The windings 1021, 1023 are thus spread in such a way to provide a more even distribution of radiolucence. This distribution of the windings 1021, 1023 may smooth the contrast that could appear in a radiological image (e.g., X-ray image). FIG. 10D illustrates an embodiment in which the windings 1023 are spaced directly below the gaps between windings 1021 without overlapping the windings 1021 in a lateral direction in the horizontal plane. In other embodiments the windings 1023 may instead slightly overlap the windings 1021. In some embodiments the windings 1021, 1023 may cross over each other although such crossings may have an adverse effect on radio transparency. Many other configurations of the coils 1017, 1019 and the windings 1021, 1023 will be apparent to those of skill in the art and fall within the scope of this disclosure. The configuration of windings illustrated in FIG. 10D are given only by way of example and do not limit the scope of the disclosure. The patient support structure 26 and antenna 1016 are not drawn to scale. Relative heights, widths, and separations of the patient support structure 26 and antenna coils 1017, 1019 may be different in practice than what is shown in FIG. 10D.
  • This design may minimize interference with radiological imagery sources (e.g., X-rays, CAT scans, MRIs) which may be employed while a patient is on the patient support structure 26. Radiological imaging is commonly employed while patients are on the patient support structure 26, for example during surgery. This may, for example, be performed by positioning an X-ray machine above the patient support structure 26 and positioning an X-ray sensitive film below the patient support structure 26. An X-ray image is formed by exposing the film to the X-rays through the patient and patient support structure 26. Any object or material that absorbs or reflects X-rays more than its surroundings will cause an area of contrast in the developed X-ray image. Thus, portions of the patient support 26 structure that absorb more or less than other portions of the patient support structure 26 will appear as a high level of contrast in the developed X-ray image. This can make it difficult to interpret the X-ray image. For this reason it may be beneficial to spread the coils of an antenna, even where nominally radio transparent to reduce the contrast which the antenna may otherwise cause in an X-ray image. A coil antenna with many windings which are stacked or layered are above others may produce a relatively high contrast and appear in an X-ray image even if a single layer of coil is nominally radio transparent. A coil whose windings are spread apart, spread laterally from one another, may also produce relatively large changes in contrast, even where nominally radio transparent. As disclosed herein, the windings of the coils are positioned to be in adjacent non-overlapping relationship to one another when viewed along the longitudinal axis 1018. Such creates an area having a very uniform distribution of antenna material, and hence a very uniform radiological attenuation distribution across that area. Such advantageously may cause any attenuation to be uniform, reducing the antenna's effect on the radiological image.
  • FIGS. 10E and 10F show a patient support structure 26 according to one embodiment.
  • The patient support structure carries six antennas 1016 a-1016 f. Each of the antennas 1016 a-1016 f may be similar or identical in form to the antenna 1016 illustrated in FIG. 10A-10D. The antennas 1016 a-1016 f are positioned to provide little or no gap between antennas in the lateral directions of the horizontal plane of the patient support surface 26, while not overlapping. As described above, this configuration may help to reduce areas of sharp contrast in radiological images. FIG. 10E shows the antennas 1016 a-1016 f embedded within the patient support structure 26. Of course the antennas 1016 a-1016 f may not actually be visible from a top view of the support structure 26. However, FIG. 10F shows the antennas 1016 a-1016 f from the top view to illustrate the relative positions of the antennas 1016 a-1016 f. The number and configuration of coils, as well as the number and configuration of the winding forming those coils, shown in FIG. 10F is not meant to be limiting. In practice there may be a greater or lesser number of coils and/or a greater or lesser number of windings. In practice, the windings are typically not independent loops, but are illustrated as such in FIG. 10F for ease of illustration.
  • FIG. 11 shows a patient support structure carrying an antenna 1116, according to another illustrated embodiment.
  • The antenna 1116 comprises a top coil 1117 and a bottom coil 1119 as previously described. The top coil 1117 comprises windings 1121, while the bottom coil comprises windings 1123. The windings 1121, 1123 are laterally offset from each other in two perpendicular directions in a horizontal plane that is perpendicular to a longitudinal axis of the antenna 1116. The top coil 1117 is formed adjacent to and below a top surface 1137 of the support structure 26, for example in a channel or recess formed in the top section 1137. The bottom coil 1119 is formed above and adjacent to a bottom surface 1152 of the support structure 26, for example, in a channel or recess formed in the bottom section 1152.
  • FIG. 12 illustrates a patient support structure that carries an antenna 1126, according to yet another illustrated embodiment. The antenna 1216 comprises a top coil 1217 and a bottom coil 1219. The top coil 1217 comprises windings 1221, while the bottom coil comprises windings 1223. The windings 1221, 1223 are laterally offset from each other in a horizontal plane that is perpendicular to a longitudinal axis of the antenna 1216. The top coil 1217 is carried directly on a top surface 1237 of the support structure 26. The bottom coil 1219 is carried directly on a bottom surface 1252 of the support structure 26. The top and/or bottom coils 1217, 1219 may be adhered or otherwise physically coupled to the respective surfaces 1237, 1252. The relative dimensions of the features shown in FIG. 12 may not be accurate. For instance, the antenna windings 1221, 1223 may not, in practice, protrude from the surfaces 1237, 1252 to the same extent as illustrated. Many other configurations for the antennas are possible and the preceding embodiments are given only by way of non-limiting example.
  • FIG. 13A shows a surgical environment 1310 that includes a surgical table 1312 and an interrogation and detection system 1314, according to another illustrated embodiment. The embodiment of FIG. 13A is similar in some respects to one or more of the previously described embodiments, hence only significant differences in structure and operation will be discussed.
  • The surgical table 1310 may include a patient support structure 1326 and a pedestal or base 1328. The patient support structure 1326 may be a laminate structure having multiple layers. Alternatively, the patient support structure 1326 may be a shell type structure or housing having an open interior. Alternatively, the patient support structure 1326 may be a solid structure, for example a roto-molded structure.
  • The plurality of antennas 1316 a-1316 f (collectively 1316) of the interrogation and detection system 1314 are carried by the surgical table 1312, for example carried by inner layers of the patient support structure 1326 or positioned in an interior of a shell or housing forming the patient support structure 1326. While illustrated as being in overlapping relationship, in some embodiments the antennas 1316 may not overlap. The controller 1318 of the interrogation and detection system 1314 may be positioned in the pedestal or base 1328, for example in an interior 1330 of the pedestal or base 1328. One or more wired or wireless communication paths may communicatively couple the controller 1318 to the antennas 1316 and/or to an interrogation and detection system interface 1336, for example coaxial cable 1320.
  • The interrogation and detection system 1314 may receive power for a variety of sources, for example from a wall outlet or receptacle via a conventional power cord and plug 1332.
  • The antennas of the interrogation and detection system 14 are not limited to being implemented in a patient support structure 26. Previous embodiments have, by way of example, described various ways of implementing antennas within a patient support structure. These embodiments have been given purely by way of example and are not intended to be limiting. Those of skill in the art will recognize that the antennas may be implemented in many configurations throughout the environment in which medical procedures are performed.
  • FIG. 13B shows an environment in which medical procedures are performed 1340 that includes a bed (e.g., patient bed) 1342 and an interrogation and detection system 1344, according to another illustrated embodiment. The embodiment of FIG. 13B is similar in some respects to one or more of the previously described embodiments, hence only significant differences in structure and operation will be discussed.
  • The environment 1310, may for example, take the form of a hospital room, clinic room, or examination room of a medical practitioner's office.
  • The bed 1342 may include a patient support structure 1346 and a frame or base 1348. The patient support structure 1346 may support one or more mattresses, for example a segmented mattress 1347. The frame 1348 may be made of plastic, metal, composite, reinforced composited, and/or roto-molded materials. Various commercially available designs of frames for patient beds are suitable. The frame 1348 may include a set of wheels 1350 (only one called out in FIG. 13B) allowing the bed 1342 to be easily moved. The frame 1348 may include one or more rails 1352, which may, or may not, be removable or which may, or may not, fold down.
  • The bed 1342 may include one or more electric motors 1354 (only one called out in FIG. 13B) and linkages 1356 (only one called out in FIG. 13B) which are selectively actuated to move or articulate portions of the bed 1342 or mattress 1346. Other mechanisms may be used to move portions of the mattress 1346. Commercially available patient or hospital beds 1342 typically include one or more pieces of electrical or electronic equipment (e.g., electric motors 1354) which are sources of radio noise which may interfere with the interrogation and detection system 1344. Such equipment typically produce very consistent or periodic (i.e., non-random) noise. Some embodiments of the interrogation and detection system 1344 discussed herein employ various techniques to address such non-random noise.
  • The interrogation and detection system 1344 includes a plurality of antennas 1366 a-1366 f (collectively 1366) of the interrogation and detection system 1344 are carried by the patient support structure 1346, mattress 1347 or frame 1348. For example, the antennas 1366 may be carried by inner layers of the mattress 1347 or positioned in an interior of a shell or housing forming the patient support structure 1346. While illustrated as being in non-overlapping relationship, in some embodiments the antennas 1366 may overlap. A controller 1368 of the interrogation and detection system 1344 may be carried by the frame or base 1348. One or more wired or wireless communication paths may communicatively couple the controller 1368 to the antennas 1366 and/or to an interrogation and detection system interface, for example coaxial cable 1370.
  • The interrogation and detection system 1314 may receive power for a variety of sources, for example from a wall outlet or receptacle via a conventional power cord and plug (not shown in FIG. 13B).
  • In some embodiments, antennas, for instance antennas 1316, 1366 (FIGS. 13A, 13B, respectively) may form strain sensors as part of a strain gauge. For example, the antennas may be carried by flexible substrate, for instance a flexible printed circuit board such as a polyimide (Kapton®) or polyester (Mylar®) printed circuit board. The resistance of the antenna varies as the substrate flexes in response to an asserted force. The change in resistance may be measured to determine strain, and hence force applied. The antennas may be configured and coupled in groups of fours to form full Wheatstone bridges. The antennas may additionally, or alternatively, be oriented along various axes or dimensions to detect strain in different directions. Multiple layers of antennas may be employed to detect flex in two opposite directions, normal to the plane of the substrate. Alternatively, dedicated strain sensors or gauges may be employed, which function only to sense force (e.g., strain or pressure) and which do not function as antennas. Sensing strain may be useful in detecting excessive and/or prolonged pressure asserted between a patient and the patient support surface. Excess and/or prolonged pressure may cause the patient to develop “bed sores” or ulcers. Tracking or monitoring pressure may allow the medical care provider to intervene before the “bed sores” or ulcers occur. Thus, the control system may be configured to provide a warning or alert (e.g., visual, aural and/or tactile) when pressure or strain exceeds some threshold in amplitude and/or time. For instance, the controller may produce a notification if the force exerted on at least one of the antenna exceeds an amplitude threshold over a period of time that exceeds a time duration threshold. The control system may additionally, or alternatively, provide an indication of a position or location on the patient support surface or patient where the excessive pressure is occurring or being asserted. For instance, the controller may display a map of the patient support structure and/or patient, with icons or alphanumeric indications indicative of various locations where excessive force is being asserted and/or an amplitude of force being asserted at respective locations on the map.
  • FIG. 14A shows a number of antennas 1416 carried by a lightshade 1432 of a light fixture 1434 used in medical procedures, according to one illustrated embodiment, in which the lightshade is shown in a retracted or undeployed position or configuration. The light fixture 1434 may house one or more lights to be used during surgery, birth delivery or other medical procedure, including dental procedures. During a medical procedure such as surgery, the patient laying on a patient support structure is typically illuminated brightly by an overhead light fixture 1434. The light fixture 1434 may be situated directly above the operating table or slightly offset as desired. The light fixture 1434 is also generally positioned as close to the patient as possible without impeding the medical services providers (e.g., surgeons and staff) during the medical procedure (e.g., surgery, birth delivery). The proximal overhead position allows the light fixture 1434 to brightly illuminate the patient. The light fixture 1434 is positioned so as to reduce or eliminate any shadows on the patient's body during the surgery.
  • The proximal overhead position of the light fixture 1434 provides an excellent location for the antennas 1416 of an interrogation and detection system. There are five loop antennas 1416 visible in the lightshade 1432 illustrated in FIG. 14A. However, there may be more antennas 1416 on a far side of the lightshade 1432, not visible in FIG. 14A. The number of antennas 1416 located on the lightshade 1432 may be any number suitable for the interrogation process.
  • The lightshade 1432 may be attached to the light fixture 1434 by extendable and retractable support arms 1436. As noted, FIG. 14A illustrates the lightshade 1432 in a retracted or undeployed position or configuration, raised relative to the light fixture 1434. The support arms 1436 may include hinges 1438 or other linkages. The hinges 1436 or other linkages enable the lightshade 1432 to be moved to an extended or deployed position or configuration, lowered relative to the light fixture 1434 and the patient support surface, for example, as illustrated in FIG. 14B. In one embodiment the antennas 1416 of the lightshade 1432 may be operable in the raised position. In one embodiment the antennas 1416 may be attached to the light fixture 1434 in a form other than that of a lightshade 1432.
  • FIG. 14C shows a lightshade 1432 is coupled to the light fixture 1434 without the use of supporting arms 1436, according to yet another illustrated embodiment.
  • The lightshade 1432 may be a flexible sheet carrying a number of antennas 1416. The flexible sheet is coupleable to the light fixture 1434 by wrapping the flexible sheet around the light fixture 1434 and securing the flexible sheet thereto. The lightshade 1432 may be attached to the light fixture 1434 by hooks, hook-and-loop fasteners (e.g., VELCRO®), clips, or any other suitable fasteners or adhesives. Two ends of the lightshade 1432 may be attached to each other to create an opening sized to securely receive a portion of the light fixture 1434 therein. In this configuration the lightshade 1432 remains on the light fixture by virtue of having a smaller diameter opening than a diameter of the portion of the light fixture. The lightshade 1432 may alternatively be an integral part of the light.
  • In one embodiment, the antennas 1416 of the lightshade 1432 are communicatively coupled to an interrogation and detection system interface 36. The interrogation and detection system interface 36 may be located at any suitable position in the room or in another room. The antennas 1416 may be connected to the system interface 36 by a wired connection (e.g., wire bundle 1450) or a wireless connection. The wire bundle 1450 may run along a ceiling, wall and/or floor of the operating room to communicatively couple with a controller 18. In one embodiment the light fixture 1434 is attached to a mobile support which can be moved about the room or even from one room to another. In one embodiment the system interface 36 is also attached to the light fixture 1434. In one embodiment the controller 18 may be attached to the mobile support of the light fixture 1434 with the antennas 16 directly connected to the controller by 1450.
  • The function and operation of the interrogation and detection system 14 in embodiments in which the antennas 1416 are coupled to a light fixture 1434 may be substantially the same as those embodiments in which the antennas 1416 are coupled to the patient support structure 26.
  • While FIGS. 14A, 14B, illustrate the antennas 1416 in a particular non-overlapping configuration, the antennas 1416 may be carried by the lampshade 1432 in any suitable configuration. In contrast to the previously described embodiments in which the patient support structure carried the structures, the lightshade 1432 are unlikely to interfere with radiological imaging. Hence, the antennas 1416 may overlap each other, or may be in a non-overlapping configuration. The antennas 1416 may be attached to one or both exterior surfaces of the lightshade 1432. Alternatively the antennas 1416 may be formed within the lightshade 1432, for example, via lamination or weaving. The lightshade 1432 may be made of any material suitable to not interfere with the function of the antennas 1416.
  • FIG. 15A shows a drape or curtain 1542 that carries a number of antennas 1516 according to one illustrated embodiment.
  • The terms drape and curtain are used interchangeably herein and in the claims. The drape or curtain 1542 may, for example, be used on, over, or in conjunction with a table, bed, frame or other structure during a medical procedure. The drape or curtain 1542 may be coupled to a track 1540 which surrounds a patient support structure 26. The track 1540 is typically in close proximity to the patient support structure and affords a suitable location for the antennas 1516 of the interrogation and detection system 14. In one embodiment, the track may be fastened to a ceiling of a room, for example an operating room, patient room or physician's office or examination room. In such an embodiment, a wire bundle 1550 may also be attached to the ceiling as the wire bundle runs to the system interface 36 or controller 18 situated elsewhere in the surgical environment. The system interface 36 and controller 18 may be attached to a wall of the environment or may be in any other suitable location within the environment in which medical procedures are performed. In another embodiment, the track 1540 may be supported by a freestanding structure or structure fixed or coupled to a floor of the room such as a frame.
  • The antennas 1516 may be carried on either exterior surface of the drape or curtain 1542 or be situated (e.g., laminated) within the drape or curtain 1542. While FIG. 15A shows the antennas 1516 on two opposing sides of the patient support structure 26, the antennas 1516 may be positioned on a few or greater number sides of the patient support structure 26 while in use. The drape or curtain 1542 may be selectively deployed and retracted along the track 1540 during use. For example, the drape or curtain 1542 may be retained in a retracted, undeployed position or configuration during times or periods when scanning or interrogation is not being performed. The drape or curtain 1542 may be moved to an extended, deployed position or configuration in preparation for scanning or interrogation, for example, just prior to completing the medical procedures (e.g., surgery) and, for example closing the patient. In other embodiments, the drape or curtain 1542 may be retained in the extended or deployed position or configuration throughout the surgical procedure. The antennas 1516 may be connected to system interface 36 by means of the wire bundle 1550 extending from the curtain 1540.
  • FIG. 15B shows a sheet 1544 carrying a number of antennas 1516 which sheet 1544 may be quickly hung on a rack or frame 1540. The term sheet is used interchangeably herein and in the claims the terms drape or curtain. The term rack is used herein and in the claims interchangeably with the term frame. The sheet 1544 can be hung from the rack 1540 by connectors 1546. More than one sheet 1544 may be hung from the rack 1540 on one or more sides of the patient support structure 26. The antennas 1516 may be attached on either exterior surface of the sheet 1544 or be situated (e.g., laminated or woven) within the sheet 1544. While the sheet 1544 is illustrated as having four antennas 1516, there may be as few or as many antennas 1516 on the sheet as desired. Connectors 1546 may include hooks, clamps, or any other fastener suitable to attach the sheet 1544 to the rack 1540. The antennas 1516 may be connected to the system interface 36 by means of a wire bundle 1550 extending from the sheet 1544.
  • FIG. 16 shows a controller 1618, according to one illustrated embodiment.
  • The controller 1618 may include a housing 1670. The housing 1670 may contain a motherboard 1672 with a number of ports or connectors 1674 a-1674 f (collectively 1674) to communicatively couple the motherboard 1672 to respective ones of the antennas (e.g., antennas 16). The motherboard 1672 may also include a number of slot connectors 1676 a-1676 f (collectively 1676) to physically receive respective plug-in boards 1678 a-1678 f (collectively 1678) and communicatively couple the plug-in boards 1678 to the motherboard 1672. There may, for example be one plug-in board 1678 for each antenna, each of the antennas 16 and plug-in boards 1678 constituting a separate channel. The motherboard 1672 may include additional slot connectors, allowing expansion or use with different antenna configurations or different patient support structures (e.g., surgical tables, patient beds). The plug-in boards 1678 may each carry one or more circuits (e.g., analog and/or digital circuit components) configured to transmit interrogation signals from the respective antenna and to monitor the antenna for responses to the interrogation signals. For example, the plug-in boards 1678 may implement or carry the circuits disclosed in U.S. patent application Ser. No. 11/759,141 filed Jun. 6, 2007, U.S. Provisional Patent Application Ser. No. 61/056,787 filed May 28, 2008, and U.S. Provisional Patent Application Ser. No. 61/091,667 filed Aug. 25, 2008, with or without change, which Patent Applications are incorporated herein by reference in its entirety.
  • The motherboard 1672 may also include one or more ports 1679 to receive control signals, for example from the interrogation and detection system interface 36, 1336 (FIG. 1, FIG. 13A). The motherboard 1672 may also include one or more synchronization circuits 1680 configured to control and synchronize the operation of the various plug-in boards 1678. The synchronization circuit 1680 may be configured to cause one of the plug-in boards 1678 to transmit an interrogation signal from a first antenna, and cause one or more of the other plug-in boards to monitor for a response by a transponder to the interrogation signal. For instance, the synchronization circuit 1680 may cause the plug-in boards 1678 to have all of the antennas monitor for a response to the interrogation signal. Alternatively, the synchronization circuit 1680 may cause the plug-in boards 1678 to have all of the antennas other than the antenna that transmitted a most recent interrogation signal monitor for a response. Such may advantageously allow monitoring sooner than would otherwise be possible since such can avoid the need to allow the transmitting antenna to return to a quiescent state after transmitting before monitoring for a response. The synchronization circuit 1680 may synchronize the plug-in boards 1678 to successively cause the various antennas to transmit, for example starting with an antenna at one end, and successively transmitting from each of the antennas in order along the longitudinal axis 30 (FIGS. 1 and 2). Alternatively, the synchronization circuit may synchronize the plug-in boards 1678 to cause the various antennas to transmit, but not in order along the longitudinal axis 30. As a further alternative, the synchronization circuit 1680 may synchronize the plug-in boards 1678 to cause the transmission of interrogations signals from a subset of the total set of antennas.
  • While illustrated as a motherboard 1672 and plug-in boards 1678, other embodiments are possible. For example, the various antennas may be controlled by respective circuits integrated into a signal circuit board. Alternatively, the various antennas may be controlled by a single circuit.
  • FIG. 17 shows a control system 1700 of a controller of an interrogation and detection system, according to one illustrated embodiment.
  • The control system 1700 includes a field programmable gate array (FPGA) board 1702, one or more analog boards 1704, and a display board 1706, communicatively coupled to one another. The analog board(s) 1704 may take the form of one or more plug-in boards 1678, as discussed in reference to FIG. 16. Hence, there may be a respective analog board 1704 for each of the antennas 16 (FIGS. 1 and 2).
  • The FPGA board includes an FPGA 1708, configuration jumpers 1710, RS-232 drivers 1712, oscillator 1714, random access memory (RAM) 1716, flash memory 1718, and voltage monitoring (VMON) analog-to-digital converter (ADC) 1720.
  • The FPGA 108 may take the form of a Xilinx Spartan 3 FPGA, which runs FPGA and application software. As explained below, on power up, the FPGA reads the configuration information and application software program from the flash memory 1718.
  • The configuration jumpers 1710 are used to select the application software configuration.
  • The RS-232 drivers 1712 are used to allow the application software to communicate using serial RS-232 data for factory test and diagnostics.
  • The oscillator 1714 sets the clock frequency for the operation of the FPGA 1708. The oscillator 1714 may, for example, take the form of 40 MHz oscillator, although other frequencies are possible.
  • The RAM 1716 is connected to the FPGA 1708 and is available for use by the application software. The application software uses this memory space for storage of both the executable program and program data. The RAM 1716 may, for example, have a capacity of 1 MB.
  • The flash memory 1718 contains both the FPGA configuration data and the binary application program. On power up the FPGA 1708 reads the flash memory to configure the FPGA 1708 and to copy the application program binary data from the flash memory 1718 to the RAM 1702.
  • The voltage monitor ADC 1720 is connected to the FPGA 1708 and controlled by the application software to monitor a power supply and regulated voltage forms in controller electronics.
  • The analog board 1704 includes transmit control circuits 1722, capacitor selection circuits 1724, an antenna detection circuit 1726, signal ADC 1728, audible beeper 1730 and self-test signal 1732.
  • The transmit control circuits 1722 on the analog board 1704 are controlled by signals from the FPGA 1708 to generate a transmit waveform. These signals are denominated as LO_FET_ON and HI_FET_ON, which control the transmit or drive transistors Q1, Q2 (FIG. 18A) along with a signal denominated as DUMP_ON which controls a dump TRIAC (FIG. 18A).
  • Optional capacitor selection circuits 1724 on the analog board 1704 are controlled by the signals from the FPGA 1708 to tune the drive circuit to match an inductance of the antenna 16 (FIGS. 1 and 2).
  • The antenna detection circuit 1726 detects when an antenna 16 (FIGS. 1 and 2) is connected to the controller 20. The output of the antenna detection circuit 1726 drives a signal denominated as the LOOP_LEVEL_OUT signal, which is an input to the FPGA 1708.
  • The signal ADC 1728 is used to sample the signals received at the antenna 16 from the transponders 24 (FIG. 1). The signal ADC 1728 may, for example, operate at a 1 MHz sample rate and may have 12-bits of resolution. The FPGA board 1702 generates the timing and control signals for the signal ADC 1728, which signal are denominated as ADC_CTRL, CS1, SCLK, SDO.
  • The aural indicator (e.g., speaker or beeper) 42 (FIGS. 1 and 2) can be controlled by the FPGA 1708 to emit sounds to indicate various states, modes or operating conditions to the medical provider.
  • The FPGA 1708 can cause the generation of the self test signal 1732 on the analog board 1704 at the signal ADC 1728. Self-testing may be performed at start up, and/or at other times, for example periodically or in response to the occurrence of certain conditions or exceptions.
  • The display board 1706 includes user interface elements, for example a number of visual indicators (e.g., LEDs, LCDs, etc.) 40 (FIGS. 1 and 2). The FPGA board 1702 can control the visual indicators 40 on the display board 1706. The display board 1706 also includes a user selectable activation switch 44, denominated as front panel button 1736. The front panel button 1736 is connected to the display board 1706 which allow the FPGA 1708 to monitor when the front panel button 1736 is activated (e.g., pressed).
  • FIG. 18 shows a software configuration 1800 of the interrogation and detection system 14, according to one illustrated embodiment.
  • The software may include application software 1802 that is responsible for operating the controller 18 (FIGS. 1 and 2). The application software 1802 controls the timing for generating transmit pulses, processes sampled data to detect transponders 24 (FIGS. 1 and 2), and indicates status to the user with the visual indicators 40 (FIGS. 1 and 2) on the display board 1706 (FIG. 17) and/or via the aural indicator 42 on the analog board 1704 (FIG. 17). The application software 1802 is stored in the flash memory 1718 (FIG. 17) and transferred into the RAM 1716 by a boot loader 1804.
  • The boot loader 1904 is automatically loaded when the FPGA 1708 is configured, and starts execution after a processor core 1806 is reset. The boot loader 1804 is responsible for transferring the application software 1802 from the flash memory 1718 to the external RAM 1716.
  • The processor platform 1808 is configured into the FPGA 1708 (FIG. 17) on power up from the configuration information stored in the flash memory 1718. The processor platform 1808 implements a custom microprocessor with a processor core 1806, peripherals 1810 a-1810 n, and custom logic 1812.
  • The processor core 1806 may take the form of a soft processor core supplied by XILINX under the name MICROBLAZE™, that implements a 32-bit processor including memory caches and a floating point unit. A soft core processor is one that is implemented by interconnected FPGA logic cells instead of by a traditional processor logic. The processor core 1806 is connected to the internal FPGA peripherals 1810 a-1810 n using a 32-bit processor bus 1811 called the On-Chip Peripheral Bus. The XILINX supplied peripherals for the MICROBLAZE™ processor core 1806 include external memory interfaces, timers, and general purpose I/O.
  • The custom logic 1812 to create the transmit signals, sample the ADC, and accumulate the transponder return signals is designed as a peripheral to the processor core 1806. The custom logic 1812 is the part of the design of the FPGA 1708.
  • Some embodiments may substitute a full microprocessor for the soft processor core. Thus, for example, a microprocessor such as the ATOM™ processor, commercially available from Intel Corporation, may be employed in place of the MICROBLAZE™ processor core. The full microprocessor may be communicatively coupled to multiple analog antenna channels via one or more FPGAs and one or more suitable buses. The FPGA may, for example, act as a co-processor and/or cache. Additionally, or alternatively, a higher bandwidth bus architecture may be employed. For example, a PCI express™ or PCIe™ bus architecture may be employed, rather than an ISA bus architecture. Suitable FPGAs may include those from ATMEL Corporation. Such FPGAs may advantageously have built in PCIe bus architecture, allowing easy integration. This approach may enable more I/O ports, such as USB ports, may provide more or better video options, and may provide faster data rates from the analog antenna channels that otherwise possible using the ISA bus architecture and soft processor core approach.
  • FIGS. 19A-19I show a control circuit 1900 according to one illustrated embodiment. The control circuit 1900 is used to drive the antenna 16 (FIGS. 1 and 2) to excite or interrogate transponders 24 (FIGS. 1 and 2), and to detect and process signals received by the antenna 16 from the transponders 24. As previously noted, there may be a respective control circuit 1900 for each of the antennas 16, or a single control circuit may be configured to control multiple antennas.
  • The control circuit 1900 includes a transmitter circuit 1902 formed by a pair of drive transistors (e.g., field effect transistors) Q1, Q2 operated in a push-pull configuration between a high voltage rail (e.g., 24 V) and a low voltage rail (e.g., GND). The drive transistors Q1, Q2 are responsive to respective drive signals DRIVE_HI, DRIVE_LO, which are applied to the gates of the respective drive transistors Q1, Q2. The drive transistors Q1, Q2 are coupled to the antenna 16 by a non-switched capacitor C8 and the coaxial cable 20. The antenna 16 and capacitor C8, as well as capacitance provided by the coaxial cable 20, form an LC circuit.
  • Optionally, the control circuit 1900 may also include a dynamic tuning circuit 1904. The dynamic tuning circuit 1904 selectively adjusts the capacitance of the LC circuit. In the illustrated embodiment, the dynamic tuning circuit 1904 includes a number of switched capacitors C33-C36 and relays U9, U10. The relays U9, U10 are operated to selectively couple the switched capacitors C33-C36 in series with the non-switched capacitor C8, thereby adjusting the LC characteristics of the LC circuit, and allowing fine tuning of the LC circuit around center frequencies or center channels of a number of wide band frequency bands, as described in more detail below.
  • FIG. 20 illustrates a detection cycle 2000 that employs an approach that optimizes signal to noise ratio (SNR), according to one illustrated embodiment. Such may, for example, advantageously increase range or increase sensitivity at a given range.
  • One embodiment is optimized based on having an overall detection cycle that performs well for transponders with resonant frequencies from approximately 136 KHz to approximately 154 KHz, and which has a pulse timing that is consistent with hardware limitations. An optimal SNR may be achieved by, for example, transmitting a single wideband frequency pulse.
  • The application software 1802 (FIG. 18) implements the detection cycle 2000 using transmission or interrogation in a frequency band centered around a center channel or frequency. In the illustrated embodiment, the application software 1802 sequences through a non-measurement portion (i.e., gap) 2000 a, and two distinct measurement portions, denominated as a noise detection portion 2000 b and an interrogation or signal detection portion 2000 c, each detection cycle 2000. In at least one embodiment, the detection cycle 2000 may, for example, be approximately 275 milliseconds, the gap portion may be approximately 10 milliseconds, the noise portion approximately 37 milliseconds and the interrogation or signal portion approximately 228 milliseconds.
  • During the noise detection portion 2000 b, which may, for example be a first measurement portion of each detection cycle 2000, ambient or background noise is measured or sampled, providing a value indicative of a level of ambient or background noise for the particular environment. The noise measurements or samples are taken or captured at a time sufficiently after excitement of the transponders 24 (FIG. 1) by the interrogation signal emitted by the transmitter such that the transponders 24 are substantially not resonating or responding to any previous excitation by interrogation signals. In particular, a number N of measurements or samples are taken during the noise detection or first measurement portion 2000 b.
  • During the interrogation portion 2000 c, which may, for example take the form of the second measurement portion of each detection cycle 2000, responses by transponders 24 are measured or sampled. The response measurements or samples are taken with the transmitter transmitting or at a time sufficiently close to excitement of the transponders 24 by the interrogation signal emitted by the transmitter such that the transponders 24 are still substantially resonating or responding to the interrogation signal. In particular, a number M of measurements or samples are taken during the interrogation or second measurement portion 2000 c.
  • While the interrogation portion 2000 c is illustrated as one contiguous or continuous portion 2000 c, in some embodiments the interrogation portion 2000 c may take the form of two or more separate portions or intervals. Each of the portions 2000 c may employ the same transmit frequency band, for example centered around 145 KHz. Other center channels or frequencies may for example be 136 KHz, 139 KHz, 142 KHz, 145 KHz, 148 KHz, 151 KHZ and/or 154 KHz, or any other frequency suitable for exciting the transponder to resonate. Some embodiments may employ frequency hopping, for example transmitting a different center channel or frequency for each of a plurality of interrogation portions 2000 c of each detection cycle 2000. Such is discussed further in U.S. provisional patent application Ser. No. 60/892,208, filed Feb. 28, 2007 and U.S. non-provisional application Ser. No. 11/743,104, filed May 1, 2007.
  • The gap portion 2000 a may provide time for the response of the transponders 24 to the interrogation signal to decay sufficiently to allow measurement of noise.
  • Some embodiments may arrange the gap 2000 a, the noise detection portion 2000 b and/or the interrogation portion 2000 c, or parts thereof, in a different order.
  • In one embodiment, the time to accumulate the noise sample or value indicative of a noise level may, for example, be approximately 37 milliseconds, and the time to accumulate the transponder signal measurement approximately 228 milliseconds. Along with a gap 2000 a of approximately 10 milliseconds between the signal and noise portions, the time for a single detection cycle 2000 would be approximately 275 milliseconds. As noted above, the transmitter is OFF during the noise measurement portion 2010 b of each detection cycle to measure ambient noise, and the signal measurement portion 2010 c is taken with the transmitter transmitting a wideband interrogation signal about the particular center channel or frequency.
  • The noise samples may be accumulated and a highest one or more of multiple samples or measurements over one or more detection cycles selected or used to prevent unwarranted fluctuations. The response signals from the transponder 26 may be accumulated and/or averaged or integrated over one detection cycle or over multiple detection cycles.
  • The number N of noise measurements or samples and/or the number M of response measurements or samples may be selected to achieve a desired ratio of N to M, in order to achieve or maintain a desired signal to noise ratio. For example, obtaining 200 noise measurements or samples and 800 response measurements or samples each detection cycle results in an SNR of approximately 2 (e.g., the square root of the 800 divided by 200). While an SNR as low as 1.1:1 may be sufficient in some embodiments, an SNR approaching 2:1 ensures sufficient differentiation to eliminate or reduce the possibility of false positives to an acceptable level for the particular applications envisioned herein. Any known hardware and software accumulators, summer, integrators and/or other hardware or software may be suitable.
  • FIG. 21A illustrates pulse timing, according to one illustrated embodiment.
  • The custom logic in the FPGA 1708 (FIG. 17) generates the timing and control signals for each pulse 2110. During a transmit portion 2110 a of the pulse 2110, the logic of the FPGA 1708 drives the drive transistor control lines to generate the transmit signal. The FPGA logic controls the frequency of the transmit signal. During a dump portion 2110 b of the pulse 2110, the logic of the FPGA 1708 drives the gate of the dump TRIAC T1 to quickly drain the transmit energy from the antenna 21 in order to allow detection of the response signal form the transponder 24, if any. A recovery portion 2110 c of the pulse 2110 allows receiver filters and amplifiers to recover from the transmitted pulse before detecting the response signal from the transponder 24, if any. During the receive response portion 2110 d of the pulse 2110, the FPGA 1708 controls the signal ADC 1728 to sample the response signal from the transponder 24, if any. The signal ADC 1728 may, for example, sample at a 1 MHz sample rate with a 12-bit resolution. A dither portion 2110 e of the pulse 2110 has a random variable length of time, and may, for example be generated by a pseudo-noise (PN) sequence generator. Adding a random length of time between pulses de-correlates the response signal received from the transponder 24 from constant frequency sources of interference, if any.
  • For example, within each of 228 millisecond signal measurement intervals 400 c discussed above, the custom logic of the FPGA 1708 (FIG. 17) accumulates the received signals from, for example 800 pulses.
  • FIG. 21B illustrates pulse timing, according to one illustrated embodiment. The pulse timing is similar in some respects to that illustrated in FIG. 21A, hence similar or identical structures, acts or features are identified using the same reference numbers. Only significant differences between the two are discussed below.
  • In contrast to the embodiment of FIG. 21A, the embodiment of FIG. 21B may advantageously eliminate the dump portion 2110 b of the pulse 2110. Such may be omitted, for example, where the antenna 21 that transmitted the most recent interrogation signal is not being used to monitor for a response to the interrogation signal. Such may advantageously allow monitoring for the response to occur sooner than would otherwise be possible if the dump portion 2110 b were needed.
  • Also in contrast to the embodiment of FIG. 21A, the embodiment of FIG. 21B may advantageously eliminate the recovery portion 2110 c of the pulse 2110. Such may be omitted, for example, where the antenna 16 that transmitted the most recent interrogation signal is not being used to monitor for a response to the interrogation signal. Such may advantageously allow monitoring for the response to occur sooner than would otherwise be possible if the recovery portion 2110 c were needed.
  • Removal of the dump portion 2110 b and/or recovery portion 2110 c may allow for a more favorable sampling rate or better resolution or may allow a longer noise detection portion, which may significantly enhance performance.
  • FIG. 22 shows signal timing for driving the drive transistors Q1, Q2 (FIG. 19A), according to one illustrated embodiment.
  • The custom logic in the FPGA 1708 (FIG. 17) generates the signals 2220 a, 2220 b to drive the drive transistors Q1, Q2 (FIG. 19A) during the transmit portion 2110 a (FIG. 21) of the pulse 2110. A transmit (TX) period value is used by the logic of the FPGA 1708 to set the transmit frequency. The low transistor (e.g., Low FET) Q2 turns ON at the beginning of the transmit period. The Low FET off value controls when the low transistor (e.g., Low FET) Q2 is turned OFF. The low transistor Q2 is turned OFF before the high transistor (e.g., High FET) Q1 is turned ON to avoid a short circuit through the transistors Q1, Q2. The High FET on value controls when the high transistor (e.g., High FET) Q1 is turned ON. The High FET Off value controls when the high transistor Q1 is turned OFF. The high transistor is turned OFF before the low transistor Q2 is turned ON to avoid a short circuit through the transistors Q1, Q2. For example, to achieve a transmit frequency of 144.9 KHz, the transmit period should be set to 6.9 μsec. Also for example, a suitable duration that both the low and high transistors Q1, Q2 are OFF may be set to 400 nsec.
  • The ADC converts the signal received from the transponder 24, if any, from analog to digital. Such conversion may, for example, be performed at a sampling rate of 1 MHz with a 12-bit data resolution. The sampled ADC data is then accumulated together or integrated, for example over 800 measurements or samples, to compute the total summed response signal received from the transponder 24, if any.
  • The accumulated or integrated received signal may be match filtered with both in-phase and quadrature reference signals to determine the signal magnitude. The received receive signal is matched filtered with a plurality of reference signals, for example with the seven reference signals, for instance as shown in Table 1 below. Some embodiments, may employ match filtering before accumulating or integrating the received signal.
  • TABLE 1
    Match Frequency
    136 KHz
    139 KHz
    142 KHz
    145 KHz
    148 KHz
    151 KHz
    154 KHz
  • The maximum value for the matched filters (e.g., seven matched filters) with active transmit is compared with an adjusted detection threshold. If the maximum value is greater than the detection threshold, then a response signal from a transponder 26 is considered as having been detected, and appropriate action is taken.
  • Noise faults may be detected as well as antenna transmit voltage faults. Noise faults may be detected when the matched filter output during the noise detection portion is greater than a noise fault threshold (e.g., a threshold magnitude 2.7 mV over a threshold time, e.g., 7 seconds or threshold magnitude 7 mV over a time threshold of 7 seconds). Antenna transmit voltage faults may be detected when the antenna transmit voltage drops below an antenna voltage fault threshold (e.g., 270 VPeak-to-Peak). Two environmental faults in a row such as the above, may trigger an Environmental Error Mode, while two normal measurements in a row may return to a normal Scan Mode. Faults in general are discussed in more detail below. Alternatively, the interrogation and detection system may employ a fast Fourier transform approach in lieu of match filtering.
  • FIG. 23A shows a method 2300 of operating the interrogation and detection system 14, according to one illustrated embodiment.
  • The method 2300 starts at 2302. For example, the method 2300 may start on application of power to the interrogation and detection system 12 or in response to activation of a switch by a user such as a clinician, surgeon
  • In response to detecting an application of power, the interrogation and detection system 14 may enter a Power-Up mode. The Power UP mode 502 may, for example, in response to the application of power to the controller 18 and turning ON the switch on the controller 18. In the Power-Up mode, a Power indicator (e.g., LED) may be turned ON or illuminated, and may remain ON or illuminated as long as the power is applied and the switch is in the ON state. In response to entering the Power UP mode, the software 1800 may perform software initialization, built in tests, and an audio/visual test. If a fault is detected, the software 1800 may progress to a System Fault Mode. If no faults are detected, the software 1800 may turn a System Ready indicator (e.g., LED green), and enter an antenna Detection Mode. In the System Fault mode, the software 1800 may cause an indication of the detection of a system fault by blinking a System Ready indicator (e.g., LED) yellow, and/or issuing a sequence of rapid beeps or other sounds. The corrective action for the System Fault Mode may be to cycle power to reinitiate the Power Up mode. Continued failure indicates a failed controller 18.
  • In the Antenna Detection Mode, the software 1800 checks for antennas 16 connected to the controller 18. The Antenna Detection Mode may be indicated by turning the System Ready indicator (e.g., LED) green and turning the Antenna Ready indicator (e.g., LED) OFF. If no antenna 16 is detected, the software 1800 remains in the Antenna Detection Mode. If one or more antennas 16 are detected, the software 1800 makes note of the total number of antennas and progresses to the Antenna Initialization Mode.
  • At the start of the Antenna Initialization Mode, after the detection of the antennas 16, the software 1800 may turn the Antenna Ready indicator (e.g., LED) yellow and optionally check for the presence of a respective fuse coupled to antennas 16. If a fuse is found, the software 1800 may attempt to blow the fuse and verify that the fuse was correctly blown. After the fuse is blown the software 1800 may verify that respective antenna 16 is operating within tolerances. The software 1800 may indicate that the antenna 16 is ready by turning the Antenna Ready indicator green. The software 1800 may also start a timer which will allow the antenna 16 to be disconnected and reconnected to the controller for a period to time (e.g., 5 hours) after the fuse is blown. The controller 18 may determine the adjustments or fine tuning to be made about the center frequencies or channels during Antenna Initialization Mode. In particular, the controller 18 may determine the particular frequency in each of the frequency bands that elicits the response with the highest voltage. The controller 18 may determine such be varying the capacitance of the LC circuit using the switched capacitors C33-C36 during the Antenna Initialization Mode. The particular combination of switched capacitors C33-C36 which achieved the response with the highest voltage may then be automatically employed during the Scan Mode (discussed below) to adjust or fine tune about the center frequency or channel in each broad band of transmission. Other approaches to determining the fine tuning may be employed.
  • If the software 1800 does not successfully complete the Antenna Initialization Mode, the software 1800 enters an Invalid Antenna Mode. If the software 1800 successfully completes the Antenna Initialization Mode, the software 1800 progresses to the Scan Mode to automatically start scanning. In the Invalid Antenna Mode, the software 1800 may blink the Antenna Ready indicator yellow and issues a slow beep pattern. The Invalid Antenna Mode may be entered in response to any of the following conditions: 1) the antenna 16 connected to the controller 18 is out of tolerance; 2) the controller 18 is unable to blow the fuse of the antenna 16; 3) the antenna 16 does not have a fuse and more than the set time period has past (e.g., 5 hours) since a fuse was blown; 4) the antenna 16 does not have a fuse and the controller 18 has been restarted; 5) the antenna 16 has been connected to the controller 18 for more than the set time period (e.g., 5 hours); 6) the antenna 16 is detuned due to close proximity to metal. The corrective action for the Invalid Antenna Mode is to remove the invalid antenna 16 and attach a new antenna 16 to the controller 18 that contains a fuse or to reconnect the antenna 16 while holding it in the air at least 2 feet away from large metallic objects. The software 1800 enters the Scan Mode when the antennas 16 are ready and the operator presses a Start/Stop button. The software 1800 may issue a short three beep pattern via the speaker or beeper when entering the Scan Mode to identify the entry to the user.
  • In the Scan Mode, the software 1800 may continuously or periodically perform the following functions: 1) look for response signals from transponders 24; 2) monitor the noise level; 3) insure the antennas 16 are connected and operating correctly; and 4) blink the appropriate indicator in a circular pattern. The interrogation and monitoring for response may be performed using a detection cycle, such as that set out in FIGS. 21A, 21B and the description related to those Figures. While, not specifically set out in FIG. 18, such may also include optimization of signal to noise ratio, such as set out in FIG. 20 and the description related thereto.
  • At 2304, a timer starts. The timer allows a limit to be set on the amount of time spent scanning for a transponder 24 (i.e., scan maximum time interval). Alternatively, a counter could be employed to set a limit of the number of iterations that the antennas 16 are successively employed to transmit interrogation signals.
  • At 2306, an antenna counter i is set, for example set to 1. The antenna counter allows the method 2300 to successively iterate through each of a number N of antennas 16 to transmit the interrogation signal. The number N of antennas 16 may have been determined during the Antenna Detection Mode.
  • At 2308, an interrogation signal is transmitted from an ith antenna 16. In particular, the FPGA 1708 (FIG. 17) may cause one of the plug-in boards to cause the antenna 16 coupled thereto to transmit an interrogation signal. The interrogation signal may advantageously take the form of an unmodulated interrogation signal, for example in the radio or microwave portions of the electromagnetic spectrum.
  • At 2310, one or more antennas 16 are monitored for a response to the interrogation signal. In particular, a number of the plug-in boards may monitor the respective antenna coupled thereto for the response to the interrogation signal. For example, all of the antennas 16 may be monitored to a response to the interrogation signal. Alternatively, all except the antenna 16 that transmitted the most recent interrogation signal (i.e., i th antenna) may be monitored for a response to the interrogation signal. As another alternative, some subset of all of the antennas 16 may be monitored for a response to the interrogation signal. The response may advantageously take the form of an unmodulated response signal, for example in the radio or microwave portions of the electromagnetic spectrum.
  • At 2312, it is determined if a response to the interrogation signal was received. For example, the FPGA 1708 (FIG. 17) may poll or otherwise monitor each of a number of plug-in or analog boards to determine if a response signal was detected via any of the antennas coupled to those plug-in or analog boards. If a response to the interrogation signal was received, a suitable indication is provided at 2314, and the method 2300 terminates at 2316. For example, when an appropriate response signal from a transponder 24 is detected while in Scan Mode, the software 1800 may turn ON an amber DETECT indicator (e.g., LEDs) and/or provide an audible alarm. The alarm may, for example, beep a continuous solid tone as long as the transponder is detected, with a minimum of beep duration of, for instance 0.5 second. If a response to the interrogation signal was not received, it is determined whether there are additional antennas to transmit the interrogation signal from at 2318.
  • If there are additional antennas to transmit from, the counter is incremented at 2320 and control returns to 2308 to transmit via the next i+1th antenna 16. This can allow iteration through a number of antennas 16 as the antenna that transmits the interrogation signal. As previously explained, antennas 16 may be operated to transmit an interrogation signal in an order of appearance along a longitudinal axis of the patient support surface or may be operated in any other order. Also as previously noted, all or some lesser number of antennas may be employed to transmit the interrogation signal in any single pass or iteration through the set or subset of antennas 16.
  • If there are not further antennas to transmit the interrogation signal from, it is determined if a time limit (i.e., scan maximum time interval) has been exceeded at 2322. If the time limit has been exceeded the method 2300 terminates at 2316. If the time limit has not been exceeded, the counter is reset at 2306. This allows multiple passes through the use of each antenna in a set or subset of antennas 16 as the interrogating antenna 16. When the operator or user pushes the Start/Stop button or the a scan maximum time interval (e.g., 4 minute) has been reached, the software 1800 may issue a short three beep pattern and return to the Antenna Ready Mode.
  • If the software 1800 detects that one of the antennas 16 is disconnected while in the Scan Mode, the software 1800 enters the Scan Fault Mode. In the Scan Fault Mode, the software 1800 may issue a sequence of rapid beeps and blink ON and OFF the amber DETECT indicator. The Scan Fault Mode can be cleared by pushing the Start/Stop button. The software 1800 will automatically clear the scan fault mode after 10 beeps.
  • While in the Scan Mode, if excess noise or loss of transmit signal is detected, the software 1800 may progress to the Environment Error Mode. In the Environment Error Mode, the software 1800 may issue or produce an appropriate indication. For example, the software 1800 may cause the production of a sequence of slow beeps and the blinking ON and OFF the green circle indicator. The corrective action for the Environment Error Mode is to reposition the antenna with respect to any large metal objects or sources of electrical interference. The software 1800 may automatically stop the scan if the environment error condition lasts for more than a set time or number of beeps (e.g., 5 beeps).
  • FIG. 23B shows a method 2310 b of monitoring all antennas for a response to an interrogation signal, according to one illustrated embodiment.
  • At 2318, an interrogation and detection system monitors all antennas 16 for a response to the interrogation signal.
  • FIG. 23C shows a method 2310 c of monitoring all antennas except a transmitting antenna for a response to an interrogation signal, according to one illustrated embodiment.
  • At 2320, an interrogation and detection system monitors all antennas 16 for a response to the interrogation signal, except the antenna 16 the transmitted the most recent interrogation signal.
  • FIG. 24A shows a method of operating an interrogation and detection system to detect transponders 2400 a, according to one illustrated embodiment.
  • The method 2400 a starts at 2401. For example, the method 2400 a may start when the interrogation of detection system is turned ON, or when power is supplied, or in response to a call from a procedure or function.
  • At 2402, an antenna counter I is set, allowing the method 2400 a to iterate through one or more antennas (n) of the interrogation and detection system. The interrogation and detection system iterates through the antennas by transmitting interrogations signals successively from each of a number of the antennas, typically one antenna at a time, and monitoring or listening for response signals on one or more of the antennas.
  • At 2403, the interrogation and detection system measures averaged noise and averaged signals. At 2404, the interrogation and detection system processes the averaged noise and averaged signal, and at 2405 determines whether a transponder (i.e., return or response signal from transponder) has been detected.
  • In the embodiment illustrated in FIG. 24A, the interrogation and detection system requires more than one (e.g., two) successive detections of the transponder to conclude that the signal detected indicates the presence of a transponder. Such prevents against false positive determinations. Hence, at 2406, the interrogation and detection system again measures averaged noise and averaged signals. At 2407, the interrogation and detection system again processes the averaged noise and averaged signal and at 2408 determines whether a transponder (i.e., return or response signal from transponder) has been detected.
  • If a transponder has been detected an adequate number of times (e.g., twice), the interrogation and detection system provides notification at 2409. Notification may, for example, include sending an electrical or optical signal and/or producing a visual, aural or tactile alert to a user (e.g., medical service provider). If the interrogation and detection system determines that a transponder has not been detected at either 2405, 2407, control passes to 2410.
  • At 2410, the interrogation and detection system determines whether there are further antennas to iterate through. If so, the antenna counter is iterated, and control returns to 2403. If not, the method 2400 a, may terminate at 2412. Alternatively, the method 2400 a may return to 2402 and continuously repeat as long as power is supplied to the interrogation and detection system.
  • FIG. 24B shows a method of operating an interrogation and detection system to sample noise and responses and to adjust sampling times and perform noise correction 2400 b, according to one illustrated embodiment, the method useful with the method of FIG. 24A.
  • The method 2400 b starts at 2420. For example, the method 2400 b may start in response to a call from a procedure that implements the method 2400 a. The method 2400 b may, for example, be employed in measuring averaged noise and averaged signal 2403 (FIG. 24A).
  • At 2421 a transmitter of the interrogation and detection system is OFF (i.e., not transmitting interrogation signals) or is turned OFF if not already OFF. This starts a noise detection portion of a transponder detection cycle. At 2422 ambient noise received by the antennas is sampled. For example, ambient noise detected by all of the antennas may be sampled by the interrogation and detection system.
  • At 2423, the interrogation and detection system determines noise cancellation factors for each antenna. The interrogation and detection system may employ a variety of approaches for determining the noise cancellation factors, for example computing a noise cancellation factor for each antenna based on ambient noise detected on all of the other antennas except the antenna for which the respective noise cancellation factor is being computed.
  • At 2424, the interrogation and detection system determines a sample averaging time for sampling nose based on the measured ambient noise level. At 2425, the interrogation and detection system determines a sample response averaging time based on the measured ambient noise level. The sample averaging times determine how long samples of noise or response will be averaged in determining noise or response measurements or levels. Such dynamic determination of sample averaging times allows the interrogation and detection system to accommodate a changing noise environment. For example when a piece of equipment is introduced or removed from the environment or a piece of equipment turns ON or OFF, or otherwise changes amount or frequency distribution of noise it generates in the environment. Thus, the interrogation and detection system may obtain adjust the noise floor to increase range in real time or almost real time in response to the actual noise in the environment.
  • At 2426, the interrogation and detection system averages noise corrected noise samples for the noise sample averaging time. As noted above, the noise sample averaging time may be determined dynamically. The noise samples may be corrected, for example, using the determined nose cancellation factors.
  • At 2427, the interrogation and detection system transmits interrogation signal(s) from one of the antennas. As previously noted, the interrogation and detection system may iterate through the antennas one at a time, for example using an antenna counter I. At 2428, the interrogation and detection system averages noise corrected responses for the response averaging time. As noted above, the response sample averaging time may be determined dynamically. The response samples may be corrected, for example, using the determined nose cancellation factors. It is noted that as received, the response signals typically contain a mix of signal and noise, hence is generally referred to herein as responses. After noise correction, the result is theoretically pure signal. In practice there may be some still be some amount of noise remaining, however the signal will typically dominate the noise after noise correction.
  • The method 2400 b may terminate at 2429, for example until called again by the procedure that implements 2400 a (FIG. 24A) to transmit interrogation signals from a next antenna.
  • FIG. 24C shows a method of operating an interrogation and detection system to determine whether a transponder has been detected 2400 c, according to one illustrated embodiment, the method useful with the method of FIG. 24A.
  • The method 2400 c starts at 2440. For example the method 2400 c may start in response to a call from a procedure that implement the method 2400 a (FIG. 24A). The method 2400 c may, for example, be employed in processing transponder detection 2404 (FIG. 24A).
  • FIGS. 25A-25E are flow diagrams of methods of operating an interrogation and detection system by measuring and/or compensating for noise, according to various illustrated embodiments, the methods useful with the method of FIG. 24A.
  • At 2441, the interrogation and detection system transforms the averaged noise and response samples from a time domain to a frequency domain. The interrogation and detection system may, for example, perform fast Fourier transforms on the averaged samples. At 2442, the interrogation and detection system may find a peak of response fast Fourier transformed spectrum data.
  • At 2443, the interrogation and detection system determines an amplitude threshold based on the averaged noise level. At 2444, the interrogation and detection system determines whether the response amplitude is equal or exceeds the determined amplitude threshold. If so, control passes to 2445. If not, control passes to 2448 where a signal may optionally be produced indicative of no tag being detected.
  • At 2445, the interrogation and detection system determines whether the signal is in appropriate frequency range. While the frequency range is illustrated as being between 137 KHz and 165 KHz, inclusive, other frequency ranges may be employed depending on the specific structure and frequency of the transponders. The disclosed embodiments are particular suited for use with low Q transponders in which the response frequencies of various transponders are not closely controlled, advantageously allowing large manufacturing tolerances to reduce cost. If the signal is in the appropriate frequency range, control passes to 2446, otherwise control goes to 2448.
  • At 2446, the interrogation and detection system determines the Q value of the response. For example, the interrogation and detection system may compute the slope of the received signal decay at a number of windows (e.g., 5 windows). At 2450, the interrogation and detection system determines if the determined Q value is greater than or equal to a threshold Q value (e.g., 35). While the threshold Q value is illustrated as being 35, other Q values may be employed depending on the Q value(s) of the specific transponders. If the tag response Q value below the Q value threshold, the interrogation and detection system determines that a transponder has been detected at 2450. If the tag response Q value is equal or above the Q value threshold, the interrogation and detection system determines that a tag has not been detected 2448.
  • The method 2400 c may terminate at 2449, for example until called again by the procedure that implements the method 2400 a (FIG. 24A).
  • FIG. 25A shows a method 2500 a of measuring or sampling responses, according to one illustrated embodiment.
  • In particular, at 2510, the interrogation and detection system measures or samples response on all antennas or antenna channels.
  • FIG. 25B shows a method 2500 b of determining noise estimates, according to one illustrated embodiment.
  • In particular, at 2520, the interrogation and detection system determines noise estimates based on measures or samples from all antennas or antenna channels other than the respective antenna or antenna channel for which the noise estimate will provide the compensation factors.
  • FIG. 25C shows a method 2500 c of determining noise estimates, according to one illustrated embodiment.
  • In particular, at 2530, the interrogation and detection system determines an average noise estimate based on averaging of measures or samples from all antennas or antenna channels other than the respective antenna or antenna channel for which the noise estimate will provide the compensation factors.
  • FIG. 25D shows a method 2500 d of determining noise estimates, according to one illustrated embodiment.
  • In particular, at 2540, the interrogation and detection system determines an average noise estimate based on averaging of measures or samples from all antennas or antenna channels other than the respective antenna or antenna channel for which the noise estimate will provide the compensation factors. The averaging includes averaging of noise detection portions which occur both before and after an interrogation portion of a transponder detection cycle. Such allows the interrogation and detection system to essentially determine whether the noise is consistent, periodic, or non-random.
  • FIG. 25E shows a method 2500 e of determining noise estimates, according to one illustrated embodiment.
  • In particular, at 2550, the interrogation and detection system determines an average noise estimate by determining a decomposed least squares average of noise measurements or samples. While a decomposed least squares approach is illustrated, a wide variety of other approaches may be employed (e.g., Bayesian averaging).
  • FIG. 25F shows a method 2500 f of determining noise estimates, according to one illustrated embodiment.
  • In particular, at 2560, the interrogation and detection system compares noise measured from before an interrogation portion of the transponder detection to noise measured after the interrogation portion of the transponder detection cycle. A difference between the noise measurements may represent variation in noise. At 2562, the interrogation and detection system may increase the sample averaging time for sampling responses to interrogation signals if a determined difference (i.e., variation in noise) is greater than a variation threshold. Such may allow the interrogation and detection system to accommodate different noise sources, such as those that produce periodic or non-random versus those that produce random noise.
  • FIG. 26A shows a measured or sampled response 2600 a, according to one illustrated embodiment.
  • The response 2600 a in the time domain was measured in an environment which contained a noise source (e.g., fluoroscope) but no transponder. The response 2600 a has not been subjected to noise cancellation or adjustment. The amplitude (Y-axis) is in mV, while the time (X-axis) is in ps.
  • FIG. 26B shows a measured or sampled response 2600 b, according to one illustrated embodiment.
  • The response 2600 b is the response 2600 a having been subjected to noise cancellation or adjustment. Most of the peaks have noticeably been diminished.
  • FIG. 26C shows a measured or sampled response 2600 c, according to one illustrated embodiment.
  • The response 2600 c is the response 2600 a after a fast Fourier transformation to the frequency domain. The amplitude (Y-axis) is in mV, while the time (X-axis) is in frequency. There are three distinctive peaks of noise.
  • FIG. 26D shows a measured or sampled response 2600 d, according to one illustrated embodiment.
  • The response 2600 d is the noise cancelled response 2600 b after a fast Fourier transformation to the frequency domain. The peaks have been noticeable diminished, indicating that almost all noise has been removed by the noise cancelation.
  • FIG. 27A shows a sampled or measured response 2700 a, according to one illustrated embodiment.
  • The response 2700 a in the time domain was measured in an environment which contained a noise source (e.g., fluoroscope) and a transponder. The response 2700 a has not been subjected to noise cancellation or adjustment. The amplitude (Y-axis) is in mV, while the time (X-axis) is in ps.
  • FIG. 27B shows a measured or sampled response 2700 b, according to one illustrated embodiment.
  • The response 2700 b is the response 2700 a after being subjected to noise cancellation. While many the peaks (associated with noise) have noticeably been diminished, other distinctive peaks remain.
  • FIG. 27C shows a measured or sampled response 2700 c, according to one illustrated embodiment.
  • The response 2700 c is the response 2700 a after a fast Fourier transformation to the frequency domain. The amplitude (Y-axis) is in mV, while the time (X-axis) is in frequency. There are three distinctive peaks.
  • FIG. 27D shows a measured or sampled response 2700 d, according to one illustrated embodiment.
  • The response 2700 d is the noise cancelled response 2700 b after a fast Fourier transformation to the frequency domain. Two of the three peaks have been noticeable diminished, indicating that almost all noise has been removed by the noise cancelation, and leaving a single distinctive peak at the resonant frequency of the transponder.
  • The above described embodiments may improve a detection range versus noise performance over other more conventional approaches. The embodiment of the present disclosure may be capable of achieving far superior performance, having greater detection range in even mildly noisy environments. Such is particularly advantageous in environments such as operating theaters, and substantially helps reduce false readings (e.g., false positives, false negatives). Thus, such may provide the level of performance demanded by hospitals and doctors.
  • Thus, during each of a plurality of detection cycles, the interrogation and detection system performs a number of acts or operations. The interrogation and detection system receives unmodulated electromagnetic signals during a noise detection portion of the detection cycle.
  • The interrogation and detection system determines a noise value indicative of a noise level that corresponds to a highest one of a number N of samples or measurements of the unmodulated electromagnetic signals received during the noise detection portion of the detection cycle, where the number N is greater than one. The interrogation and detection system may determine a noise value indicative of a noise level based at least in part on the unmodulated electromagnetic signals received during the noise detection portion of the detection cycle by setting the noise value based on the highest one of six samples or measurements of the unmodulated electromagnetic signal received during the noise detection portion of the detection cycle. The interrogation and detection system adjusts a signal detection threshold based at least in part on the determined noise value of at least one of the detection cycles. The interrogation and detection system may adjust the signal detection threshold by adjusting the signal detection threshold based at least in part on a first number of determined noise values indicative of a noise level during at least one noise detection portion that occurred before the receive response portion of a first one of the detection cycles and a second number of determined noise values indicative of a noise level during at least one noise detection portion that occurred after the receive response portion of the first one of the detection cycles. The interrogation and detection system may adjust the signal detection threshold based at least in part on the determined noise value of at least one of the detection cycles by adjusting the signal detection threshold to be approximately twice an average of at least one of the first and the second number of determined noise values. The interrogation and detection system may, for example, adjust the signal detection threshold based at least in part on the determined noise value of at least one of the detection cycles by adjusting the signal detection threshold to be approximately twice a greatest one of at least one of the first and the second number of determined noise values.
  • The interrogation and detection system emits at least one electromagnetic interrogation signal during a transmit portion of the detection cycle. The interrogation and detection system receives unmodulated electromagnetic signals during a receive response portion of the detection cycle that follows the transmit portion of the detection cycle.
  • The interrogation and detection system determines the presence or absence of a transponder based at least in part on a number M of samples or measurements of the unmodulated electromagnetic signals received during the detection cycle and the adjusted signal detection threshold, where the number M is greater than one. A ratio of N:M may be at least equal to 4. N may be equal to about 200 and M may be equal to about 800. For example, the interrogation and detection system may determine the presence or absence of a transponder by comparing a maximum value of a plurality of matched filter outputs with the adjusted signal threshold.
  • In some embodiments, the interrogation and detection system determines if an output of at least one matched filter during the noise detection portion of the detection cycle exceeds a noise fault threshold indicative of a noise fault. Such may be employed to prevent extraneous objects (e.g., metal table, EKG leads, etc.) from producing a positive result. For example, the interrogation and detection system may determine if the output of the at least one matched filter during the noise detection portion of the detection cycle exceeds the noise fault threshold for a defined period of time. The interrogation and detection system may then terminate the detection cycle in response to the output of the at least one matched filter exceeding the noise fault threshold for the defined period of time.
  • The interrogation and detection system may convert the received signal(s) from the time domain to the frequency domain spectrum. Such may be employed, for example in lieu of the match filtering. The interrogation and detection system may, for example, perform a Fourier transform, for instance a fast Fourier transform such as a 256 point fast Fourier transform. Suitable algorithms and/or sets of software code for performing such are available or can be written. The interrogation and detection system may search the frequency domain spectrum to determine the object with the strongest resonance in a defined frequency band. For example, the interrogation and detection system may search the frequency domain spectrum from about 120 KHz to about 175 KHz. An amplitude of the resonant object may be computed as the sum of the resonant power plus and minus 2 fast Fourier transform bins from the peak resonance frequency. This approach may provide a more accurate measurement of power than simply using the peak value. The frequency of the resonant object may be computed using an interpolation approach. This approach may provide a more accurate determination of resonant frequency than simply using the fast Fourier bin number. The interrogation and detection system may determine the presence or absence of a transponder based at least in part on a frequency of the unmodulated electromagnetic signals received during the detection cycle being within a defined frequency range. The defined frequency range may extend from about 137 KHz to about 160 KHz.
  • The interrogation and detection system may ignore any unmodulated electromagnetic signals received during a recovery portion (if any) of the detection cycle that precedes the receive response portion of the detection cycle. Such may be useful in preventing false positives (i.e., tag detections) from being triggered by the transmission of the interrogation or excitement signals.
  • The interrogation and detection system may determine a Q value (i.e., Quality factor) of the resonant object from a signal decay slope for the received unmodulated electromagnetic signal(s) returned by the resonant object. For example, the interrogation and detection system may determine a Q value of the unmodulated electromagnetic signals received during the detection cycle being at least equal to a threshold Q value. The threshold Q value may, for example, be 35. The interrogation and detection system may, for example, use multiple windows, for instance five (5) window positions may provide suitable results. The interrogation and detection system may determine the presence or absence of a transponder based at least in part on a Q value of the unmodulated electromagnetic signal(s) received during the detection cycle. The interrogation and detection system may preferably employ the Q value determination in conjunction with determination based on the frequency and on the determination based on the adjusted signal detection threshold.
  • Consequently, in some embodiments the tag detection may advantageously be based on the received unmodulated electromagnetic signal(s) satisfying all three conditions: 1) measured amplitude is above a threshold, which may be an adjustable threshold, 2) measured frequency is between a lower limit and an upper limit, and 3) measured Q value is above a minimum Q threshold. Interference, for example from RFID tags or EKG cables, are rejected when any of the following three conditions are satisfied: a) measured frequency is below the lower frequency limit, b) measured frequency is above the upper frequency limit, or c) measured Q value is below the threshold Q value. Such may provided significantly superior results over previous approaches, preventing false positives which could otherwise cause a patient to remain open for longer period of time during surgery and tie up hospital personnel and resources.
  • The above description of illustrated embodiments, particularly the use of multiple antennas, the pulsed wide band frequency hopping with dynamic adjustment of the transmission frequency in the various frequency bands and the use of switched capacitors to achieve such, advantageously permit the use of inexpensive transponders which are not accurately tuned to a chosen or selected resonant frequency. This is in marked contrast to the approach typically taken with other types of resonant transponders (i.e., transponders without memory). Such approaches typically interrogate or excite the resonant transponder using narrow frequency bands centered closely on specific frequencies, to achieve a selected resonant response from a highly accurate transponder in order to differentiate signal from noise. This is also in marked contrast to the approach typically taken with radio frequency identification (RFID) tags whether active or passive, which also typically employ are narrow band to achieve a selected response from a highly accurate RFID tag.
  • The interrogation and detection system herein described may further implement a handheld wand 2802 as illustrated in FIG. 28. Wand 2802 comprises a loop antenna 2806, a handle 2808, and a cord 2810. The wand 2802 may be configured to interface with the interrogation and detection system. The wand 2802 may be connected to the controller 18 by means of the chord 2810. The wand 2802 may be waved over the patient on the patient support structure 26 while emitting an interrogation signal to excite any transponder 24 which may be in or near the patient. The antennas 16 a-16 f may then all be used to detect a signal from the transponder as previously described. In one embodiment the controller 18 controls the wand 2802. In one embodiment the wand 2802 emits an interrogation signal and monitors for a response from a transponder 24. In one embodiment the wand 2802 operates independent of the antennas 16 and the controller 18. In one embodiment the wand 2802 is wirelessly operated. In one embodiment the wand 2802 only detects a transponder and does not emit an interrogation signal. Many other implementations of the wand 2802 will be apparent to those of skill in the art in light of the illustrated embodiments. For example, the wand 2802 may be implemented in a form other than a loop antenna. The illustrated embodiments are given only by way of non-limiting example.
  • In some embodiments, the wand 2802 may interact (e.g., inductively) with the other antennas 16 and/or the transponders to, for example, advantageously increase sensitivity and/or range. For example, the antennas 16 may emit interrogation signals and the wand 2802 may be used to detect return or response signals from the transponders. Alternatively, the wand 2802 may emit interrogation signals and the antennas 16 may be used to detect return or response signals from the transponders. Also for example, an electromagnetic field may be set up between the wand 2602 and one or more of the antennas 16, and disturbances of the electromagnetic field caused by the presence of a transponder therein detected. Other approaches that combined the wand 2802 and one or more of the antennas 16 may be advantageously employed.
  • The above-described interrogation and detection system 14 may additionally be utilized to reduce the total number of wired devices used in a medical procedure environment such as a surgical environment and attendant clutter associated with such wired devices. In an operating room or even in most modern patient rooms or clinician's offices there is typically a large number of electronic instruments and equipment used to aid in surgery. This may include various medical instruments which monitor the vital signs or other characteristics or aspects of the patient and hence which may provide telemetry (telemetry medical instruments). A non-exhaustive list of these medical telemetry instruments includes EKG machines, other types of electrogram devices, pulse oximeters, intracranial pressure monitors, blood pressure monitors, thermometers or other temperature sensitive devices, pH sensors, electrical conductivity sensors, etc. There may also be life support equipment, for example, cardiopulmonary bypass machines, ventilators, intra-aortic balloon pumps, an infusion pumps, etc. All of these instruments may comprise one or more wires including power cords and wires that extend between the patient and the instrument and/or monitors or displays. These wires may be an obstacle to medical personnel performing or assisting in the surgery. This may put the patient at risk, as well as increase the risk of damaging the equipment. Additionally, many of these cords and wires must be sterilized after each use. Sterilizing a wire can be extremely expensive since inventory control must be maintained, wires are typically difficult to sterilize, and repeated sterilization may shorten the useful life of the wire.
  • The interrogation and detection system 14 described herein may advantageously enable the wireless operation of many systems and instruments in a surgical environment. As described above in relation to FIGS. 1-28 the interrogation and detection system 14 may comprise antennas 16 embedded in a patient support structure 26, or situated in other configurations throughout the operating room. The interrogation and detection system 14 may further comprise a controller 18 configured to control the operation of the antennas 16. The antennas 16 and controller 18 comprise a useful infrastructure which reduces a total number of wires used in the vicinity of a patient. The reduction of wires can reduce complications and costs of surgery.
  • FIG. 29 shows an environment in which medical procedures (e.g., therapeutic and/or diagnostic medical procedures) are performed, according to one illustrated embodiment. As previously noted, the medical procedure environment may take a variety of forms such as an operating room or theater, a patient room, examination room, a clinician's office, etc.
  • The medical procedure environment includes a plurality of antennas 2916 a-2916 f (collectively 2916). As illustrated, some or all of the antennas 2916 may be carried by a patient support structure 2926 (e.g., operating table, bed, pads, mattress). Alternatively, one or more of the antennas 2916 may be located elsewhere in the medical procedure environment, for example carried by a light fixture or associated shade, a curtain or drape, etc.
  • The medical procedure environment may include a controller 2918 communicatively coupled to one or more of the antennas 2916. The controller 2918 is preferably communicatively coupled to the antenna(s) 2916 via one or more wired communications channels, for example via one or more cables, for instance shielded coaxial cables (not shown in FIG. 29). The controller 2918 may, for example, be positioned on or within a pedestal 2928 which supports the patient support structure 2926.
  • As previously described, one or more of the antennas 2916 may emit interrogation signals and receive responses to interrogation signals in order to detect a presence or absence of transponders which mark various types of objects used in medical procedures, for instance instruments, implements, and various other supplies such as sponges, pads, gauze. Thus, the controller 2918 may provide a notification (e.g., visual, aural, tactile) in response to a detection of a presence or absence of a transponder in the range of one or more of the antennas 2916. Advantageously, one or more of the antennas 2916 may also be used to provide wireless communications with one or more pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 2959 a, 2059 b (collectively 2959). The dedicated medical diagnostic, therapeutic or monitoring equipment 2959 may include one or more antennas 2961 a, 2961 b, receivers, transmitters and/or transceivers (not shown in FIG. 29) to provide wireless communications to and/or from the dedicated medical diagnostic, therapeutic or monitoring equipment 2959. As explained in more detail with respect to other Figures below, the antennas 2916 may serve as a relay between pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 2959, for example as a relay between sensors (not illustrated in FIG. 29) and a dedicated controller or control system of a piece of dedicated medical diagnostic, therapeutic or monitoring equipment 2959, remotely located from the sensors. Additionally, or alternatively, the controller 2918 of the interrogation and detection system 2914 may serve as a user interface to display information from and/or to interact with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 2959, for instance as described directly below.
  • A display 2950 and a user input device 2952 may be communicatively coupled to the controller 2918. The display 2950 may be any screen or monitor (e.g., LCD panel, CRT) suitable to display information and/or a user interface (e.g., graphical user interface). The display 2950 may be a touch-sensitive display device, capable of functioning as a user input device of a user interface. The display 2950 may be a stand alone, separate piece of equipment. Alternatively, the display 2950 may be integrated into the controller 2918 or the patient support structure 2926.
  • The display 2950 and/or user input device 2952 may be a dedicated medical telemetry terminal or part of a piece of dedicated medical diagnostic, therapeutic or monitoring equipment 2959. Alternatively, the display 2950 and/or user input device 2952 may be general purpose equipment capable of providing display of information from, and/or control over, a variety of pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 2959.
  • The display 2950 may be configured to display medical telemetry or data received via antennas 2916. The medical telemetry or data may be received by one or more of the antennas 2916 from one or more of a variety of medical telemetry devices such as dedicated medical diagnostic, therapeutic or monitoring equipment 2959 (e.g., EKG sensors or electrodes, intra-cranial pressure sensors, pulse oximetry sensors or pulse oximeters, or any other of numerous medical measurement or sensor devices). The medical telemetry or data may be related to a characteristic or physiological condition of a patient. Alternatively, or additionally, the telemetry or data may be related to one or more operational characteristics of the dedicated medical diagnostic, therapeutic, or monitoring equipment themselves, whether equipment dedicated to medically related measurement or sensing, or equipment that performs a therapeutic function on the patient. The telemetry or data may be conveniently displayed by the display 2928, either in processed and/or raw form. Processing may be preformed by the dedicated medical diagnostic, therapeutic or monitoring equipment 2959 or by the controller 2918 of the interrogation and detection system 2914. Telemetry or data from multiple pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 2959 may be displayed sequentially or concurrently (e.g., substantially simultaneously) on the display 2950.
  • One or more of the antennas 2916 of the interrogation and detection system 2914 may communicate with the dedicated medical diagnostic, therapeutic or monitoring equipment, for example receiving data from, and/or providing data, instructions and/or new programs to the dedicated medical diagnostic, therapeutic or monitoring equipment. For example, one or more of the antennas 2916 may relay commands to the dedicated medical diagnostic, therapeutic or monitoring equipment such as a cardiopulmonary bypass machine, ventilator, intra-aortic balloon pump, infusion pump, etc. Also for example, one or more of the antennas 2916 may relay data or telemetry from the dedicated medical diagnostic, therapeutic or monitoring equipment, such as an EKG electrodes, pulse oximetry sensors, blood pressure sensors, intracranial pressure monitor sensors, etc. The user input device (e.g., keyboard, keypad, pointer device, and/or graphical user interface) 2952 can be used to instruct the controller 2918 to control one or more of the dedicated medical diagnostic, therapeutic or monitoring equipment in wireless communication with the interrogation and detection system 2914. These pieces of dedicated medical diagnostic, therapeutic or monitoring equipment or instruments (e.g., life support equipment) are not shown in FIG. 29, but one or more may be present in the environment in which medically related diagnostic, therapeutic and/or monitoring procedures are performed. Exemplary embodiments of dedicated medical diagnostic, therapeutic or monitoring equipment which can communicate via one or more of the antennas 2916 are described below.
  • The medical procedure environment may include one or more automatic data collection readers 2990 a, 2990 b (collectively 2990, only two illustrated). The automatic data collection readers 2990 are dedicated to reading and/or writing data to one or more data carriers 2924 a-2924 d (collectively 2924, only three illustrated), hence may be denominated as dedicated automatic data collection readers herein and in the claims. Such denomination means that the dedicated automatic data collection readers 2990 perform only reading and/or writing to data carriers 2924, and are not otherwise used to measure or sense physiological conditions of a patient or therapeutically interact with a patient.
  • The dedicated automatic data collection readers 2990 may, for example, take the form of, or include, a machine-readable symbol reader 2990 a, for instance a scanner or imager capability of optically reading machine-readable symbols 2924 c (e.g., barcode, area or matrix code or stacked code symbols). Also for example, the dedicated automatic data collection readers 2990 may take the form of, or include, a radio frequency identification (RFID) reader 2990 b, for instance an RFID interrogator capability of wirelessly reading information from an RFID data carrier such as an RFID tag 2924 b. The dedicated automatic data collection readers 2990 may combine machine-readable symbol and RFID reading capabilities. Suitable dedicated automatic data collection readers 2990 may be commercially available from Intermec Technologies or Symbol Technologies. Additionally, or alternatively, the dedicated automatic data collection readers 2990 may be capable of reading or writing to other data carriers such as optical memories, touch memories (e.g., available from Dallas Semiconductor), magnetic stripes, etc.
  • The data carriers 2924 may take a large variety of forms, including but not limited to labels or tags that carry machine-readable symbols or that otherwise encode machine-readable information (e.g., RFID, optical memories, touch memories, magnetic stripes). The data carrier 2924 may advantageously encode information in two or more forms, for example an RFID transponder that carries or bears a machine-readable symbol. Also for example, the data carrier 2924 may include a transponder and an RFID transponder. Details of such are discussed in U.S. patent application Ser. No. 12/472,199 filed May 26, 2009, as well as in U.S. provisional patent applications Ser. Nos. 61/056,299 and 61/102,749, filed May 27, 2008 and Oct. 3, 2008, respectively, and which are incorporated by reference herein in their entireties.
  • The dedicated automatic data collection readers 2990 may include one or more processors and/or memory. The dedicated automatic data collection readers 2990 may be configured to process or pre-process information read from the data carrier. For example, the dedicated automatic data collection readers 2990 may be configured to automatically recognize symbols from various symbologies and decode the same. The dedicated automatic data collection readers 2990 may be configured to write data to a data carrier 2924. For example, the dedicated automatic data collection reader 2990 b may be configured to automatically write information to an RFID data carrier 2924.
  • The dedicated automatic data collection readers 2990 may be communicatively coupled to the controller 2918, either via a physical or wired channel (e.g., electrical or optical) as illustrated for the reader 2990 a or wirelessly as illustrated for the reader 2990 b. Wireless communications may occur via one or more of the antennas 2916 of the interrogation and detection system. While FIG. 29 illustrates all antennas 2916 of the interrogation and detection system as being carried by the patient support structure, one, more or all of the antennas of the interrogation and detection system may be carried by other structures, for example a shade associated with a light fixture or a drape. The dedicated automatic data collection readers 2990 may form part of a network, along with the communications channel(s) and controller 2918.
  • The dedicated automatic data collection readers 2990 may be employed to read information from data carriers 2924 physically associated with various objects (e.g., implements 2922 a, tools, machines 2922 d, devices, sponges 2922 b, pads, gauze, articles and/or other supplies), and/or a patient and/or one or more medical care providers (e.g., doctors, nurses, anesthesiologist, radiology technician), for instance from a data carrier of a wrist band 2922 c, anklet or badge worn by the patient or medical care provider. Such can be integrated with other automatically collected information, such as information indicative of a physiological condition of the patient or subject, or information indicative of an operational parameter of a piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • In addition to the dedicated automatic data collection readers 2990, or alternatively, one or more of the antennas 2916 of the interrogation and detection system may be used to reader from, and/or write to, data carriers 2924. For example, the controller 2918 may be configured to cause one or more of the antennas 2916 to emit interrogation signals in a frequency band employed by RFID transponders or tags, and to receive response signals encoding information from the RFID transponder's memory.
  • Information received from the RFID transponder may, for example, include an identifier, such as a unique identifier that uniquely identifies the RFID transponder or tag. A database stored on a computer-readable medium may associate the identifier with information that identifies the object to which the RFID transponder or tag is attached, as well as information about the object. The information may include identity of the object such as manufacturer, model, type, classification, lot number and/or date of manufacture. The information may include a history of the object, for instance number of uses, number and/or type of sterilization cycles, number and/or date of refurbishment, dates and/or times of use, dates of inspection and/or identity of inspector. The information may be accessible (e.g., read, write) by the controller 2918 of the interrogation and detection system, and/or by one or more pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • An EKG machine may be used to monitor the heart activity of a patient during surgery. Conventionally, a plurality of electrodes or sensors are attached to a patient at various locations on the patient. Each electrode or sensor is electrically coupled to the EKG machine by a respective electrically conductive wire. Each EKG electrode and wire is commonly referred to as a lead. As many as twelve or more electrodes may be attached to the patient simultaneously, each electrode having its own wire coupled to an EKG machine. EKG lead wires can be particularly obtrusive during surgery. The EKG lead wires frequently become tangled. Medical personnel moving about the patient are impeded by the wires. Medical personnel may bump into the wires and either break a wire or detach one or more of the EKG electrodes. Once detached, the electrodes may be difficult to reattach as there may be bodily fluid covering the area where the detached electrode was previously attached. If more than one electrode becomes detached, the electrodes are particularly susceptible to being replaced in the wrong location. Also, fluid on the electrodes may cover a distinguishing mark meant to indicate the proper location of the electrodes. Reattaching the electrodes wastes valuable time and can lead to improper placement of the electrodes and faulty EKG data. Reducing the amount of wires leading from the EKG electrodes to an EKG machine is desirable.
  • FIG. 30A shows a piece of dedicated medical diagnostic, therapeutic or monitoring equipment in the form of wireless sensor or transducer 3054, according to one embodiment. The wireless sensor or transducer may take the form of an electrode 3054 a, for instance an electrode suitable for measuring EKGs. While such may be referred to as a “wireless lead,” applicants understand that such term is somewhat a misnomer since the “lead” or electrical wire is eliminated and all that remains of the original “lead” is the electrode (i.e., electrically sensitive sensor or transducer).
  • The wireless sensor or transducer 3054 carries a battery 3056 and a radio 3058. The radio 3058 comprises at least a transmitter and may include a receiver as well, and may be formed as a transceiver. The wireless sensor or transducer 3054 may also include an inscription or marker indicating a proper position of the wireless sensor or transducer 3054 on the body of the patient. The individual wireless electrodes 3054 a may sense activity of the heart or other physiological activity (e.g., electrical) in any suitable manner. While illustrated as an active component having a discrete exhaustible power source (e.g., chemical battery, fuel cell), the wireless sensor or transducer 3054 may take a passive form, deriving power from a wireless interrogation signal, similar to radio frequency identification (RFID) transponders. While discussed in terms of an electrode 3054 a to sense electrical physiological characteristics (e.g., conductivity, impedance, resistivity, capacitance), a wireless sensor or transducer 3054 can be employed which is responsive to other physiological characteristics (e.g., temperature, moisture, pH, salt, pressure, stress, strain or force).
  • FIG. 30B shows a plurality of “wireless leads” or electrodes 3054 a attached to a patient 3060 according to one embodiment.
  • As described above, a patient may have twelve or more EKG electrodes positioned on the torso, back, limbs, or any suitable location. The configuration of the wireless electrodes 3054 a in FIG. 30B is given only by way of broad example of the number and positioning of the wireless electrodes 3054 a. In practice, the number and positioning of wireless electrodes 3054 a may be different from that shown in FIG. 30B.
  • Each wireless electrode 3054 a comprises a radio 3058 configured to transmit EKG data to an antenna 16 coupled to the interrogation and detection system 14. In one embodiment the controller 18 processes the data received from the wireless electrodes 3054 a and displays the resulting EKG waveform on the display 2950 (FIG. 29).
  • Each wireless electrode 3054 a may transmit a unique identifier to the controller 18 so that the controller 18 may know which data came from which wireless electrode 3054 a. The identifier may also indicate the position of an individual wireless electrode on the patient's body. The electrodes 3054 a may bear a marking which identifies the wireless electrode 3054 a and/or a location on the body at which the wireless electrode 3054 a should be placed or is placed.
  • Two or more electrodes 3054 a may be wirelessly communicatively coupled to each other. Two wireless electrodes 3054 a are wirelessly coupled when at least one of the wireless electrodes 3054 a is configured to transmit data to the other wireless electrode 3054 a. One wireless electrode 3054 a can send a signal to a second wireless electrode 3054 a and the second wireless electrode 3054 a can then transmit data to the antenna 16 representing the data gathered by one or both wirelessly coupled wireless electrodes 3054 a. The controller 18 may receive wireless transmissions from only one or from both wireless electrodes 3054 a.
  • The configuration shown in FIG. 30B greatly reduces the number of wires in the vicinity of the patient. Medical personnel moving about the patient support structure 2726 will face a much lower risk of bumping a wire and either detaching an electrode 2854 or stumbling themselves. There are fewer wires on the body of the patient to impede surgeons performing delicate and precise operations on the body of the patient. In addition to this, the EKG machine no longer needs to be present in the surgical environment. The controller 18 may process the data sent from the electrodes 3054 a and displays the data (e.g., EKG waveform) on the display 2950 (FIG. 29).
  • While it has been noted that the dedicated piece of medical diagnostic, therapeutic or monitoring equipment (e.g., EKG machine) may not be present in the medical procedure environment, typically the dedicated piece of medical diagnostic, therapeutic or monitoring equipment will be co-located in the same room as the patient. The wireless electrodes 3054 may wirelessly transmit telemetry or data to a piece of dedicated medical diagnostic, therapeutic or monitoring equipment (e.g., an EKG machine). The piece of dedicated medical diagnostic, therapeutic or monitoring equipment may in turn transmit data to the controller 18 of the interrogation and detection system, for example via the antennas 16 or via one or more wired connections (e.g., electrically conductive cables or optical fiber cables). The controller 18 may also transmit instructions to the piece of piece of dedicated medical diagnostic, therapeutic or monitoring equipment. For example, the controller 18 may transmit operating instructions which cause the piece of piece of dedicated medical diagnostic, therapeutic or monitoring equipment to operate in a certain fashion, or may transmit new software or firmware instructions or upgrades of existing software or firmware instructions, to reconfigure the piece of piece of dedicated medical diagnostic, therapeutic or monitoring equipment. Alternatively, one or more of the antennas 2916 (FIG. 29) may provide wireless communications between the display 2950, user input device 2952 and the piece of piece of dedicated medical diagnostic, therapeutic or monitoring equipment, which may employ conventional wired electrodes (not shown).
  • FIG. 30C shows sensor or transducer 3054 according to an alternative embodiment. One electrode 3054 a may be connected by a wire 3062 to another wireless lead or electrode 3054 a. One or both of the electrodes 3054 a comprises a radio 3058 (i.e., transmitter and/or receiver or transceiver that communicates via portions of the electromagnetic spectrum typically associated with radio communications such as the radio and microwave portions of the electromagnetic spectrum) and optionally a discrete consumable power source such as battery 3056 or fuel cell. At least one of the pair of wireless electrodes 3054 a transmits telemetry or data (e.g., EKG signals) to one or more of the antennas 16 of the interrogation and detection system 14. There may be one or more pairs of wireless electrodes 3054 a attached to the patient in which one wireless electrode 3054 a of each pair is wired to the other wireless electrode 3054 a of the pair.
  • FIG. 31 shows a plurality of sensors or transducers 3154 in the form of leads or electrodes 3154 a and an intermediary relay 3164, according to one illustrated embodiment.
  • The leads 3154 a may, for example, include an electrode, sensor or other transducer, and a physical communications conduit, for example an electrically conductive or optical wire or cable. Each of the leads 3154 a is attached to a patient 3160 at various locations on the patient to sense a physiological characteristic of the patient. Each lead 3154 a is also communicatively attached or coupled to the intermediate relay 3164. The intermediate relay 3164 is a commonly shared communications device 2964 (i.e., common communications device shared by two or more of the leads 3154 a), and is interchangeably referred to as such herein.
  • The intermediate relay or common communications device 3164 may take the form of, or include, a multiplexer and/or demultiplexer. The common communications device 2964 includes a radio 3158 operable to transmit telemetry or data (e.g., signals) detected by the leads 3154 a to one or more of the antennas 16 of the interrogation and detection system 14. The radio 3158 includes one or more antennas, a transmitter and may also include a receiver, and may be formed as transceiver. The common communications device 3164 may be powered by a battery 3156 or other power source. The leads 3154 a may be powered by respective batteries located at the electrode portions of the leads 3154 a. Alternatively, the leads 3154 a may receive power from the intermediate relay or common communications device 3164 via the respective wires. As a further alternative, the leads 3154 a may wirelessly receive power via an interrogation signal.
  • The intermediate relay or common communications device 3164 wireless transmits telemetry or data (e.g., EKG signals) to the controller 18 of the interrogation and detection system via one or more antennas 16. The controller 18 may displays the telemetry or data on the display 2950 (FIG. 29), either in processed or raw form. Alternatively, the controller 18 may communicate the telemetry or data to a piece of dedicated medical diagnostic, therapeutic or monitoring equipment. For instance, the controller 18 may relay the telemetry or data to an EKG machine for processing and display or printing. Such may take place over a physical media, such as electrical wires or optical fibers. This advantageously eliminates many of the wires around the patient 3160 which would have connected the leads 3154 a directly to an EKG machine. The EKG machine likewise may not be needed as the common communications device 3164 and the controller 18 may process the EKG data.
  • Another piece of dedicated medical diagnostic, therapeutic or monitoring equipment that provides dedicated medical telemetry or data is a pulse oximeter. A typical pulse oximeter sensor is attached to a finger of a patient to measure the blood-oxygen level of a patient. The pulse oximeter sensor is normally connected by one or more wires to a pulse oximeter processing system to process raw data from pulse oximeter sensor. The pulse oximeter processing system includes or is coupled to a display to display processed data.
  • FIG. 32 shows a wireless pulse oximeter sensor 3266, according to one embodiment. The pulse oximeter sensor 3266 may be used to monitor the oxygen content of a patient's blood.
  • The wireless pulse oximeter sensor 3266 is physically attached to a portion of the patient, for example a finger 3268 of the patient. The wireless pulse oximeter sensor 3266 comprises a transducer 3257 and a radio 3258 transmitter and/or receiver or transceiver). The radio 3258 includes an antenna (now shown) and is configured to wirelessly transmit data sensed by the transducer 3257 to at least one antenna 16 coupled to the interrogation and detection system 14. The controller 18 may process the data received via the at least one antenna. The controller 18 may display the patient's blood-oxygen data on the display 2950 (FIG. 29) in processed or raw form. The data may advantageously be displayed simultaneously with EKG data on a single display 2950 (FIG. 29). Of course, more than one display 2950 may be utilized. Alternatively, the controller 18 may relay the sensed measurements to a dedicated pulse oximeter processing system or controller, either via wireless or wired communications. Thus, the interrogation and detection system 14 may advantageously be utilized to eliminate extraneous wire, and/or an extra display or processor.
  • Hence, some embodiments may take advantage of the proximity of antennas 16 to the patient to wirelessly collect data from various sensors or transducers, and to relay that data directly to associated processing equipment dedicated to a particular function or task. Alternatively, the controller 18 of the interrogation and detection system 14 may itself implement some or all of the processing usually performed by the associated dedicated processing system.
  • FIG. 33 illustrates an intracranial pressure monitor 3370 according to one embodiment.
  • The intracranial pressure monitor 3370 is a dedicated piece of medical diagnostic, therapeutic or monitoring equipment which is attached to a head of the patient to monitor pressure in the head. The intracranial pressure monitor 3370 may include one or more pressure sensors or transducers (e.g., piezo-electric or resistance based strain gauge) 3371 and a radio 3372 (i.e., transmitter and/or receiver or transceiver) that includes an antenna (not shown). The pressure sensors or transducers 3371 may be implemented in a MEMS device or other suitable mechanism. The radio 3172 is communicatively coupled to the pressure sensor 3371. The radio 333172 transmits data from the pressure sensor or transducer 3371 to an antenna 16 of the interrogation and detection system 14.
  • The controller 18 may process the data and display the processed data on the display 2950 (FIG. 29). Alternatively, the controller 18 may simply display raw, unprocessed data via the display 2950. Additionally, or alternatively, the controller 18 may relay the raw or partially processed data to a controller of a dedicated intracranial pressure monitor processing system or controller. In one embodiment, the display 2950 (FIG. 29) advantageously displays intracranial pressure monitor sensor data along with pulse oximetry and/or EKG data collected from one or both of the pulse oximeter 3266 (FIG. 32) and/or electrodes 3054 (FIG. 30A). When processing occurs in dedicated medical diagnostic, therapeutic or monitoring equipment, that dedicated medical diagnostic, therapeutic or monitoring equipment may relay processed data back to the interrogation and detection system 14, via antennas 16, for display on display 2950, possibly with other processed data. Alternatively, the dedicated medical diagnostic, therapeutic or monitoring equipment may be communicatively coupled directly to the display 2950, for example via one or more wired or wireless connections.
  • The interrogation and detection system 14 can further be utilized to communicate with and issue commands to other dedicated medical diagnostic, therapeutic or monitoring equipment, for example dedicated medical therapeutic equipment used to perform a therapeutic function on the patient or dedicated medical diagnostic equipment used to collect diagnostic information from the patient.
  • FIG. 34 illustrates an infusion pump 3474 according to one illustrated embodiment.
  • The infusion pump 3474 is a piece of dedicated medical diagnostic, therapeutic or monitoring equipment that may be used to inject fluid (e.g., intravenously) into a patient. The fluid may be one or more drugs, anesthetic, blood, plasma, saline, food or sucrose, etc. The infusion pump 3474 may be programmed to introduce fluid into the patient at a desired rate. The infusion pump 3474 may include a radio (e.g., transmitter and/or receiver, or transceiver) 3458 configured to communicate wirelessly with an antenna 16 of the interrogation and detection system 14. The radio 3458 may receive wireless control signals from a remotely located controller, for instance the controller 18. The control signals may indicate, for example, an infusion rate at which to pump the fluid into the patient, a start time, a stop time, a duration, a delivery profile indicating various rates over time. The radio 3458 may additionally or alternatively, transmit monitoring signals to a remotely located controller, for instance the controller 18. The monitoring signals may indicate various operational characteristics of the infusion pump 3474, for instance, amount and/or rate of actual fluid delivery, an amount of fluid remaining, and whether a battery of the infusion pump 3474 is nearing depletion. The data from the infusion pump 3474 may be displayed on the display 2950 (FIG. 29) along with other medical telemetry or data described in relation to FIGS. 30-33. Additionally, or alternatively, the medical telemetry or data may be relayed by the controller 18 of the interrogation and detection system 14 to a dedicated controller of an infusion pump system. Such may be done over one or more wired or wireless communications channels.
  • In one embodiment, a user may use the input device 2952 and/or touch screen of the display 2950 (FIG. 29) to enter a new fluid infusion rate for the infusion pump 3474. The controller 18 then sends a control signal to the infusion pump 3474 via an antenna 16 of the interrogation and detection system 14. Alternatively, the user may enter a new rate via a user input device of a dedicated infusion pump system, which relays control instructions to the interrogation and detection system 14. The signal is received at the radio 3458 of the infusion pump 3474 and the infusion pump 3474 adjusts the fluid infusion rate accordingly.
  • The controller 18 may be configured to communicate with remotely located equipment, such as a display at a nurse's station outside of the room in which the medical procedure is preformed. Any of the data received by the controller 18 can be displayed at the nurse's station. In this way medical personnel remote to the patient's room may monitor any of the equipment communicating with the interrogation and detection system 14.
  • The controller 18 may be configured to receive commands from the nurse's station to adjust the fluid infusion rate of the infusion pump 3474. The controller 18 may be configured to receive commands from the nurse's station to adjust a function of any of the equipment coupled to the interrogation and detection system.
  • FIG. 35 illustrates an intra-aortic balloon pump system 3576, according to one illustrated embodiment. Typically, a balloon pump system is a dedicated piece of medical diagnostic, therapeutic or monitoring equipment used to inflate or deflate catheter balloons. The balloon pump system is typically controlled by a computer coupled to an EKG machine. The computer controls the pulsation of the balloon pump according to data from the EKG.
  • The intra-aortic balloon pump system 3576 comprises a pump 3577 operable to selectively inflate and deflate an intra-aortic balloon. The intra-aortic balloon pump system 3576 may include a user interface 3578 including a display 3578 a and one or more user input devices (e.g., keys, switches, knobs, pointer devices) 3578 b. The display 3578 a and user input devices 3578 b are dedicated to the display of information related to operation of the aortic balloon pump system 3576 and control thereof, respectively.
  • The intra-aortic balloon pump system 3576 may include a radio (e.g., transmitter and/or receiver or transceiver) 3558 configured to communicate with an antenna 16 of the interrogation and detection system 14. The controller 18 may be configured to control the balloon pump 3576 from a remote location, for example in response to EKG data. The controller 18 may transmit data, for instance EKG data, to the balloon pump system 3576 and allow the balloon pump system 3576 to process the data and control the pump 3577 accordingly. In either case, the balloon pump system 3576 does not need to be connected by wire to another piece of dedicated medical diagnostic, therapeutic or monitoring equipment (e.g., EKG machine), thus enhancing the environment in which the medical procedure is preformed. Alternatively, or additionally, the interrogation and detection system 14 may function as a relay between sensors or transducers (e.g., electrodes), pumps (e.g., pump of inter-aortic balloon system) and other dedicated medical diagnostic, therapeutic or monitoring equipment or dedicated medical diagnostic, therapeutic or monitoring control systems of such dedicated medical diagnostic, therapeutic or monitoring equipment. The interrogation and detection system 14 may be further utilized to interact with a balloon pump during or after surgery.
  • FIG. 36 illustrates a controller 3618, according to one illustrated embodiment.
  • The controller 3618 is similar to that of FIG. 16 but has been adapted to enable operation of the antennas 16 to communicate with pieces of dedicated medical diagnostic, therapeutic or monitoring equipment as described in relation to FIGS. 29-34. The controller 3618 comprises a motherboard 3672. The motherboard 3672 includes or is communicatively coupled to a plurality of ports or connectors 3674 to communicatively couple the motherboard 3672 to respective antennas 16 as previously described in relation to FIG. 16. The motherboard 3672 may also include slot connectors 3676 to receive plug-in boards 3678 as previously described in relation to FIG. 16. The controller 3618 has been expanded to include one or more additional slot connectors 3676 for receiving one or more additional plug-in boards 3678 for enabling communication through the antennas 16 or additional antenna(s) with one or more medical telemetry or data and support or control pieces of dedicated medical diagnostic, therapeutic or monitoring equipment, for example equipment such as EKG electrodes 3054, pulse oximeter sensor 3266, intracranial pressure monitor 3370, fusion pump 3474, and balloon pump system 3576. There are of course many other dedicated medical diagnostic, therapeutic or monitoring equipment which may be used during and after a medical procedures (e.g., operation), any or all of which may be fitted with radios (e.g., transmitter and/or receiver, or transceiver) and configured to interface with the interrogation and detection system. The one or more additional plug-in boards 3676 enable the controller 3618 to operate the interrogation and detection antennas 16 in a mode for interacting with pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • A single antenna 16 of the interrogation and detection antennas may be dedicated to communicate with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment. Alternatively more than one antenna 16 of the interrogation and detection system 14 may be configured to communicate with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment. In some embodiments, all of the antennas 16 of the interrogation and detection system 14 are configured to communicate with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment. In some embodiments, one or more of the antennas 16 of the interrogation and detection system 14 are dedicated to communications with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment, the plug-in boards being different from the plug-in board used with antennas 16 that perform interrogations to locate transponders 24. In some embodiments, one or more antennas 16 are used to perform all of interrogation, detection of transponders and to communicate with sensors, pumps, and/or other instruments or equipment, and/or with dedicated control systems of the same. In some embodiments, one or more additional antennas 16 may be connected to ports 3674 of the motherboard 3672 dedicated solely to interface with the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • The controller 18 of the interrogation and detection system may be operable to communicate with radios 3058, 3258, 3372, 3458, 3558 of the various pieces of dedicated medical diagnostic, therapeutic or monitoring equipment 3054, 3266, 3370, 3474, 3576. Radios 3058, 3258, 3372, 3458, 3558 may operate in more precise frequency bands than the transponders 24.
  • Antennas of the interrogation and detection system 14 may be configured to operate in a first mode to detect transponders 24 and in a second mode to communicate with the pieces of dedicated medical equipment. The first mode may include operating in a first broad frequency range as previously described with regards to the interrogation and detection process. The second mode may include operating in a second frequency range, more narrow than the first frequency range. In one embodiment, the first and second frequency ranges may overlap. In other embodiments, the first and second frequency ranges do not overlap.
  • In an alternative embodiment, the radios may be passive, employing passive RFID type technology. Such radios may employ a first antenna dedicated solely to receiving a first signal to charge a charge pump of the radio to power the radio. The second antenna operates at a different frequency than the first antenna and is configured to communicate with an antenna 16 of the interrogation and detection system 14. A dedicated power antenna may be installed in the interrogation and detection system 14 to supply a constant signal to power EKG wireless leads or electrodes 3054. Alternatively the power antenna could be installed in the operating room independent of the interrogation and detection system 14. In either case, the power antenna should be near the patient support structure 26 in order to supply an adequately strong signal to the radios. In one embodiment the power generated by the charge pump supplements the battery 3056 to extend the life thereof in the case of a long medical procedure which may last several hours. Otherwise, the battery 3056 of the wireless leads or electrodes 3054 may run out of power. Thus, the power generated by the charge pump from the power antenna signal may advantageously prolong the life of the battery 3056. The radios may also comprise two antennas to supplement the batteries of the pieces of dedicated medical diagnostic, therapeutic or monitoring equipment.
  • The above description of illustrated embodiments, including what is described in the Abstract, is not intended to be exhaustive or to limit the embodiments to the precise forms disclosed. Although specific embodiments of and examples are described herein for illustrative purposes, various equivalent modifications can be made without departing from the spirit and scope of the disclosure, as will be recognized by those skilled in the relevant art. The teachings provided herein of the various embodiments can be applied to other transponders and interrogation and detection systems, not necessarily the exemplary surgical object transponders and interrogation and detection systems generally described above.
  • For instance, the teachings herein may employ any variety of other electrodes, sensors or transducers and diagnostic, therapeutic or monitoring equipment. For example, photo-electric pulse plethysmograph transducers, respiratory effort transducers, GSR finger electrode transducers, physiological sounds microphone, active electrodes, air flow transducers, blood pressure transducers, blood pressure cuff transducers, hand dynamometers, variable range force transducer, twin axis goniometer, torsion meter, laser Doppler surface flow probe, skin surface temperature, fast response temperature probe, surface temperature banjo probe, liquid immersion probe, digit surface temperature probe, accelerometer, pulse oximeters transducer.
  • Also for instance, the foregoing detailed description has set forth various embodiments of the devices and/or processes via the use of block diagrams, schematics, and examples. Insofar as such block diagrams, schematics, and examples contain one or more functions and/or operations, it will be understood by those skilled in the art that each function and/or operation within such block diagrams, flowcharts, or examples can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or virtually any combination thereof. In one embodiment, the present subject matter may be implemented via Application Specific Integrated Circuits (ASICs). However, those skilled in the art will recognize that the embodiments disclosed herein, in whole or in part, can be equivalently implemented in standard integrated circuits, as one or more computer programs running on one or more computers (e.g., as one or more programs running on one or more computer systems), as one or more programs running on one or more controllers (e.g., microcontrollers) as one or more programs running on one or more processors (e.g., microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of ordinary skill in the art in light of this disclosure.
  • In addition, those skilled in the art will appreciate that the mechanisms of taught herein are capable of being distributed as a program product in a variety of forms, and that an illustrative embodiment applies equally regardless of the particular type of physical signal bearing media used to actually carry out the distribution. Examples of signal bearing media include, but are not limited to, the following: recordable type media such as floppy disks, hard disk drives, CD ROMs, digital tape, and computer memory.
  • The various embodiments described above can be combined to provide further embodiments. To the extent not inconsistent with the teachings herein, all U.S. patents, U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications and non-patent publications commonly owned with this patent application and referred to in this specification and/or listed in the Application Data Sheet including: U.S. Patent Publication No. US 2004/0250819, published Dec. 16, 2004; U.S. Provisional Patent Application No. 60/811,376 filed Jun. 6, 2006; U.S. Provisional Patent Application No. 61/109,104 filed Oct. 28, 2008; U.S. Provisional Patent Application No. 61/222,443 filed Jul. 1, 2009; U.S. Provisional Patent Application No. 61/222,847 filed Jul. 2, 2009; U.S. Provisional Patent Application No. 61/242,704, filed Sep. 15, 2009 and entitled “METHOD AND APPARATUS TO DETECT TRANSPONDER TAGGED OBJECTS, FOR EXAMPLE DURING MEDICAL PROCEDURES”; U.S. provisional patent application Ser. No. 61/242,699 filed Sep. 15, 2009; U.S. Non-Provisional patent application Ser. No. 11/743,104 filed May 1, 2007; U.S. Non-Provisional patent application Ser. No. 12/472,199 filed May 26, 2009; U.S. Non-Provisional patent application Ser. No. 12/473,059 filed May 27, 2009; and U.S. Pat. No. 6,026,818, issued Feb. 22, 2000, are incorporated herein by reference, in their entirety. Aspects of the embodiments can be modified, if necessary, to employ systems, circuits and concepts of the various patents, applications and publications to provide yet further embodiments.
  • These and other changes can be made to the embodiments in light of the above-detailed description. In general, in the following claims, the terms used should not be construed to limit the claims to the specific embodiments disclosed in the specification and the claims, but should be construed to include all possible embodiments along with the full scope of equivalents to which such claims are entitled. Accordingly, the claims are not limited by the disclosure.

Claims (17)

1.-47. (canceled)
48. A method of operating a system in a medical facility, the system including a plurality of antennas and a controller communicatively coupled to the antennas, the method comprising:
selectively transmitting a number of wideband interrogation signals from at least one of the antennas;
determining whether a response to the wideband interrogation signals was received from a transponder that marks an object used in a medical procedure via the at least one of the antennas used to transmit the number of wideband interrogation signals; and
selectively providing wireless communications that encode at least one of information, commands and data with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to transmit the interrogation signal and receive the response signal.
49. The method of claim 48 wherein transmitting a number of wideband interrogation signals from at least one of the antennas includes transmitting the wideband interrogation signals from a number of antennas carried by a patient support structure that carries a patient during a medical procedure.
50. The method of claim 49 wherein transmitting a number of wideband interrogation signals from at least one of the antennas includes transmitting the wideband interrogation signals from a handheld antenna that inductively cooperates with the plurality of antennas carried by the patient support structure.
51. The method of claim 49 wherein at least one of the number of antennas is a handheld antenna, and transmitting the wideband interrogation signals includes transmitting the wideband interrogation signals by one of the handheld antenna or the plurality of antennas carried by the patient support structure, and further comprising receiving any response signals to the wideband interrogation signals by the other one of the handheld antenna or the plurality of antennas carried by the patient support structure.
52. The method of claim 48 wherein transmitting a number of wideband interrogation signals from at least one of the antennas includes transmitting the wideband interrogation signals from at least three loop antennas spaced along a longitudinal axis of one of an operating table, a bed, a mattress or a sheet.
53. The method of claim 48 wherein transmitting a number of wideband interrogation signals from at least one of the antennas includes transmitting the wideband interrogation signals from a plurality of antennas carried by a drape that at least partially surrounds a patient support structure that carries a patient during a medical procedure.
54. The method of claim 48 wherein transmitting a number of wideband interrogation signals from at least one of the antennas includes transmitting the wideband interrogation signals from a plurality of antennas carried by a shade that extends from a light fixture positioned relatively above a patient support structure that carries a patient during a medical procedure.
55. The method of claim 48 wherein providing communications that encode at least one of information, commands and data with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to transmit the interrogation signal and receive the response signal includes receiving data signals from the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to transmit the interrogation signal and receive the response signal, the data signals representing physiological characteristics of the patient measured by the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
56. The method of claim 48 wherein providing communications that encode at least one of information, commands and data with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to transmit the interrogation signal and receive the response signal includes receiving data signals from the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to transmit the interrogation signal and receive the response signal, the data signals representing operational characteristics of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
57. The method of claim 48 wherein providing communications that encode at least one of information, commands and data with at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to transmit the interrogation signal and receive the response signal includes transmitting control signals to the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via the at least one of the antennas used to transmit the interrogation signal and receive the response signal, the control signals representing operational instructions to control operation of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
58. The method of claim 48, further comprising:
transmitting information by the controller to a display to display information related to at least one of the patient or the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
59. The method of claim 48, further comprising:
receiving by the controller user input entered by a user via a user input device; and
transmitting control signals by the controller based on the received user input to the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment via at least one of the number of antennas, the control signals representing operational instructions to control operation of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
60. The method of claim 48, further comprising:
receiving data signals by the controller via at least one of the antennas from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment; and
transmitting the received data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment.
61. The method of claim 60 wherein receiving data signals by the controller via at least one of the antennas from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment includes receiving data signals from a transducer coupled to the patient and transmitting the received data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment includes transmitting the data signals to a dedicated control system for the transducer.
62. The method of claim 60 wherein receiving data signals by the controller via at least one of the antennas from a first one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment includes receiving data signals from one of an electrocardiogram electrode, a pulse oximetry transducer and transmitting the received data signals to a second one of the at least one piece of dedicated medical diagnostic, therapeutic or monitoring equipment includes transmitting the data signals to one of a dedicated electrocardiogram processing system or a pulse oximetry processing system.
63. The method of claim 48 wherein at least one of the antennas is responsive to a force exerted thereon and further comprising:
receiving signals by the controller indicative of the force exerted on the antenna; and
producing a notification if the force exceeds at least one of an amplitude threshold or a time duration.
US15/786,001 2009-07-02 2017-10-17 Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures Abandoned US20180039753A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/786,001 US20180039753A1 (en) 2009-07-02 2017-10-17 Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22284709P 2009-07-02 2009-07-02
US24269909P 2009-09-15 2009-09-15
US12/606,963 US9792408B2 (en) 2009-07-02 2009-10-27 Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures
US15/786,001 US20180039753A1 (en) 2009-07-02 2017-10-17 Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/606,963 Division US9792408B2 (en) 2009-07-02 2009-10-27 Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures

Publications (1)

Publication Number Publication Date
US20180039753A1 true US20180039753A1 (en) 2018-02-08

Family

ID=43413086

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/606,963 Active 2034-01-22 US9792408B2 (en) 2009-07-02 2009-10-27 Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures
US15/786,001 Abandoned US20180039753A1 (en) 2009-07-02 2017-10-17 Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/606,963 Active 2034-01-22 US9792408B2 (en) 2009-07-02 2009-10-27 Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures

Country Status (1)

Country Link
US (2) US9792408B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722323B2 (en) 2009-11-23 2020-07-28 Covidien Lp Method and apparatus to account for transponder tagged objects used during medical procedures
US11234787B1 (en) 2020-11-20 2022-02-01 Stryker Corporation Manifold for filtering medical waste being drawn under vacuum into a medical waste collection system
US11786647B1 (en) 2022-01-31 2023-10-17 Stryker Corporation Medical waste collection systems, manifolds, and related methods

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303597A1 (en) 2002-12-31 2004-07-29 Therasense, Inc. Continuous glucose monitoring system and methods of use
US7587287B2 (en) * 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US7679407B2 (en) * 2003-04-28 2010-03-16 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
US7722536B2 (en) * 2003-07-15 2010-05-25 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
CA2556331A1 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
CA2572455C (en) * 2004-06-04 2014-10-28 Therasense, Inc. Diabetes care host-client architecture and data management system
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
US7768408B2 (en) 2005-05-17 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
JP2009507224A (en) 2005-08-31 2009-02-19 ユニヴァーシティー オブ ヴァージニア パテント ファンデーション Improving the accuracy of continuous glucose sensors
US7756561B2 (en) * 2005-09-30 2010-07-13 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US7583190B2 (en) * 2005-10-31 2009-09-01 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
US7801582B2 (en) 2006-03-31 2010-09-21 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US8478557B2 (en) 2009-07-31 2013-07-02 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US20090105571A1 (en) * 2006-06-30 2009-04-23 Abbott Diabetes Care, Inc. Method and System for Providing Data Communication in Data Management Systems
US20080199894A1 (en) 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US8930203B2 (en) * 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
EP3741291A1 (en) * 2007-04-14 2020-11-25 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
ES2784736T3 (en) * 2007-04-14 2020-09-30 Abbott Diabetes Care Inc Procedure and apparatus for providing data processing and control in a medical communication system
ES2461090T3 (en) * 2007-04-14 2014-05-16 Abbott Diabetes Care Inc. Procedure and apparatus for providing data treatment and control in a medical communication system
US9008743B2 (en) * 2007-04-14 2015-04-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US8140142B2 (en) * 2007-04-14 2012-03-20 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20080278332A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281171A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281179A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en) * 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en) * 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8597188B2 (en) 2007-06-21 2013-12-03 Abbott Diabetes Care Inc. Health management devices and methods
WO2008157819A1 (en) * 2007-06-21 2008-12-24 Abbott Diabetes Care, Inc. Health management devices and methods
AU2008265542B2 (en) * 2007-06-21 2014-07-24 Abbott Diabetes Care Inc. Health monitor
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US20090036760A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US8358212B2 (en) * 2008-05-27 2013-01-22 Rf Surgical Systems, Inc. Multi-modal transponder and method and apparatus to detect same
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
WO2010022258A2 (en) * 2008-08-21 2010-02-25 Intersil Americas Inc. Noise cancellation for antenna module
US8726911B2 (en) 2008-10-28 2014-05-20 Rf Surgical Systems, Inc. Wirelessly detectable objects for use in medical procedures and methods of making same
US8264342B2 (en) 2008-10-28 2012-09-11 RF Surgical Systems, Inc Method and apparatus to detect transponder tagged objects, for example during medical procedures
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US8368556B2 (en) 2009-04-29 2013-02-05 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
DE102009021232B4 (en) * 2009-05-14 2017-04-27 Siemens Healthcare Gmbh Patient couch, method for a patient couch and imaging medical device
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US9792408B2 (en) * 2009-07-02 2017-10-17 Covidien Lp Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures
AU2010286917B2 (en) 2009-08-31 2016-03-10 Abbott Diabetes Care Inc. Medical devices and methods
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
EP2482720A4 (en) 2009-09-29 2014-04-23 Abbott Diabetes Care Inc Method and apparatus for providing notification function in analyte monitoring systems
WO2011041531A1 (en) 2009-09-30 2011-04-07 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US9514336B2 (en) * 2009-12-17 2016-12-06 Symbol Technologies, Llc Method and system for adaptive operation of a power amplifier of a radio frequency identification (RFID) reader device
WO2012170000A1 (en) * 2010-01-22 2012-12-13 Abbott Diabetes Care Inc. Method, device and system for providing analyte sensor calibration
WO2011091336A1 (en) * 2010-01-22 2011-07-28 Abbott Diabetes Care Inc. Method and apparatus for providing notification in analyte monitoring systems
US9138186B2 (en) * 2010-02-18 2015-09-22 Bank Of America Corporation Systems for inducing change in a performance characteristic
US8715179B2 (en) * 2010-02-18 2014-05-06 Bank Of America Corporation Call center quality management tool
US8715178B2 (en) * 2010-02-18 2014-05-06 Bank Of America Corporation Wearable badge with sensor
WO2011112753A1 (en) 2010-03-10 2011-09-15 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
EP2553650A4 (en) * 2010-03-31 2014-08-06 Welch Allyn Inc Extensibility for manipulation of medical data
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US20120053423A1 (en) * 2010-08-24 2012-03-01 Christopher Kenalty Smart mattress
US8920167B2 (en) * 2010-09-21 2014-12-30 Implantdent Co., Ltd. Surgical guide preparation tool and method for preparing surgical guide
EP2624745A4 (en) 2010-10-07 2018-05-23 Abbott Diabetes Care, Inc. Analyte monitoring devices and methods
KR101183886B1 (en) * 2011-01-05 2012-09-19 전자부품연구원 Method for providing selective service by selective service module and home gateway using the same
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
CA3177983A1 (en) 2011-02-28 2012-11-15 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9136597B2 (en) 2011-03-17 2015-09-15 Rf Surgical Systems, Inc. Mat based antenna system to detect transponder tagged objects, for example during medical procedures
US9277829B2 (en) 2011-07-22 2016-03-08 TC13—Pressure Applications LLC Systems and methods for monitoring and providing therapeutic support for a user
US10368796B2 (en) 2011-07-22 2019-08-06 Tc13-Pressure Applications Llc Systems and methods for monitoring and providing therapeutic support for a user
US9622691B2 (en) 2011-10-31 2017-04-18 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
WO2013066873A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
WO2013070794A2 (en) 2011-11-07 2013-05-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
WO2013123119A1 (en) * 2012-02-15 2013-08-22 Stryker Corporation Patient support apparatus and controls therefor
EP3395252A1 (en) 2012-08-30 2018-10-31 Abbott Diabetes Care, Inc. Dropout detection in continuous analyte monitoring data during data excursions
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
WO2014052136A1 (en) 2012-09-26 2014-04-03 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US20140118160A1 (en) * 2012-10-30 2014-05-01 Quantitative Sampling Technologies, LLC Controller for supervising data acquisition devices
EP2740514B1 (en) * 2012-12-04 2017-04-05 BIOTRONIK SE & Co. KG Implantable electrostimulation arrangement and adapter and alectrode lead of the same
US8704178B1 (en) 2013-03-15 2014-04-22 Surgitrac Corporation Container for surgical object and fluid monitoring system
US8692140B1 (en) 2013-03-15 2014-04-08 Surgitrac Corporation Surgical object and fluid monitoring system having highly sensitive and reliable detection of objects being placed in a container
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US8963025B2 (en) 2013-03-15 2015-02-24 Surgitrac Corporation Surgical object and fluid monitoring system having highly sensitive and reliable detection of objects being placed in a container
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US9347817B2 (en) 2013-03-15 2016-05-24 Surgitrac Corporation Surgical object and comprehensive fluid monitoring system having capability of mobile monitoring and having highly sensitive and reliable detection of objects being placed in a container
US9872732B2 (en) 2013-10-24 2018-01-23 Covidien Lp Surgical sponge distribution systems and methods
US9326661B2 (en) 2013-11-18 2016-05-03 Gyrus Acmi, Inc. Line of sight wireless endoscopy
US9744321B2 (en) * 2013-12-16 2017-08-29 General Electric Company System and method of detecting integrity of breathing systems for safe and optimal delivery
EP3125761B1 (en) 2014-03-30 2020-09-30 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
CN106132339B (en) 2014-03-31 2019-06-04 柯惠Lp公司 For detecting the method for being marked with the object of transponder, equipment and object
WO2015160820A1 (en) * 2014-04-14 2015-10-22 The University Of Memphis Wireless analog passive sensors
WO2015161322A1 (en) * 2014-04-18 2015-10-22 Owens Jeanette Medical procedure table with integral ports and wires for electrocardiography
WO2016118755A1 (en) 2015-01-21 2016-07-28 Covidien Lp Sterilizable wirelessly detectable objects for use in medical procedures and methods of making same
US10193209B2 (en) 2015-04-06 2019-01-29 Covidien Lp Mat based antenna and heater system, for use during medical procedures
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
US9833294B2 (en) * 2015-10-02 2017-12-05 Synaptive Medical (Barbados) Inc. RFID medical device control interface
WO2017069581A1 (en) * 2015-10-23 2017-04-27 주식회사 아모텍 Vehicle antenna module
CN105411574B (en) * 2016-01-13 2018-02-09 济南市儿童医院 A kind of electrocardiogram examinating couch
CN105411573B (en) * 2016-01-13 2018-01-05 王加峰 A kind of electrocardiogram examinating couch
GB2551364B (en) * 2016-06-15 2023-02-01 Time To Act Ltd Axial flux generators
AU2017295835A1 (en) 2016-07-11 2018-12-06 Covidien Lp Method and apparatus to account for transponder tagged objects used during clinical procedures employing a shielded receptacle with antenna
JP2019527093A (en) 2016-07-11 2019-09-26 コヴィディエン リミテッド パートナーシップ Method and apparatus for confirming the location of transponder tagged objects used during clinical procedures, including, for example, count-in and / or count-out and presence detection
WO2018013411A1 (en) 2016-07-11 2018-01-18 Covidien Lp Method and apparatus to account for transponder tagged objects used during clinical procedures, employing a shielded receptacle
WO2018013417A1 (en) 2016-07-11 2018-01-18 Covidien Lp Method and apparatus to account for transponder tagged objects used during clinical procedures, employing a trocar
US10429423B2 (en) * 2016-09-27 2019-10-01 PIM Solutions LLC Passive intermodulation (PIM) probe
US9882610B1 (en) * 2016-11-08 2018-01-30 Welch Allyn, Inc. Near field communication sensor system
FR3060133B1 (en) * 2016-12-09 2020-10-30 Biomediqa DEVICE FOR MEASURING A RADIO-ELECTRIC DOSE ON A SURFACE, ESPECIALLY FOR MEASURING THE RADIOLOGICAL DOSE OF A PATIENT DURING A RADIOLOGY OPERATION
US11564694B2 (en) * 2017-01-12 2023-01-31 Takeda Pharmaceutical Company Limited Smart tourniquet
US10646303B1 (en) * 2017-02-04 2020-05-12 S. D. Strano Method and apparatus for delineating the position of a specific tissue
EP3600014A4 (en) 2017-03-21 2020-10-21 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
CN109933230A (en) * 2017-12-19 2019-06-25 祥达光学(厦门)有限公司 Method that electronic device is operated with it with can wireless control electronic building brick
US10716641B2 (en) 2018-03-27 2020-07-21 Covidien Lp Method and apparatus to account for transponder tagged objects used during clinical procedures, employing a trocar
US10849713B2 (en) 2018-03-27 2020-12-01 Covidien Lp Method and apparatus to account for transponder tagged objects used during clinical procedures, employing a trocar
US20200000548A1 (en) 2018-07-02 2020-01-02 Covidien Lp Method and apparatus related to fabricated wireless transponder devices to be used in medical procedures
US11172819B2 (en) * 2018-07-31 2021-11-16 Freedom Cardio LLC Single point wireless biopotential monitoring systems and methods
US10784920B2 (en) 2018-10-04 2020-09-22 Covidien Lp Wirelessly detectable object that emits a variable-frequency response signal, and method and system for detecting and locating same
US11478185B2 (en) * 2019-02-12 2022-10-25 Hill-Rom Services, Inc. Skin dressing having sensor for pressure ulcer prevention
JP2022537884A (en) * 2019-06-21 2022-08-31 ユニスト(ウルサン ナショナル インスティテュート オブ サイエンス アンド テクノロジー) Biosensors using resonator assemblies and electromagnetic waves for biosensing
JPWO2021144839A1 (en) * 2020-01-14 2021-07-22
USD980198S1 (en) 2021-03-04 2023-03-07 Inspire Medical Systems, Inc. Wireless communication controller
USD1017048S1 (en) * 2021-03-04 2024-03-05 Inspire Medical Systems, Inc. Wireless communications assembly
EP4301272A1 (en) * 2021-03-05 2024-01-10 Covidien LP Interrogation and detection systems for radio-frequency tags, and methods
EP4385449A1 (en) 2022-12-16 2024-06-19 Caranx Medical SAS System for positioning a module

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040250819A1 (en) * 2003-03-27 2004-12-16 Blair William A. Apparatus and method for detecting objects using tags and wideband detection device
US20060187059A1 (en) * 2005-02-10 2006-08-24 Fabian Carl E Surgical implement detector utilizing a radio-frequency identification marker
US20070285249A1 (en) * 2006-06-06 2007-12-13 Rf Surgical Systems, Inc. Method, apparatus and article for detection of transponder tagged objects, for example during surgery
US20080001735A1 (en) * 2006-06-30 2008-01-03 Bao Tran Mesh network personal emergency response appliance
US20090322485A1 (en) * 2008-05-28 2009-12-31 Barnes Bruce E Method, apparatus and article for detection of transponder tagged objects, for example during surgery
US20100022900A1 (en) * 2008-01-04 2010-01-28 Peterson Stephen C Non-Invasive Method And Device For Measuring Cardiac Output
US20100057167A1 (en) * 2008-09-02 2010-03-04 Xander Evers System and Method for the Interrogation of Implantable Medical Devices
US8545416B1 (en) * 2005-11-04 2013-10-01 Cleveland Medical Devices Inc. Integrated diagnostic and therapeutic system and method for improving treatment of subject with complex and central sleep apnea
US9792408B2 (en) * 2009-07-02 2017-10-17 Covidien Lp Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures

Family Cites Families (127)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US82006A (en) * 1868-09-08 Improvement in beex- hives
US3717876A (en) 1971-04-23 1973-02-20 Volkers Res Corp Ferrite antenna coupled to radio frequency currents in vehicle body
US3783282A (en) 1971-06-07 1974-01-01 R Hoppenstein Stereoscopic radiography techniques and apparatus
US3984695A (en) 1975-01-06 1976-10-05 Medi-Ray, Inc. Radiation guard apparatus
US4034297A (en) 1976-01-13 1977-07-05 General Electric Company Circuit for disabling a radio transmitter which is continuously operated longer than a predetermined time
US4603074A (en) 1985-05-22 1986-07-29 Gencorp Inc. Vinyl chloride polymer laminate
US4788730A (en) 1987-12-02 1988-12-06 Bexton Robert A Gel-filled, variably-adjustable cushioning system for supporting a person
US4966595A (en) 1988-09-06 1990-10-30 Medical Action Industries, Inc. Surgical sponge assembly
AUPO055296A0 (en) 1996-06-19 1996-07-11 Integrated Silicon Design Pty Ltd Enhanced range transponder system
US5966763A (en) 1996-08-02 1999-10-19 Hill-Rom, Inc. Surface pad system for a surgical table
US5931824A (en) 1996-09-04 1999-08-03 Stewart; William W. Identification and accountability system for surgical sponges
US6353406B1 (en) 1996-10-17 2002-03-05 R.F. Technologies, Inc. Dual mode tracking system
ATE261290T1 (en) 1997-11-07 2004-03-15 Hill Rom Services Inc OPERATING TABLE
US6484334B1 (en) 1997-11-07 2002-11-26 Hill-Rom Services, Inc. Surgical table
US6026818A (en) 1998-03-02 2000-02-22 Blair Port Ltd. Tag and detection device
US6295671B1 (en) 1998-03-06 2001-10-02 Ohio Medical Instrument Company, Inc. Medical surgical table including interchangeable orthopedic attachment and scanning table
GB9826596D0 (en) 1998-12-04 1999-01-27 P J O Ind Limited Conductive materials
US6974935B2 (en) 1998-12-04 2005-12-13 Inditherm Plc Electrical connection
AU2222800A (en) 1999-01-04 2000-07-24 Medivance, Incorporated Improved cooling/heating pad and system
US6378149B1 (en) 1999-01-25 2002-04-30 Steris Inc Radiolucent split-leg accessory for a surgical table
US20050154336A1 (en) 1999-04-30 2005-07-14 Kloecker Richard J. Segmented pneumatic pad for regulating pressure upon parts of the body during usage
US6578219B1 (en) 1999-05-26 2003-06-17 Kci Licensing, Inc. Mattress overlay for operating room table
US6599448B1 (en) 2000-05-10 2003-07-29 Hydromer, Inc. Radio-opaque polymeric compositions
US6933469B2 (en) 2000-06-14 2005-08-23 American Healthcare Products, Inc. Personal warming systems and apparatuses for use in hospitals and other settings, and associated methods of manufacture and use
US6967309B2 (en) 2000-06-14 2005-11-22 American Healthcare Products, Inc. Personal warming systems and apparatuses for use in hospitals and other settings, and associated methods of manufacture and use
AU6687401A (en) 2000-06-14 2001-12-24 Inc American Healthcare Produc Heating pad systems, such as for patient warming applications
US6744378B1 (en) 2000-09-01 2004-06-01 Traffic Monitoring Services, Inc. Roadway sensor with improved insulated signal carrying wires
US6499158B1 (en) 2000-10-30 2002-12-31 Steris, Inc. Surgical table top and accessory clamp used thereon
GB0100983D0 (en) 2001-01-13 2001-02-28 Smiths Group Plc Surgical tables
US7020917B1 (en) 2001-03-12 2006-04-04 Steris Corporation Radiolucent surgical table with low shadow accessory interface profile
US6861954B2 (en) 2001-03-30 2005-03-01 Bruce H. Levin Tracking medical products with integrated circuits
US6774800B2 (en) 2001-03-30 2004-08-10 Augmentech, Inc. Patient incontinence monitoring apparatus and method of use thereof
US7299981B2 (en) 2001-05-21 2007-11-27 Scott Laboratories, Inc. Smart supplies, components and capital equipment
US7158030B2 (en) 2001-09-19 2007-01-02 Avante International Technology Medical assistance and tracking system and method employing smart tags
US6660027B2 (en) 2001-10-11 2003-12-09 Medivance Incorporated Patient temperature control system with fluid preconditioning
US6699267B2 (en) 2001-10-11 2004-03-02 Medivance Incorporated Patient temperature control system with fluid temperature response
US6722783B2 (en) 2001-12-31 2004-04-20 Ronnie W. Jackson, Sr. X-ray chair
US6648905B2 (en) 2002-02-27 2003-11-18 Medivance Incorporated Enhanced medical thermal energy exchange pad
US6799063B2 (en) 2002-02-27 2004-09-28 Medivance Incorporated Temperature control pads with integral electrodes
US6692518B2 (en) 2002-02-27 2004-02-17 Medivance Incorporated Patient temperature control system
US6669715B2 (en) 2002-02-27 2003-12-30 Medivance Incorporated Medical thermal energy exchange pad
US20030175473A1 (en) 2002-03-14 2003-09-18 Timothy Gillum Surgical table pad with fluid waste channel
US20050203470A1 (en) 2002-04-17 2005-09-15 Ballard Marlin D. Radiographically detectable object assemblies and surgical articles comprising same
US20040008123A1 (en) 2002-07-15 2004-01-15 Battelle Memorial Institute System and method for tracking medical devices
US6802855B2 (en) 2002-08-08 2004-10-12 Medivance Incorporated Patient temperature control system connector apparatus
US6827728B2 (en) 2002-08-08 2004-12-07 Medivance Incorporated Patient temperature control system
AU2003250460A1 (en) 2002-08-28 2004-03-19 Koninklijke Philips Electronics N.V. Method of inventorying transponders by means of a communication station
EP1553908A1 (en) 2002-10-23 2005-07-20 Tcam Technologies, Inc. Smart decubitus mat
US7464713B2 (en) 2002-11-26 2008-12-16 Fabian Carl E Miniature magnetomechanical tag for detecting surgical sponges and implements
EP1572450B1 (en) 2002-12-12 2019-07-24 Ahlstrom-Munksjo Nonwovens LLC Ethylene oxide sterilizable, low cost nonwoven laminates with high wet peel strength and improved barrier properties
US7541933B2 (en) 2003-03-03 2009-06-02 Veroscan, Inc. Interrogator and interrogation system employing the same
US6918144B2 (en) 2003-04-04 2005-07-19 Michael Friedman Self-heating portable massage table
US7446646B2 (en) 2003-06-30 2008-11-04 Nokia Corporation System and method for supporting multiple reader-tag configurations using multi-mode radio frequency tag
GB0316327D0 (en) 2003-07-12 2003-08-13 Inditherm Plc Conductive materials
US7399899B2 (en) 2003-08-28 2008-07-15 Fabian Carl E Attachment of electronic tags to surgical sponges and implements
DE10357193A1 (en) 2003-12-08 2005-07-07 Schreiner Group Gmbh & Co. Kg Textile label and method for its production
WO2005098746A2 (en) 2004-03-26 2005-10-20 Digimarc Corporation Identification document having intrusion resistance
US7333013B2 (en) 2004-05-07 2008-02-19 Berger J Lee Medical implant device with RFID tag and method of identification of device
US7644016B2 (en) 2004-08-25 2010-01-05 Warsaw Orthopedic, Inc. Automated pass-through surgical instrument tray reader
ITRN20040042A1 (en) 2004-08-31 2004-11-30 Alessandro Galdenzi SURGICAL GAUZE WITH IDENTIFICATION MATRIX
US8470012B2 (en) 2004-09-08 2013-06-25 Arizant Healthcare Inc. Inflatable convective pad for surgery
US7492261B2 (en) 2004-11-22 2009-02-17 Warsaw Orthopedic, Inc. Control system for an RFID-based system for assembling and verifying outbound surgical equipment corresponding to a particular surgery
US7227469B2 (en) 2004-11-22 2007-06-05 Sdgi Holdings, Inc. Surgical instrument tray shipping tote identification system and methods of using same
US20060137099A1 (en) 2004-12-28 2006-06-29 Steve Feher Convective cushion with positive coefficient of resistance heating mode
US7420468B2 (en) 2005-02-10 2008-09-02 Fabian Carl E Surgical implement detector
US7517360B2 (en) 2005-03-16 2009-04-14 Smiths Medical Asd, Inc. System for automatically inflating temperature regulated blankets and a blanket for coupling to the system
US20060232407A1 (en) 2005-04-14 2006-10-19 Ballard Marlin D Radio frequency detectable assemblies and detectable surgical articles comprising same
DE102005019472B4 (en) 2005-04-27 2010-02-04 Dräger Medical AG & Co. KG System for the perioperative warming of a patient
US7837694B2 (en) 2005-04-28 2010-11-23 Warsaw Orthopedic, Inc. Method and apparatus for surgical instrument identification
US7550000B2 (en) 2005-05-27 2009-06-23 Smiths Medical Asd, Inc. Restrictor regulated air flow blanket, system utilizing such blanket and method therefor
US20060276864A1 (en) 2005-06-03 2006-12-07 Alsius Corporation Systems and methods for sensing patient temperature in temperature management system
CN2865741Y (en) 2005-07-14 2007-02-07 天津市赛远保健品有限公司 Power-saving heating magnetic therapeutic bedding
CA2624454A1 (en) 2005-09-29 2007-04-12 Augustine Biomedical And Design Llc Heating blanket and pads
US7795491B2 (en) 2005-10-11 2010-09-14 Patient Safety Technologies, Inc. Systems and methods for counting surgical implements
US7909861B2 (en) 2005-10-14 2011-03-22 Thermotek, Inc. Critical care thermal therapy method and system
US7266852B2 (en) 2005-10-31 2007-09-11 Woodlark Circle, Inc. Inflatable transfer mattress
DE102005055842A1 (en) 2005-11-23 2007-05-24 Alpha-Fit Gmbh Pressure sensor for incorporation in clinical test socks or stockings incorporates pressure-sensitive threads or ribbons
US20070238982A1 (en) 2006-03-29 2007-10-11 Caylor Edward J Iii System and method for monitoring kinematic motion of a patient
US7666214B2 (en) 2006-04-12 2010-02-23 Smiths Medical Asd, Inc. Underbody thermal blanket
CA2654505A1 (en) 2006-06-06 2007-12-21 Rf Surgical Systems, Inc. Method, apparatus and article for detection of transponder tagged objects, for example during surgery
US7558255B2 (en) 2006-07-13 2009-07-07 Alcatel-Lucent Usa Inc. Method of switching modes of uplink transmission in a wireless communication system
US20080051746A1 (en) 2006-08-23 2008-02-28 Jane Shen-Gunther Surgical sponge incorporating rfid technology and method of use
US8181860B2 (en) 2006-09-13 2012-05-22 Clearcount Medical Solutions, Inc. Apparatus and methods for monitoring objects in a surgical field
US7927329B2 (en) 2006-09-28 2011-04-19 Covidien Ag Temperature sensing return electrode pad
US20080119757A1 (en) 2006-11-21 2008-05-22 Suzanne Winter Temperature management system with wireless patient temperature sensor
US20080126122A1 (en) 2006-11-28 2008-05-29 General Electric Company Smart bed system and apparatus
US8048137B2 (en) 2006-12-28 2011-11-01 Smiths Medical Asd, Inc. Tube blanket
WO2008098152A1 (en) 2007-02-08 2008-08-14 Acist Medical Systems, Inc. Medical procedure mat and draping system
WO2008106552A1 (en) 2007-02-28 2008-09-04 Rf Surgical Systems, Inc. Method, apparatus and article for detection of transponder tagged objects, for example during surgery
EP2062234A1 (en) 2007-03-12 2009-05-27 Rf Surgical Systems, Inc. Transponder housing and device to mark implements
US9283109B2 (en) 2007-03-16 2016-03-15 Innovative Medical Equipment, Llc Fluid manipulating device and tissue interacting device for a thermal therapy system
US20120279953A1 (en) 2011-03-16 2012-11-08 Augustine Biomedical And Design Llc Heated under-body warming systems
US8021360B2 (en) 2007-04-03 2011-09-20 Tyco Healthcare Group Lp System and method for providing even heat distribution and cooling return pads
US20080249524A1 (en) 2007-04-03 2008-10-09 Tyco Healthcare Group Lp System and method for providing even heat distribution and cooling return pads
US8777940B2 (en) 2007-04-03 2014-07-15 Covidien Lp System and method for providing even heat distribution and cooling return pads
WO2008133634A1 (en) 2007-05-01 2008-11-06 Rf Surgical Systems, Inc. Method and apparatus for detection of transponder tagged objects
US7696877B2 (en) 2007-05-01 2010-04-13 Rf Surgical Systems, Inc. Method, apparatus and article for detection of transponder tagged objects, for example during surgery
US20090000614A1 (en) 2007-06-29 2009-01-01 Carrano Aaron W Inflatable pad for medical system
US8197123B2 (en) 2007-10-29 2012-06-12 Smiths Medical Asd, Inc. Thermistor circuit calibration
US20090228082A1 (en) 2008-03-07 2009-09-10 Smiths Medical Asd, Inc. Patient heat transfer device
US8608788B2 (en) 2008-03-31 2013-12-17 Smiths Medical Asd, Inc. Underbody convective blanket and method for manufacturing thereof
US20090267765A1 (en) 2008-04-29 2009-10-29 Jack Greene Rfid to prevent reprocessing
US8358212B2 (en) 2008-05-27 2013-01-22 Rf Surgical Systems, Inc. Multi-modal transponder and method and apparatus to detect same
WO2010008846A2 (en) 2008-06-23 2010-01-21 John Richard Dein Intra-operative system for identifying and tracking surgical sharp objects, instruments, and sponges
US20100057170A1 (en) 2008-09-04 2010-03-04 Smiths Medical Asd, Inc. Full view access upper underbody blanket
US8264342B2 (en) 2008-10-28 2012-09-11 RF Surgical Systems, Inc Method and apparatus to detect transponder tagged objects, for example during medical procedures
US8726911B2 (en) 2008-10-28 2014-05-20 Rf Surgical Systems, Inc. Wirelessly detectable objects for use in medical procedures and methods of making same
US20100137704A1 (en) 2008-12-02 2010-06-03 Surgivision, Inc. Medical mats with electrical paths and methods for using the same
US20100198320A1 (en) 2009-01-30 2010-08-05 Smiths Medical Asd, Inc. Lateral access blanket
US8872662B2 (en) 2009-02-12 2014-10-28 Haldor Advanced Technologies Ltd. Antenna, apparatus and method for identifying and tracking multiple items
US8193938B2 (en) 2009-02-12 2012-06-05 Haldor Advanced Technologies Ltd. Apparatus for identifying and tracking multiple tools and disposables
US8197525B2 (en) 2009-02-13 2012-06-12 Smiths Medical Asd, Inc. Full body split access blanket
US8308785B2 (en) 2009-02-18 2012-11-13 Smiths Medical Asd, Inc. Multi-access blanket
US8172890B2 (en) 2009-02-18 2012-05-08 Smiths Medical Asd, Inc. Combination underbody and overbody blanket
US8021353B2 (en) 2009-03-17 2011-09-20 Smiths Medical Asd, Inc. Heat exchanger connector assembly
US8234727B2 (en) 2009-09-04 2012-08-07 Stryker Corporation Patient transfer device
US8371448B1 (en) 2009-10-01 2013-02-12 Brian K. Reaux Storage system for medical waste materials
US9226686B2 (en) 2009-11-23 2016-01-05 Rf Surgical Systems, Inc. Method and apparatus to account for transponder tagged objects used during medical procedures
WO2011156671A1 (en) 2010-06-10 2011-12-15 Clearcount Medical Solutions, Inc. Method and apparatus for automating the counting of sharps using rfid tags
US9041479B2 (en) 2010-12-06 2015-05-26 Stryker Combo, L.L.C. Systems and methods for providing modulation of switchmode RF power amplifiers
US8477076B1 (en) 2012-01-25 2013-07-02 Clearcount Medical Solutions, Inc. Antenna coupler mechanism
US9872732B2 (en) 2013-10-24 2018-01-23 Covidien Lp Surgical sponge distribution systems and methods
US20150216610A1 (en) 2014-02-06 2015-08-06 Augustine Biomedical And Design, Llc System, apparatus and methods for counting and detecting surgical sponges
AU2016200113B2 (en) 2015-01-21 2019-10-31 Covidien Lp Wirelessly detectable objects for use in medical procedures and methods of making same
AU2016200173B2 (en) 2015-01-21 2019-10-31 Covidien Lp Wirelessly detectable objects for use in medical procedures and methods of making same
US9690963B2 (en) 2015-03-02 2017-06-27 Covidien Lp Hand-held dual spherical antenna system
US10193209B2 (en) 2015-04-06 2019-01-29 Covidien Lp Mat based antenna and heater system, for use during medical procedures

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040250819A1 (en) * 2003-03-27 2004-12-16 Blair William A. Apparatus and method for detecting objects using tags and wideband detection device
US20060187059A1 (en) * 2005-02-10 2006-08-24 Fabian Carl E Surgical implement detector utilizing a radio-frequency identification marker
US8545416B1 (en) * 2005-11-04 2013-10-01 Cleveland Medical Devices Inc. Integrated diagnostic and therapeutic system and method for improving treatment of subject with complex and central sleep apnea
US20070285249A1 (en) * 2006-06-06 2007-12-13 Rf Surgical Systems, Inc. Method, apparatus and article for detection of transponder tagged objects, for example during surgery
US20080001735A1 (en) * 2006-06-30 2008-01-03 Bao Tran Mesh network personal emergency response appliance
US20100022900A1 (en) * 2008-01-04 2010-01-28 Peterson Stephen C Non-Invasive Method And Device For Measuring Cardiac Output
US20090322485A1 (en) * 2008-05-28 2009-12-31 Barnes Bruce E Method, apparatus and article for detection of transponder tagged objects, for example during surgery
US20100057167A1 (en) * 2008-09-02 2010-03-04 Xander Evers System and Method for the Interrogation of Implantable Medical Devices
US9792408B2 (en) * 2009-07-02 2017-10-17 Covidien Lp Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722323B2 (en) 2009-11-23 2020-07-28 Covidien Lp Method and apparatus to account for transponder tagged objects used during medical procedures
US11234787B1 (en) 2020-11-20 2022-02-01 Stryker Corporation Manifold for filtering medical waste being drawn under vacuum into a medical waste collection system
US11925489B1 (en) 2020-11-20 2024-03-12 Stryker Corporation Manifold for filtering medical waste being drawn under vacuum into a medical waste collection system and related methods
US11786647B1 (en) 2022-01-31 2023-10-17 Stryker Corporation Medical waste collection systems, manifolds, and related methods

Also Published As

Publication number Publication date
US20110004276A1 (en) 2011-01-06
US9792408B2 (en) 2017-10-17

Similar Documents

Publication Publication Date Title
US20180039753A1 (en) Method and apparatus to detect transponder tagged objects and to communicate with medical telemetry devices, for example during medical procedures
US10369067B2 (en) Method and apparatus to detect transponder tagged objects, for example during medical procedures
US10722323B2 (en) Method and apparatus to account for transponder tagged objects used during medical procedures
US10709521B2 (en) Method and apparatus to account for transponder tagged objects used during clinical procedures, employing a shielded receptacle
US12062437B2 (en) Method and apparatus to account for transponder tagged objects used during clinical procedures employing a shielded receptacle with antenna
CN109561943B (en) Method and apparatus for using a trocar to allow for transponder tagged objects used during clinical procedures
US8672842B2 (en) Smart mattress
US10835348B2 (en) Method and apparatus to account for transponder tagged objects used during clinical procedures, for example including count in and/or count out and presence detection

Legal Events

Date Code Title Description
AS Assignment

Owner name: RF SURGICAL SYSTEMS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BLAIR, WILLIAM A.;BARNES, BRUCE E.;POIRIER, DAVID A.;REEL/FRAME:044750/0834

Effective date: 20100112

Owner name: RF SURGICAL SYSTEMS LLC, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RF SURGICAL SYSTEMS, INC;REEL/FRAME:044750/0850

Effective date: 20151030

Owner name: RF SURGICAL SYSTEMS LLC, MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:RF SURGICAL SYSTEMS, INC;REEL/FRAME:045173/0786

Effective date: 20151030

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION